Protein,Protein_definition,Trait_category,Trait,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
CASQ2,Calsequestrin-2,Lifestyle factors,X1050.Time spend outdoors in summer,46804,-0.0135712141645633,0.0301804965044168,-0.0727249873132202,0.0455825589840936,0.652955128404159
CASQ2,Calsequestrin-2,Lifestyle factors,X1060.Time spent outdoors in winter,45011,0.0398411594741934,0.0342769866240796,-0.0273417343090025,0.107024053257389,0.245119106665699
CASQ2,Calsequestrin-2,Physical activities,X1070.Time spent watching television (TV),47804,-0.0294795663182659,0.030261138330409,-0.0887913974458675,0.0298322648093356,0.329983599621811
CASQ2,Calsequestrin-2,Physical activities,X1080.Time spent using computer,45015,-0.0405632785216325,0.0304787418629331,-0.100301612572981,0.0191750555297163,0.183250588855739
CASQ2,Calsequestrin-2,Physical activities,X1090.Time spent driving,41541,0.0134229071125552,0.0343566234868308,-0.0539160749216332,0.0807618891467437,0.696030596058873
CASQ2,Calsequestrin-2,Lifestyle factors,X1160.Sleep duration,48472,-0.00900676814496695,0.0271974819905415,-0.0623138328464282,0.0443002965564943,0.740525843289255
CASQ2,Calsequestrin-2,Health and medical history,X120039#0.Location of pain during the past week_None of the given areas,34588,0.016249808107835,0.0228343451808277,-0.0285055084465874,0.0610051246622574,0.476719191558154
CASQ2,Calsequestrin-2,Health and medical history,X120039#1.Location of pain during the past week_Left shoulder,34588,0.00870587173426432,0.0217676181027487,-0.0339586597471231,0.0513704032156517,0.689212129031913
CASQ2,Calsequestrin-2,Health and medical history,X120039#10.Location of pain during the past week_Upper right leg,34588,-0.00899899050896767,0.0237918461395299,-0.0556310089424463,0.037633027924511,0.705268364277721
CASQ2,Calsequestrin-2,Health and medical history,X120039#11.Location of pain during the past week_Lower left leg,34588,0.00158522928030431,0.0239726863494108,-0.0454012359645408,0.0485716945251494,0.947279582429719
CASQ2,Calsequestrin-2,Health and medical history,X120039#12.Location of pain during the past week_Lower right leg,34588,-0.0348839062952492,0.023991891038761,-0.0819080127312207,0.0121402001407223,0.146007991013978
CASQ2,Calsequestrin-2,Health and medical history,X120039#13.Location of pain during the past week_Left jaw pain,34588,-0.0697213656443332,0.0631219152129565,-0.193440319461728,0.0539975881730616,0.269403522649323
CASQ2,Calsequestrin-2,Health and medical history,X120039#14.Location of pain during the past week_Right jaw pain,34588,-0.0927260603462625,0.0631364730347625,-0.216473547494397,0.0310214268018719,0.141983139086062
CASQ2,Calsequestrin-2,Health and medical history,X120039#15.Location of pain during the past week_Chest pain,34588,-0.0287862556391822,0.0416528889910449,-0.11042591806163,0.0528534067832659,0.489533284380796
CASQ2,Calsequestrin-2,Health and medical history,X120039#16.Location of pain during the past week_Abdomen,34588,-0.0212266109452835,0.0299337542405504,-0.0798967692567623,0.0374435473661953,0.478280926934697
CASQ2,Calsequestrin-2,Health and medical history,X120039#17.Location of pain during the past week_Neck pain,34588,-0.00875175585481819,0.0195911273353704,-0.0471503654321441,0.0296468537225077,0.655094898971842
CASQ2,Calsequestrin-2,Health and medical history,X120039#18.Location of pain during the past week_Upper back,34588,-0.0412935312620755,0.0294439181634244,-0.0990036108623873,0.0164165483382362,0.16083939017814
CASQ2,Calsequestrin-2,Health and medical history,X120039#19.Location of pain during the past week_Lower back,34588,-0.00683317511667234,0.0158325349167288,-0.0378649435534608,0.0241985933201161,0.666056154643854
CASQ2,Calsequestrin-2,Health and medical history,X120039#2.Location of pain during the past week_Right shoulder,34588,0.0136582273504823,0.0205723144870469,-0.0266635090441297,0.0539799637450943,0.50677436119026
CASQ2,Calsequestrin-2,Health and medical history,X120039#3.Location of pain during the past week_Upper left arm,34588,-0.0492231644133504,0.0295287689612546,-0.107099551577409,0.00865322275070872,0.0955811699628017
CASQ2,Calsequestrin-2,Health and medical history,X120039#4.Location of pain during the past week_Upper right arm,34588,0.00569655469744288,0.02761539025497,-0.0484296102022984,0.0598227195971841,0.836578514934513
CASQ2,Calsequestrin-2,Health and medical history,X120039#5.Location of pain during the past week_Lower left arm,34588,-0.0364052634177153,0.0426525073015888,-0.120004177728829,0.0471936508933988,0.393402464390224
CASQ2,Calsequestrin-2,Health and medical history,X120039#6.Location of pain during the past week_Lower right arm,34588,-0.0146280156112691,0.0405225853717969,-0.0940522829399911,0.0647962517174528,0.718125348072904
CASQ2,Calsequestrin-2,Health and medical history,X120039#7.Location of pain during the past week_Left hip,34588,-0.00347056747964926,0.0213497937806785,-0.0453161632897791,0.0383750283304806,0.870873000858248
CASQ2,Calsequestrin-2,Health and medical history,X120039#8.Location of pain during the past week_Right hip,34588,-0.00844932265173634,0.020417079343647,-0.0484667981652845,0.0315681528618118,0.679010663067522
CASQ2,Calsequestrin-2,Health and medical history,X120039#9.Location of pain during the past week_Upper left leg,34588,-0.0313634129513058,0.0256266796852736,-0.0815917051344421,0.0188648792318305,0.221059314204393
CASQ2,Calsequestrin-2,Health and medical history,X120040.Fatigue severity over the past week,34594,-0.0685810396837861,0.0527622292074284,-0.171995008930346,0.0348329295627736,0.193720517056021
CASQ2,Calsequestrin-2,Health and medical history,X120041.Waking unrefreshed severity over the past week,34593,-0.0515271906428741,0.0517622438654936,-0.152981188619242,0.0499268073334934,0.319557711955563
CASQ2,Calsequestrin-2,Health and medical history,X120042.Cognitive symptoms severity over the past week,34592,-0.0403976691466334,0.0557186205433011,-0.149606165411503,0.0688108271182367,0.468465089994242
CASQ2,Calsequestrin-2,Health and medical history,X120098.Mobility problems today,34596,-0.0312669685539638,0.0572072089528138,-0.143393098101479,0.0808591609935511,0.584706087383795
CASQ2,Calsequestrin-2,Health and medical history,X120099.Self-care problems today,34596,-0.100694130078126,0.0958429982609852,-0.288546406669657,0.087158146513405,0.293482287293353
CASQ2,Calsequestrin-2,Health and medical history,X120100.Problems doing usual activities,34596,-0.0535378851140016,0.0567244992312616,-0.164717903607274,0.0576421333792711,0.345302355248611
CASQ2,Calsequestrin-2,Health and medical history,X120101.Pain or discomfort today,34596,-0.0374437830050493,0.0517636437354359,-0.138900524726504,0.0640129587164052,0.469489676601651
CASQ2,Calsequestrin-2,Health and medical history,X120102.Anxiety or depression today,34596,-0.0561518823476734,0.0686318824340328,-0.190670371918378,0.078366607223031,0.413301760773041
CASQ2,Calsequestrin-2,Health and medical history,X120103.Scale to indicate how health is today,34576,-0.00179171570817099,0.00696030241310436,-0.0154339084378555,0.0118504770215136,0.796864998370574
CASQ2,Calsequestrin-2,Health and medical history,X120104.Little interest or pleasure in doing things over the last two weeks,34574,-0.131448884734127,0.0734797963874838,-0.275469285653595,0.0125715161853416,0.073685260594269
CASQ2,Calsequestrin-2,Health and medical history,"X120105.Feeling down, depressed, or hopeless over the last two weeks",34564,-0.147121500182781,0.076999107187346,-0.298039750269979,0.0037967499044175,0.0560975211598134
CASQ2,Calsequestrin-2,Health and medical history,"X120106.Trouble falling or staying asleep, or sleeping too much over the last two weeks",34579,-0.0431698401582586,0.0530906428345341,-0.147227500113945,0.0608878197974282,0.416176836290043
CASQ2,Calsequestrin-2,Health and medical history,X120107.Feeling tired or having little energy over the last two weeks,34582,-0.0814902193092832,0.0546684247285417,-0.188640331777225,0.0256598931586585,0.136118061576449
CASQ2,Calsequestrin-2,Health and medical history,X120108.Poor appetite or overeating over the last two weeks,34588,-0.0248157117086149,0.0797052968449541,-0.181038093524725,0.131406670107495,0.755551674541156
CASQ2,Calsequestrin-2,Health and medical history,X120109.Feeling bad about self over the last two weeks,34572,-0.146465647022676,0.083236642423235,-0.309609466172217,0.0166781721268642,0.0785275255592991
CASQ2,Calsequestrin-2,Health and medical history,X120110.Trouble concentrating over the last two weeks,34584,-0.0905927956366759,0.079778937023762,-0.246959512203249,0.0657739209298976,0.256196378873115
CASQ2,Calsequestrin-2,Health and medical history,X120111.Moving or speaking slower or faster than usual over the last two weeks,34582,-0.0909758037627842,0.115652718539957,-0.317655132101101,0.135703524575532,0.431533578274042
CASQ2,Calsequestrin-2,Health and medical history,X120112.Thoughts of being better off dead or of hurting self over the last two weeks,34560,-0.239314459413385,0.188979857458627,-0.609714980032293,0.131086061205524,0.205443139355383
CASQ2,Calsequestrin-2,Health and medical history,"X120113.Level of difficultly depression has made to do work, take care of things at home, or get along with other people",32772,-0.112729604313657,0.0830787502750722,-0.275563954852799,0.0501047462254845,0.174898445948451
CASQ2,Calsequestrin-2,Lifestyle factors,X1269.Exposure to tobacco smoke at home,46946,-0.0882319187980152,0.0725549144351338,-0.230439551090877,0.053975713494847,0.223974092344053
CASQ2,Calsequestrin-2,Lifestyle factors,X1279.Exposure to tobacco smoke outside home,45481,0.0310947457603625,0.0405467941096593,-0.0483769706945697,0.110566462215295,0.443160751704469
CASQ2,Calsequestrin-2,Diet and food preferences,X1289.Cooked vegetable intake,48093,-0.050368589099505,0.0287424455828929,-0.106703782441975,0.00596660424296511,0.0797193100076113
CASQ2,Calsequestrin-2,Diet and food preferences,X1299.Salad  or  raw vegetable intake,47409,-0.0499505029302818,0.029789820487054,-0.108338551084908,0.00843754522434399,0.0936057717198117
CASQ2,Calsequestrin-2,Diet and food preferences,X1309.Fresh fruit intake,48037,0.0278399100095295,0.0293309206960143,-0.0296486945546586,0.0853285145737176,0.342548410838189
CASQ2,Calsequestrin-2,Diet and food preferences,X1319.Dried fruit intake,47037,-0.0101515881248053,0.0294089594327256,-0.0677931486129474,0.0474899723633368,0.729957920667018
CASQ2,Calsequestrin-2,Health and medical history,X134.Number of self-reported cancers,48651,-0.0526573979463956,0.0475625544999479,-0.145880004766294,0.0405652088735022,0.268256260097546
CASQ2,Calsequestrin-2,Health and medical history,X135.Number of self-reported non-cancer illnesses,48652,-0.0383835275181052,0.0285084166201398,-0.0942600240935792,0.0174929690573688,0.178191548803879
CASQ2,Calsequestrin-2,Health and medical history,"X136.Number of operations, self-reported",48652,-0.0434805045157561,0.0280973145860748,-0.0985512411044627,0.0115902320729506,0.121759758515785
CASQ2,Calsequestrin-2,Health and medical history,X137.Number of treatments or medications taken,48652,-0.0550879958810507,0.027915259636497,-0.109801904768585,-0.000374086993516543,0.0484640438322871
CASQ2,Calsequestrin-2,Diet and food preferences,X1438.Bread intake,48123,-0.00570154464358588,0.00384446773579022,-0.0132367014057347,0.00183361211856295,0.138077307721168
CASQ2,Calsequestrin-2,Diet and food preferences,X1458.Cereal intake,47849,-0.00453276640074393,0.0278250985890425,-0.0590699596352671,0.0500044268337793,0.870597298701483
CASQ2,Calsequestrin-2,Diet and food preferences,X1488.Tea intake,48050,0.00180541067759654,0.00374504479177753,-0.00553487711428743,0.00914569846948051,0.629754810082237
CASQ2,Calsequestrin-2,Diet and food preferences,X1498.Coffee intake,47213,-0.00608914951189866,0.028231938789098,-0.0614237495385307,0.0492454505147334,0.829237287614264
CASQ2,Calsequestrin-2,Diet and food preferences,X1528.Water intake,47109,-0.0222409692917076,0.0285648929149391,-0.0782281594049883,0.0337462208215731,0.436218573937955
CASQ2,Calsequestrin-2,Lifestyle factors,X1568.Average weekly red wine intake,42474,-0.0472484785449986,0.0329038373449468,-0.111739999741094,0.0172430426510972,0.151038280373938
CASQ2,Calsequestrin-2,Lifestyle factors,X1578.Average weekly champagne plus white wine intake,42477,-0.0290757164828047,0.0338790769937689,-0.0954787073905918,0.0373272744249823,0.390786236070389
CASQ2,Calsequestrin-2,Lifestyle factors,X1588.Average weekly beer plus cider intake,42518,0.0307301065618397,0.038081432796806,-0.0439095017199001,0.105369714843579,0.419705241814858
CASQ2,Calsequestrin-2,Lifestyle factors,X1598.Average weekly spirits intake,42460,0.00739594111323967,0.0352639551856216,-0.0617214110505787,0.076513293277058,0.833880926816521
CASQ2,Calsequestrin-2,Lifestyle factors,X1608.Average weekly fortified wine intake,42505,-0.0489959583464597,0.0548639027782399,-0.15652920779181,0.0585372910988906,0.371848983560229
CASQ2,Calsequestrin-2,Lifestyle factors,X1737.Childhood sunburn occasions,43378,-0.0046745534757259,0.0341920581542469,-0.0716909874580498,0.062341880506598,0.891258331037769
CASQ2,Calsequestrin-2,Health and medical history,X1807.Father's age at death,46878,-0.00452184045032319,0.00360282953241683,-0.0115833863338602,0.0025397054332138,0.209466188385647
CASQ2,Calsequestrin-2,Health and medical history,X1845.Mother's age,32062,0.00852818358969903,0.0170224262978313,-0.0248357719540503,0.0418921391334484,0.616411719500552
CASQ2,Calsequestrin-2,Health and medical history,X1873.Number of full brothers,48299,0.00260935025106353,0.0274518290415822,-0.0511962346704377,0.0564149351725647,0.924274549764299
CASQ2,Calsequestrin-2,Health and medical history,X1883.Number of full sisters,48304,0.0369979843858746,0.0268798216014922,-0.0156864659530502,0.0896824347247993,0.168707072710435
CASQ2,Calsequestrin-2,Physical measures,X20015.Sitting height,48516,0.00297722201521656,0.00479572039672299,-0.00642238996236049,0.0123768339927936,0.534733222976437
CASQ2,Calsequestrin-2,Cognitive function,X20016.Fluid intelligence score,35654,-0.0101544752520715,0.0446819397137262,-0.0977310770909748,0.0774221265868319,0.820227776701808
CASQ2,Calsequestrin-2,Cognitive function,X20018.Prospective memory result,35932,-0.0340697012507048,0.0560066495563859,-0.143842734381221,0.0757033318798116,0.542998889700717
CASQ2,Calsequestrin-2,Physical measures,X20019.Speech-reception-threshold (SRT) estimate (left),35537,0.000113209781070712,0.00637371631243812,-0.012379274191308,0.0126056937534494,0.985829299263419
CASQ2,Calsequestrin-2,Physical measures,X20021.Speech-reception-threshold (SRT) estimate (right),35518,-0.00178642254516044,0.00634673605225305,-0.0142260252075764,0.0106531801172555,0.778358328611193
CASQ2,Calsequestrin-2,Cognitive function,X20023.Mean time to correctly identify matches,48397,-5.71018543186548e-05,0.00391671529526635,-0.0077338638330407,0.00761966012440339,0.988368191865758
CASQ2,Calsequestrin-2,Health and medical history,X20107#1.Illnesses of father_Heart disease,45771,-0.0172134600106618,0.00818327717613053,-0.0332526832758776,-0.00117423674544597,0.0354377912292201
CASQ2,Calsequestrin-2,Health and medical history,X20107#10.Illnesses of father_Alzheimer's disease or dementia,45419,-0.000372755734612558,0.0170611137985394,-0.0338125387797498,0.0330670273105247,0.982569262165199
CASQ2,Calsequestrin-2,Health and medical history,X20107#11.Illnesses of father_Parkinson's disease,45383,0.030776819155319,0.0231406665200228,-0.0145788872239256,0.0761325255345636,0.183540814336726
CASQ2,Calsequestrin-2,Health and medical history,X20107#12.Illnesses of father_Severe depression,45393,-0.0260314733375181,0.0216753072976308,-0.0685150756408745,0.0164521289658382,0.229778975333873
CASQ2,Calsequestrin-2,Health and medical history,X20107#13.Illnesses of father_Prostate cancer,45417,-0.00413133722173202,0.0152223045344694,-0.033967054109292,0.025704379665828,0.786086664767835
CASQ2,Calsequestrin-2,Health and medical history,X20107#2.Illnesses of father_Stroke,45556,0.0164203047906729,0.0103007935977031,-0.00376925066082505,0.0366098602421709,0.110937090874139
CASQ2,Calsequestrin-2,Health and medical history,X20107#3.Illnesses of father_Lung cancer,45520,0.026688019797192,0.0124478849774726,0.00229016524134563,0.0510858743530383,0.0320491915674433
CASQ2,Calsequestrin-2,Health and medical history,X20107#4.Illnesses of father_Bowel cancer,45426,-0.00187378716905535,0.0161703721451674,-0.0335677165735835,0.0298201422354728,0.907750822670063
CASQ2,Calsequestrin-2,Health and medical history,X20107#6.Illnesses of father_Chronic bronchitis or emphysema,45565,0.0234163448028223,0.0110082814873693,0.00184011308757852,0.044992576518066,0.0334219343166796
CASQ2,Calsequestrin-2,Health and medical history,X20107#8.Illnesses of father_High blood pressure,45558,2.88533142371402e-05,0.0102469342656581,-0.0200551378464527,0.020112844474927,0.997753354200487
CASQ2,Calsequestrin-2,Health and medical history,X20107#9.Illnesses of father_Diabetes,45450,0.0123636935256309,0.0147049125284849,-0.0164579350301995,0.0411853220814612,0.400479857579918
CASQ2,Calsequestrin-2,Health and medical history,X20110#1.Illnesses of mother_Heart disease,46689,0.00329112748035427,0.0088449760523855,-0.0140450255823213,0.0206272805430299,0.70983031953029
CASQ2,Calsequestrin-2,Health and medical history,X20110#10.Illnesses of mother_Alzheimer's disease or dementia,46559,-0.00394895423598239,0.0115611065561037,-0.0266087230859457,0.0187108146139809,0.732676887991619
CASQ2,Calsequestrin-2,Health and medical history,X20110#11.Illnesses of mother_Parkinson's disease,46483,-0.0351585663489472,0.0256272778329958,-0.0853880309016189,0.0150708982037246,0.170106249714705
CASQ2,Calsequestrin-2,Health and medical history,X20110#12.Illnesses of mother_Severe depression,46504,-0.010414307637985,0.016056121910817,-0.0418843065831863,0.0210556913072163,0.516593199296792
CASQ2,Calsequestrin-2,Health and medical history,X20110#2.Illnesses of mother_Stroke,46645,-0.00219339557561023,0.00963389653171268,-0.0210758327777671,0.0166890416265466,0.81990172305376
CASQ2,Calsequestrin-2,Health and medical history,X20110#3.Illnesses of mother_Lung cancer,46521,0.0285571439416686,0.0187423977160179,-0.00817795558172641,0.0652922434650637,0.127610553183903
CASQ2,Calsequestrin-2,Health and medical history,X20110#4.Illnesses of mother_Bowel cancer,46507,0.0129961888917341,0.015807600168945,-0.017986707439398,0.0439790852228663,0.411003918908322
CASQ2,Calsequestrin-2,Health and medical history,X20110#5.Illnesses of mother_Breast cancer,46513,0.010095174822975,0.0138112010898053,-0.0169747793130434,0.0371651289589935,0.464825005092687
CASQ2,Calsequestrin-2,Health and medical history,X20110#6.Illnesses of mother_Chronic bronchitis or emphysema,46554,0.00159850778100584,0.0155738846069294,-0.0289263060485758,0.0321233216105874,0.918249663229725
CASQ2,Calsequestrin-2,Health and medical history,X20110#8.Illnesses of mother_High blood pressure,46679,-0.0109348586090954,0.00858829073748651,-0.0277679084545689,0.00589819123637819,0.202953811329958
CASQ2,Calsequestrin-2,Health and medical history,X20110#9.Illnesses of mother_Diabetes,46569,0.00538752607427569,0.0131978543843762,-0.0204802685191017,0.0312553206676531,0.683122872264095
CASQ2,Calsequestrin-2,Health and medical history,X20111#1.Illnesses of siblings_Heart disease,43532,-0.0198733704522072,0.0112613412306489,-0.041945599264279,0.00219885835986466,0.0776282945000043
CASQ2,Calsequestrin-2,Health and medical history,X20111#10.Illnesses of siblings_Alzheimer's disease or dementia,43379,-0.024311251787569,0.0393493747688598,-0.101436026334534,0.0528135227593962,0.536696862199813
CASQ2,Calsequestrin-2,Health and medical history,X20111#11.Illnesses of siblings_Parkinson's disease,43372,-0.0328347023062883,0.0418051112718305,-0.114772720399076,0.0491033157864995,0.432218634913364
CASQ2,Calsequestrin-2,Health and medical history,X20111#12.Illnesses of siblings_Severe depression,43404,0.0165876002927078,0.017307953800529,-0.0173359891563291,0.0505111897417447,0.337887379066913
CASQ2,Calsequestrin-2,Health and medical history,X20111#13.Illnesses of siblings_Prostate cancer,43393,-0.0389699454864979,0.0235063799078366,-0.0850424501058576,0.00710255913286189,0.0973707506337487
CASQ2,Calsequestrin-2,Health and medical history,X20111#2.Illnesses of siblings_Stroke,43427,-0.000869601868232627,0.0186351171030255,-0.0373944313901626,0.0356552276536973,0.96278113170761
CASQ2,Calsequestrin-2,Health and medical history,X20111#3.Illnesses of siblings_Lung cancer,43395,-0.00793046840184762,0.0210966345319541,-0.0492798720844776,0.0334189352807824,0.706988275241237
CASQ2,Calsequestrin-2,Health and medical history,X20111#4.Illnesses of siblings_Bowel cancer,43388,-0.0166152387188892,0.0212740039312412,-0.0583122864241219,0.0250818089863435,0.434808839415853
CASQ2,Calsequestrin-2,Health and medical history,X20111#5.Illnesses of siblings_Breast cancer,43408,0.031555234177381,0.0171751440856568,-0.00210804823050622,0.0652185165852683,0.0661921364355667
CASQ2,Calsequestrin-2,Health and medical history,X20111#6.Illnesses of siblings_Chronic bronchitis or emphysema,43425,-0.0391745951490493,0.0204962077118372,-0.0793471622642502,0.000997971966151624,0.0559848937147315
CASQ2,Calsequestrin-2,Health and medical history,X20111#8.Illnesses of siblings_High blood pressure,43565,-0.0129791199082526,0.00947621170382337,-0.0315524948477464,0.00559425503124122,0.17081670898881
CASQ2,Calsequestrin-2,Health and medical history,X20111#9.Illnesses of siblings_Diabetes,43475,-0.00760015186168158,0.0130120877099474,-0.0331038437731785,0.0179035400498153,0.559173043863146
CASQ2,Calsequestrin-2,Mental health,X20127.Neuroticism score,44482,-0.00712176129091404,0.0282880092980035,-0.0625662595150008,0.0483227369331728,0.801230726655585
CASQ2,Calsequestrin-2,Cognitive function,X20128.Number of fluid intelligence questions attempted within time limit,35654,0.029381749507731,0.0442590788680343,-0.0573660450736162,0.116129544089078,0.506804845628274
CASQ2,Calsequestrin-2,Lifestyle factors,X20161.Pack years of smoking,35808,0.00443143393232892,0.00617599462102648,-0.00767351552488297,0.0165363833895408,0.473075214013324
CASQ2,Calsequestrin-2,Lifestyle factors,X20162.Pack years adult smoking as proportion of life span exposed to smoking,35808,0.00473589231671159,0.00638479128491159,-0.00777829860171513,0.0172500832351383,0.458267679359328
CASQ2,Calsequestrin-2,Cognitive function,X20191.Fluid intelligence score,33497,-0.00934192059483022,0.0508265176834303,-0.108961895254354,0.0902780540646932,0.854178938136045
CASQ2,Calsequestrin-2,Cognitive function,X20192.Number of fluid intelligence questions attempted within time limit,33498,0.0377825758306237,0.0521961538249835,-0.0645218856663441,0.140087037327591,0.469192693246677
CASQ2,Calsequestrin-2,Cognitive function,X20240.Maximum digits remembered correctly,32961,-0.113170097070963,0.0550128124234207,-0.220995209420868,-0.00534498472105883,0.0397397860563103
CASQ2,Calsequestrin-2,Physical measures,X20255.Spirometry QC measure,43572,-0.000482614159514547,0.035606387270125,-0.0702711332089595,0.0693059048899304,0.989185875599364
CASQ2,Calsequestrin-2,Eye measures,X20261.avMSE,33613,-0.0102613206938566,0.00742516442660074,-0.0248146429699941,0.00429200158228085,0.167052162604974
CASQ2,Calsequestrin-2,Eye measures,X20262.Myopia diagnosis,33613,0.101560704622553,0.0658353545659349,-0.0274765903266794,0.230597999571785,0.12298809530075
CASQ2,Calsequestrin-2,NMR metabolomics,X20280.Glucose-lactate,40089,-0.00885149795353244,0.00489396999449668,-0.0184436791427459,0.000740683235681047,0.0705323446518258
CASQ2,Calsequestrin-2,NMR metabolomics,X20281.Spectrometer-corrected alanine,40110,-0.00736327289084382,0.00500555001275076,-0.0171741509158353,0.00244760513414767,0.141314062249596
CASQ2,Calsequestrin-2,Mental health,X20544#11.Mental health problems ever diagnosed by a professional_Depression,35234,-0.0196044417850075,0.0305852092051193,-0.0795514518270413,0.0403425682570263,0.521561389632172
CASQ2,Calsequestrin-2,Mental health,X20544#6.Mental health problems ever diagnosed by a professional_Panic attacks,35234,0.0270775847943634,0.0591361703097385,-0.088829309012724,0.142984478601451,0.647051298886586
CASQ2,Calsequestrin-2,Mental health,X20546#1.Substances taken for depression_Unprescribed medication (more than once),35234,-0.098763352298923,0.0947857047341495,-0.284543333577856,0.0870166289800101,0.297469778670579
CASQ2,Calsequestrin-2,Mental health,X20546#3.Substances taken for depression_Medication prescribed to you (for at least two weeks),35234,-0.00111148806126691,0.0281635388428431,-0.0563120241932395,0.0540890480707057,0.968520565715027
CASQ2,Calsequestrin-2,Mental health,X20546#4.Substances taken for depression_Drugs or alcohol (more than once),35234,-0.0686529571505005,0.0601661278894021,-0.186578567813729,0.0492726535127276,0.253891610130151
CASQ2,Calsequestrin-2,Mental health,X20548#1.Manifestations of mania or irritability_I was more talkative than usual,35237,0.042887163779131,0.0714144061171223,-0.0970850722104288,0.182859399768691,0.54816933970288
CASQ2,Calsequestrin-2,Mental health,X20548#2.Manifestations of mania or irritability_I was more restless than usual,35237,-0.0140790098099893,0.047600284085222,-0.107375566617024,0.0792175469970458,0.767411504808423
CASQ2,Calsequestrin-2,Mental health,X20548#3.Manifestations of mania or irritability_My thoughts were racing,35237,-0.0512522732847913,0.0556325260533224,-0.160292024349303,0.0577874777797207,0.356949108305043
CASQ2,Calsequestrin-2,Mental health,X20548#5.Manifestations of mania or irritability_I needed less sleep than usual,35237,-0.0899506950375973,0.0864551687582015,-0.259402825803672,0.0795014357284775,0.29818102165013
CASQ2,Calsequestrin-2,Mental health,X20548#6.Manifestations of mania or irritability_I was more creative or had more ideas than usual,35237,-0.145413585262864,0.0998003348145282,-0.341022241499339,0.0501950709736111,0.145155899401678
CASQ2,Calsequestrin-2,Mental health,X20548#7.Manifestations of mania or irritability_I was easily distracted,35237,-0.0223652740365688,0.0598232307232424,-0.139618806254124,0.0948882581809863,0.708524565421125
CASQ2,Calsequestrin-2,Mental health,X20548#8.Manifestations of mania or irritability_I was more confident than usual,35237,-0.0447370821631486,0.0979959157809624,-0.236809077093835,0.147334912767538,0.64803259711201
CASQ2,Calsequestrin-2,Mental health,X20548#9.Manifestations of mania or irritability_I was more active than usual,35237,-0.0654402953739066,0.0707783067928592,-0.204165776687911,0.0732851859400975,0.355220687665638
CASQ2,Calsequestrin-2,Mental health,X20549#1.Substances taken for anxiety_Unprescribed medication (more than once),35237,-0.117729331175414,0.103655721550146,-0.3208945454137,0.0854358830628716,0.256096777687836
CASQ2,Calsequestrin-2,Mental health,X20549#3.Substances taken for anxiety_Medication prescribed to you (for at least two weeks),35237,-0.00473248586534723,0.0387718294848637,-0.0807252716556801,0.0712602999249856,0.902855633328726
CASQ2,Calsequestrin-2,Mental health,X20549#4.Substances taken for anxiety_Drugs or alcohol (more than once),35237,-0.0427739888508556,0.0720952974510804,-0.184080771854973,0.098532794153262,0.553004005293432
CASQ2,Calsequestrin-2,Mental health,X20553#4.Methods of self-harm used_Ingesting a medication in excess of the normal dose,35238,0.0725606253302616,0.119027409890079,-0.160733098054294,0.305854348714817,0.542141286909349
CASQ2,Calsequestrin-2,Diet and food preferences,X20600.Liking for adding salt to foods,35142,-0.0573723362579169,0.0473558560362411,-0.150189814088949,0.0354451415731158,0.225746239403929
CASQ2,Calsequestrin-2,Diet and food preferences,X20601.Liking for aniseed,35142,0.0281786097529103,0.047157792405983,-0.0642506633628165,0.120607882868637,0.550170505113957
CASQ2,Calsequestrin-2,Diet and food preferences,X20602.Liking for apple juice,35142,0.0205977340843254,0.0481306363038412,-0.0737383130712033,0.114933781239854,0.668699587750029
CASQ2,Calsequestrin-2,Diet and food preferences,X20603.Liking for apples,35142,0.0176951701297153,0.0491696161342518,-0.0786772774934182,0.114067617752849,0.718949538342251
CASQ2,Calsequestrin-2,Diet and food preferences,X20604.Liking for asparagus,35142,0.0394577813954205,0.0479878592100934,-0.0545984226563627,0.133513985447204,0.410970433130894
CASQ2,Calsequestrin-2,Diet and food preferences,X20605.Liking for aubergine,35142,-0.018240555168093,0.0488010864933355,-0.113890684695031,0.0774095743588446,0.708586144237173
CASQ2,Calsequestrin-2,Diet and food preferences,X20606.Liking for avocados,35142,0.0127310488960763,0.0481857275942345,-0.0817129771886233,0.107175074980776,0.791628907470026
CASQ2,Calsequestrin-2,Diet and food preferences,X20607.Liking for bacon,35142,-0.0663240979954391,0.0503180443633597,-0.164947464947624,0.0322992689567459,0.187521783030021
CASQ2,Calsequestrin-2,Diet and food preferences,X20608.Liking for baked or steamed fish,35142,0.0392400203411782,0.0484961301365187,-0.0558123947263985,0.134292435408755,0.418468677242122
CASQ2,Calsequestrin-2,Diet and food preferences,X20609.Liking for bananas,35142,0.0220685947143041,0.0489308089562323,-0.0738357908399113,0.117972980268519,0.651994233396129
CASQ2,Calsequestrin-2,Diet and food preferences,X20610.Liking for barbequed or grilled meat,35142,-0.124256822303981,0.0491545599910024,-0.220599759886346,-0.0279138847216167,0.0115010745462797
CASQ2,Calsequestrin-2,Diet and food preferences,X20611.Liking for beef steak,35142,-0.154666558605518,0.0492145646231263,-0.251127105266846,-0.0582060119441908,0.0016822187642111
CASQ2,Calsequestrin-2,Diet and food preferences,X20612.Liking for beetroot,35142,-0.0184442518707307,0.0487456259464539,-0.11398567872578,0.077097174984319,0.705163646537746
CASQ2,Calsequestrin-2,Diet and food preferences,X20613.Liking for bell pepper,35142,0.00291071487437264,0.0474677679781586,-0.0901261103628183,0.0959475401115636,0.951106571680934
CASQ2,Calsequestrin-2,Diet and food preferences,X20614.Liking for bicycling,35142,-0.0156769887400371,0.0478151188397002,-0.109394621665849,0.0780406441857753,0.743023954420491
CASQ2,Calsequestrin-2,Diet and food preferences,X20615.Liking for biscuits,35142,-0.0126684377859235,0.0488520512112515,-0.108418458159976,0.0830815825881294,0.7953953810791
CASQ2,Calsequestrin-2,Diet and food preferences,X20616.Liking for bitter foods,35142,0.0779037164600991,0.0491202015501447,-0.0183718785781844,0.174179311498383,0.112796811228381
CASQ2,Calsequestrin-2,Diet and food preferences,X20617.Liking for bitter or ale,35142,0.0153934992282209,0.049699649508525,-0.0820178138084881,0.11280481226493,0.756776743884461
CASQ2,Calsequestrin-2,Diet and food preferences,X20618.Liking for black olives,35142,0.0499913582086026,0.0483802545765332,-0.0448339407614025,0.144816657178608,0.301505203350996
CASQ2,Calsequestrin-2,Diet and food preferences,X20619.Liking for black pepper,35142,0.00223808738398336,0.0475461647227449,-0.0909523954725967,0.0954285702405634,0.962457521300068
CASQ2,Calsequestrin-2,Diet and food preferences,X20620.Liking for blue cheese,35142,-0.020233759519319,0.0493000629509521,-0.116861882903185,0.0763943638645472,0.681512270910893
CASQ2,Calsequestrin-2,Diet and food preferences,X20621.Liking for bolognese sauce,35142,-0.0451074128449037,0.0479121873402579,-0.139015300031809,0.0488004743420018,0.346507417208137
CASQ2,Calsequestrin-2,Diet and food preferences,X20622.Liking for broad beans,35142,0.0647469661721387,0.0479803014603448,-0.0292944246901372,0.158788357034415,0.177244253214959
CASQ2,Calsequestrin-2,Diet and food preferences,X20623.Liking for broccoli,35142,0.0533473031184094,0.0496937991722109,-0.0440525432591239,0.150747149495943,0.283081342604038
CASQ2,Calsequestrin-2,Diet and food preferences,X20624.Liking for brown rice,35142,0.109224078676295,0.048241331157034,0.014671069608508,0.203777087744081,0.023602751636384
CASQ2,Calsequestrin-2,Diet and food preferences,X20625.Liking for brussel sprouts,35142,0.0172821731011262,0.048881581249259,-0.0785257261474213,0.113090072349674,0.723687319683716
CASQ2,Calsequestrin-2,Diet and food preferences,X20626.Liking for burgers (meat),35142,-0.10695748017098,0.0476366862921394,-0.200325385303573,-0.0135895750383866,0.0247870980552023
CASQ2,Calsequestrin-2,Diet and food preferences,X20627.Liking for burn of spicy foods,35142,-0.00562009592113415,0.0494006363944414,-0.102445343254239,0.091205151411971,0.909427407900361
CASQ2,Calsequestrin-2,Diet and food preferences,X20628.Liking for butter on bread,35142,0.0178366662188376,0.0497408691807991,-0.0796554373755287,0.115328769813204,0.719913251882139
CASQ2,Calsequestrin-2,Diet and food preferences,X20629.Liking for butternut squash,35142,0.0721212944791489,0.0480947514646009,-0.0221444183914689,0.166387007349767,0.133779795746209
CASQ2,Calsequestrin-2,Diet and food preferences,X20630.Liking for cabbage,35142,0.0216603467710843,0.0473264153004654,-0.0710994272178278,0.114420120759996,0.647199207639874
CASQ2,Calsequestrin-2,Diet and food preferences,X20631.Liking for cake,35142,0.0894760171773059,0.0487813502207392,-0.00613542925534287,0.185087463609955,0.0666704666642321
CASQ2,Calsequestrin-2,Diet and food preferences,X20632.Liking for cake icing,35142,0.000959388403686244,0.0486087917270787,-0.0943138433813879,0.0962326201887604,0.984253892265893
CASQ2,Calsequestrin-2,Diet and food preferences,X20633.Liking for capers,35142,-0.0082480710402802,0.0490928446049388,-0.10447004646596,0.0879739043853998,0.866581417723475
CASQ2,Calsequestrin-2,Diet and food preferences,X20634.Liking for cauliflower,35142,0.00210281161308058,0.0481130446215838,-0.0921987558452237,0.0964043790713848,0.965140509334697
CASQ2,Calsequestrin-2,Diet and food preferences,X20635.Liking for cereal or granola bar,35142,0.0793171831089649,0.0484553358382919,-0.0156552751340873,0.174289641352017,0.101701571150837
CASQ2,Calsequestrin-2,Diet and food preferences,X20636.Liking for cheesecake,35142,-0.0458350746582846,0.0482292104340868,-0.140364327109095,0.0486941777925255,0.34196843090735
CASQ2,Calsequestrin-2,Diet and food preferences,X20637.Liking for cherries,35142,0.042262293346435,0.051033889833245,-0.0577641307267252,0.142288717419595,0.407634616133478
CASQ2,Calsequestrin-2,Diet and food preferences,X20638.Liking for chicken,35142,-0.00968541518030773,0.051659475621135,-0.110937987397732,0.0915671570371169,0.851286205436615
CASQ2,Calsequestrin-2,Diet and food preferences,X20639.Liking for chilli pepper,35142,-0.0328133178363614,0.0480803699010111,-0.127050842842343,0.0614242071696205,0.494969635578246
CASQ2,Calsequestrin-2,Diet and food preferences,X20640.Liking for chips or french fries,35142,-0.0248074409483598,0.0485374728624621,-0.119940887758786,0.0703260058620659,0.609300921021766
CASQ2,Calsequestrin-2,Diet and food preferences,X20641.Liking for cigarette smoking,35142,-0.0955421398489549,0.0797963329095844,-0.25194295235174,0.0608586726538304,0.231227712187932
CASQ2,Calsequestrin-2,Diet and food preferences,X20642.Liking for cod,35142,-0.0627894328053666,0.0490492207040411,-0.158925905385287,0.033347039774554,0.200549030715018
CASQ2,Calsequestrin-2,Diet and food preferences,X20643.Liking for coffee with sugar,35142,-0.0158664152284752,0.0530112134195545,-0.119768393530802,0.0880355630738515,0.764719338624111
CASQ2,Calsequestrin-2,Diet and food preferences,X20644.Liking for coffee without sugar,35142,-0.0181157028198542,0.0488903477832476,-0.11394078447502,0.0777093788353112,0.710995322619382
CASQ2,Calsequestrin-2,Diet and food preferences,X20645.Liking for coriander,35142,0.0174402384337222,0.0478062485866906,-0.0762600087961913,0.111140485663636,0.715265590797802
CASQ2,Calsequestrin-2,Diet and food preferences,X20646.Liking for corn flakes,35142,0.0430024874998049,0.049016803215691,-0.0530704468029495,0.139075421802559,0.380358688378666
CASQ2,Calsequestrin-2,Diet and food preferences,X20647.Liking for cream,35142,-0.0541356174396417,0.0477322173906618,-0.147690763525339,0.0394195286460555,0.256776327498214
CASQ2,Calsequestrin-2,Diet and food preferences,X20648.Liking for croissant,35142,0.00882418109675733,0.0485312397854058,-0.086297048882638,0.103945411076153,0.855726456817295
CASQ2,Calsequestrin-2,Diet and food preferences,X20649.Liking for cucumber,35142,0.00398630998378819,0.0474587595952768,-0.0890328588229543,0.0970054787905307,0.933063045919053
CASQ2,Calsequestrin-2,Diet and food preferences,X20650.Liking for curry,35142,0.00964493719318845,0.0484129590273666,-0.0852444625004502,0.104534336886827,0.842095738376873
CASQ2,Calsequestrin-2,Diet and food preferences,X20651.Liking for dairy products,35142,0.0738425536569236,0.050036538691426,-0.0242290621782714,0.171914169492119,0.140057957487541
CASQ2,Calsequestrin-2,Diet and food preferences,X20652.Liking for dark chocolate,35142,0.0869473717820663,0.0487716363399515,-0.00864503544423864,0.182539779008371,0.074678950108686
CASQ2,Calsequestrin-2,Diet and food preferences,X20653.Liking for diet fizzy drinks,35142,-0.0380158036120458,0.0500663521123099,-0.136145853752173,0.0601142465280815,0.447698206899321
CASQ2,Calsequestrin-2,Diet and food preferences,X20654.Liking for dried fruit,35142,0.0125022032730258,0.0479543071788793,-0.0814882387975777,0.106492645343629,0.794324616174736
CASQ2,Calsequestrin-2,Diet and food preferences,X20655.Liking for eggs,35142,0.0369822182571348,0.0489740000459551,-0.0590068218329373,0.132971258347207,0.450195029165942
CASQ2,Calsequestrin-2,Diet and food preferences,X20656.Liking for exercising alone,35142,-0.0214426234556953,0.0479684460491774,-0.115460777712083,0.0725755308006923,0.654880401566781
CASQ2,Calsequestrin-2,Diet and food preferences,X20657.Liking for exercising with others,35142,0.0690647768620233,0.0469326848870347,-0.0229232855165648,0.161052839240611,0.141189751766593
CASQ2,Calsequestrin-2,Diet and food preferences,X20658.Liking for extra virgin olive oil,35142,0.0437229012684547,0.0489986674519884,-0.0523144869374426,0.139760289474352,0.372253102428127
CASQ2,Calsequestrin-2,Diet and food preferences,X20659.Liking for fatty foods,35142,-0.0246966438704327,0.0477414495979969,-0.118269885082506,0.0688765973416412,0.604966136204236
CASQ2,Calsequestrin-2,Diet and food preferences,X20660.Liking for fresh tomatoes,35142,-0.00140768052916895,0.0519207126298051,-0.103172277283587,0.100356916225249,0.978371219827997
CASQ2,Calsequestrin-2,Diet and food preferences,X20661.Liking for fried chicken,35142,-0.0639603868814111,0.0497621118686635,-0.161494126143991,0.0335733523811693,0.198729555420576
CASQ2,Calsequestrin-2,Diet and food preferences,X20662.Liking for fried or battered fish,35142,0.00581168146248717,0.0498339760639874,-0.0918629116229281,0.103486274547902,0.907164444781347
CASQ2,Calsequestrin-2,Diet and food preferences,X20663.Liking for fruit,35142,-0.0129231272377644,0.05422367360354,-0.119201527500703,0.093355273025174,0.811633390068925
CASQ2,Calsequestrin-2,Diet and food preferences,X20664.Liking for garlic,35142,-0.0516578917602032,0.0474241252707939,-0.144609177290959,0.0412933937705528,0.276077037709868
CASQ2,Calsequestrin-2,Diet and food preferences,X20665.Liking for gherkins,35142,-0.0481894863879967,0.0483275083260945,-0.142911402707142,0.0465324299311485,0.318735228451684
CASQ2,Calsequestrin-2,Diet and food preferences,X20666.Liking for globe artichoke,35142,0.0420962606744418,0.0490551024832151,-0.0540517401926598,0.138244261541543,0.390848497610904
CASQ2,Calsequestrin-2,Diet and food preferences,X20667.Liking for goat's cheese,35142,-0.00443004078933453,0.0473409922512954,-0.0972183856018735,0.0883583040232044,0.925448123245202
CASQ2,Calsequestrin-2,Diet and food preferences,X20668.Liking for going to a cafe,35142,0.0882015980988188,0.047353083111923,-0.0046104448005502,0.181013640998188,0.0625627130225055
CASQ2,Calsequestrin-2,Diet and food preferences,X20669.Liking for going to the gym,35142,0.00406152481602536,0.0472160626859584,-0.0884819580484532,0.0966050076805039,0.931453433232989
CASQ2,Calsequestrin-2,Diet and food preferences,X20670.Liking for going to the pub,35142,0.00831098802840527,0.0468743789057703,-0.0835627946269045,0.100184770683715,0.859276105233496
CASQ2,Calsequestrin-2,Diet and food preferences,X20671.Liking for grapefruit,35142,0.0434081192394664,0.0469625005146917,-0.0486383817693294,0.135454620248262,0.355360158669284
CASQ2,Calsequestrin-2,Diet and food preferences,X20672.Liking for green olives,35142,0.0240434490026768,0.0481633053379838,-0.0703566294597715,0.118443527465125,0.617652203187669
CASQ2,Calsequestrin-2,Diet and food preferences,X20673.Liking for haddock,35142,-0.0466898252563978,0.0499422292143902,-0.144576594516603,0.051196944003807,0.349889867273443
CASQ2,Calsequestrin-2,Diet and food preferences,X20674.Liking for ham,35142,-0.0686324519877401,0.0479895530448302,-0.162691975955607,0.0254270719801271,0.152725425279502
CASQ2,Calsequestrin-2,Diet and food preferences,X20675.Liking for hard cheese,35142,-0.0156020546884218,0.0507062421681279,-0.114986289337953,0.083782179961109,0.758325251720372
CASQ2,Calsequestrin-2,Diet and food preferences,X20676.Liking for herring,35142,-0.070084694858191,0.0489969840283626,-0.166118783553782,0.0259493938373996,0.152658316511967
CASQ2,Calsequestrin-2,Diet and food preferences,X20677.Liking for honey,35142,0.0804116215705429,0.0510027738690407,-0.0195538152127769,0.180377058353863,0.11493792696276
CASQ2,Calsequestrin-2,Diet and food preferences,X20678.Liking for horseradish or wasabi,35142,-0.0659978032218669,0.0495026003270949,-0.163022899862973,0.031027293419239,0.182511108910336
CASQ2,Calsequestrin-2,Diet and food preferences,X20679.Liking for ice cream,35142,0.096635845657118,0.0488180776076098,0.000952413546202874,0.192319277768033,0.0478047775620919
CASQ2,Calsequestrin-2,Diet and food preferences,X20680.Liking for jam,35142,0.0725714888813321,0.0485316987364265,-0.0225506406420639,0.167693618404728,0.134878333397114
CASQ2,Calsequestrin-2,Diet and food preferences,X20681.Liking for kiwi fruit,35142,0.0137618170793491,0.0471369108173378,-0.0786265281226328,0.106150162281331,0.770331872086404
CASQ2,Calsequestrin-2,Diet and food preferences,X20682.Liking for lager,35142,-0.0223352604775647,0.0477365823205962,-0.115898961825933,0.0712284408708039,0.63988355502356
CASQ2,Calsequestrin-2,Diet and food preferences,X20683.Liking for lamb,35142,-0.0561679278957834,0.0506709698876542,-0.155483028875586,0.0431471730840188,0.267698000373714
CASQ2,Calsequestrin-2,Diet and food preferences,X20684.Liking for lemons,35142,0.00372577200649229,0.0479277890345805,-0.0902126945012855,0.0976642385142701,0.938039722950145
CASQ2,Calsequestrin-2,Diet and food preferences,X20685.Liking for lentils or beans,35142,0.0208061881127872,0.0480701043705893,-0.0734112164535678,0.115023592679142,0.665153920853102
CASQ2,Calsequestrin-2,Diet and food preferences,X20686.Liking for liver,35142,-0.166507530184455,0.0479963692482993,-0.260580413911122,-0.0724346464577885,0.000525777876611324
CASQ2,Calsequestrin-2,Diet and food preferences,X20687.Liking for mackerel,35142,0.0072473952707644,0.049319802029424,-0.0894194167069066,0.103914207248435,0.883178868559964
CASQ2,Calsequestrin-2,Diet and food preferences,X20688.Liking for marzipan,35142,0.0788267685378881,0.0474940039563293,-0.0142614792165173,0.171915016292293,0.0970235036885623
CASQ2,Calsequestrin-2,Diet and food preferences,X20689.Liking for mayonnaise,35142,0.0149699569472371,0.0490962373625037,-0.0812586682832702,0.111198582177744,0.76044502358426
CASQ2,Calsequestrin-2,Diet and food preferences,X20690.Liking for melon,35142,0.0393934138834025,0.0488930158768629,-0.0564368972352487,0.135223725002054,0.420444438374789
CASQ2,Calsequestrin-2,Diet and food preferences,X20691.Liking for milk chocolate,35142,0.0247966740407124,0.0489621653674688,-0.0711691700795264,0.120762518160951,0.612562657705174
CASQ2,Calsequestrin-2,Diet and food preferences,X20692.Liking for mushrooms,35142,0.122179674347984,0.049764050795005,0.0246421347897742,0.219717213906194,0.0141098917363234
CASQ2,Calsequestrin-2,Diet and food preferences,X20694.Liking for orange juice,35142,-0.028893779268377,0.0483314200892123,-0.123623362643233,0.0658358041064792,0.549978838521963
CASQ2,Calsequestrin-2,Diet and food preferences,X20695.Liking for oranges,35142,-0.0282195683294399,0.0482631632167406,-0.122815368234251,0.0663762315753716,0.558770316057889
CASQ2,Calsequestrin-2,Diet and food preferences,X20696.Liking for pasta,35142,0.0559807388209222,0.0492749167028853,-0.0405980979167331,0.152559575558577,0.255964751991142
CASQ2,Calsequestrin-2,Diet and food preferences,X20697.Liking for pears,35142,-0.00239423072927851,0.048732594516831,-0.0979101159822672,0.0931216545237102,0.960817374597842
CASQ2,Calsequestrin-2,Diet and food preferences,X20698.Liking for pizza,35142,-0.0292578449779886,0.0481739742243744,-0.123678834457762,0.0651631445017853,0.543650397452029
CASQ2,Calsequestrin-2,Diet and food preferences,X20699.Liking for plain yogurt,35142,-0.0250070989762832,0.0481849505781043,-0.119449602109368,0.0694354041568013,0.603792964506925
CASQ2,Calsequestrin-2,Diet and food preferences,X20700.Liking for plums,35142,-0.00799912684165015,0.0489238954152922,-0.103889961855623,0.0878917081723225,0.870129210932232
CASQ2,Calsequestrin-2,Diet and food preferences,X20701.Liking for pollock,35142,-0.0131365085637095,0.0471320992949771,-0.105515423181865,0.0792424060544457,0.780471861580701
CASQ2,Calsequestrin-2,Diet and food preferences,X20702.Liking for pork chop,35142,-0.114953448601639,0.0496328130729196,-0.212233762224561,-0.0176731349787164,0.0205879104792657
CASQ2,Calsequestrin-2,Diet and food preferences,X20703.Liking for porridge,35142,0.0564815491224076,0.0497074716351623,-0.0409450952825104,0.153908193527326,0.255885723599408
CASQ2,Calsequestrin-2,Diet and food preferences,X20704.Liking for potato crisps,35142,0.0105803655667664,0.0473065723706552,-0.0821405162797177,0.103301247413251,0.823033223975239
CASQ2,Calsequestrin-2,Diet and food preferences,X20705.Liking for potatoes,35142,0.0293967593748303,0.0488998059394574,-0.0664468602665061,0.125240379016167,0.54775429231834
CASQ2,Calsequestrin-2,Diet and food preferences,X20706.Liking for prawns,35142,-0.0365113719675427,0.04996885000389,-0.134450317975167,0.0614275740400817,0.465001835946562
CASQ2,Calsequestrin-2,Diet and food preferences,X20707.Liking for raw carrots,35142,-0.0224614507838027,0.0484092711741922,-0.117343622285219,0.072420720717614,0.642671426753375
CASQ2,Calsequestrin-2,Diet and food preferences,X20708.Liking for red meat,35142,-0.129655929605599,0.0491295105081263,-0.225949770201527,-0.0333620890096719,0.00833523544686322
CASQ2,Calsequestrin-2,Diet and food preferences,X20709.Liking for red wine,35142,-0.0594855550355817,0.0488008977794902,-0.155135314683383,0.0361642046122191,0.222913911181949
CASQ2,Calsequestrin-2,Diet and food preferences,X20710.Liking for regular (non-diet) fizzy drinks,35142,0.014723694672756,0.0498322525067759,-0.0829475202405247,0.112394909586037,0.767648888887032
CASQ2,Calsequestrin-2,Diet and food preferences,X20711.Liking for roast chicken,35142,-0.0391633441240495,0.0519005188095385,-0.140888360990745,0.0625616727426459,0.450528048334158
CASQ2,Calsequestrin-2,Diet and food preferences,X20712.Liking for salad dressing,35142,0.0888866644379785,0.0484649849795124,-0.00610470612186581,0.183878034997823,0.0666982361966613
CASQ2,Calsequestrin-2,Diet and food preferences,X20713.Liking for salad leaves,35142,0.0649698224990578,0.0482906731414959,-0.0296798968582742,0.15961954185639,0.178550461572385
CASQ2,Calsequestrin-2,Diet and food preferences,X20714.Liking for salami,35142,-0.0101973768968319,0.0495163425864029,-0.107249408366182,0.0868546545725177,0.836845133260715
CASQ2,Calsequestrin-2,Diet and food preferences,X20715.Liking for salmon,35142,-0.0256768406811651,0.0517081105314515,-0.12702473732281,0.0756710559604798,0.619508724290615
CASQ2,Calsequestrin-2,Diet and food preferences,X20716.Liking for salty foods,35142,-0.0049075234838881,0.0474876425644421,-0.0979833029101947,0.0881682559424185,0.917694104149707
CASQ2,Calsequestrin-2,Diet and food preferences,X20717.Liking for salty pretzels,35142,0.0281035962335845,0.0469675348971957,-0.0639527721649191,0.120159964632088,0.549621118425477
CASQ2,Calsequestrin-2,Diet and food preferences,X20718.Liking for sardines,35142,-0.037011466202053,0.0481755342112143,-0.131435513256033,0.0574125808519271,0.442361673268817
CASQ2,Calsequestrin-2,Diet and food preferences,X20719.Liking for sausages (meat),35142,-0.14587611417069,0.0493196742355652,-0.242542675672398,-0.0492095526689821,0.00311097361880043
CASQ2,Calsequestrin-2,Diet and food preferences,X20720.Liking for savoury biscuits,35142,-0.000334953879794144,0.0484758838904161,-0.0953476863050097,0.0946777785454214,0.994487131926381
CASQ2,Calsequestrin-2,Diet and food preferences,X20721.Liking for shellfish (other than prawns),35142,-0.0786562138051573,0.0501442116973541,-0.176938868731971,0.0196264411216568,0.116794430910439
CASQ2,Calsequestrin-2,Diet and food preferences,X20722.Liking for skimmed milk,35142,-0.0165638278067025,0.0476733761813768,-0.110003645122201,0.0768759895087961,0.728270105508569
CASQ2,Calsequestrin-2,Diet and food preferences,X20723.Liking for smoked fish,35142,-0.0709116219743421,0.0477733269916939,-0.164547342878062,0.0227240989293779,0.137773135262788
CASQ2,Calsequestrin-2,Diet and food preferences,X20724.Liking for soft cheese,35142,0.0124397521004621,0.0479677417115326,-0.0815770216541418,0.106456525855066,0.795385157187338
CASQ2,Calsequestrin-2,Diet and food preferences,X20725.Liking for soy sauce,35142,-0.00361671613306715,0.0470054275264911,-0.0957473540849898,0.0885139218188555,0.938671862072758
CASQ2,Calsequestrin-2,Diet and food preferences,X20726.Liking for soya milk,35142,-0.0446282480094378,0.0483626125079079,-0.139418968524937,0.0501624725060616,0.356157234637182
CASQ2,Calsequestrin-2,Diet and food preferences,X20727.Liking for spicy foods,35142,-0.0274345759644997,0.0485925647500924,-0.122676002874681,0.0678068509456814,0.572378193302162
CASQ2,Calsequestrin-2,Diet and food preferences,X20728.Liking for spinach,35142,0.0772496292966985,0.0483854158296027,-0.0175857857293228,0.17208504432272,0.110419745630561
CASQ2,Calsequestrin-2,Diet and food preferences,X20729.Liking for spirits,35142,-0.0863049328906794,0.0483657501000282,-0.181101803086735,0.00849193730537583,0.0744060694308729
CASQ2,Calsequestrin-2,Diet and food preferences,X20730.Liking for strawberries,35142,-0.0517029609857352,0.0523403189765235,-0.154289986179721,0.0508840642082509,0.32327967604355
CASQ2,Calsequestrin-2,Diet and food preferences,X20731.Liking for sweet coffee house drinks,35142,-0.0343412388964634,0.0486640932584022,-0.129722861682932,0.0610403838900049,0.480415330335662
CASQ2,Calsequestrin-2,Diet and food preferences,X20732.Liking for sweet foods,35142,0.0800727848663347,0.0474316318901244,-0.0128932136383091,0.173038783370979,0.0914305893377581
CASQ2,Calsequestrin-2,Diet and food preferences,X20733.Liking for taking the stairs,35142,0.0198093392921515,0.0484453960353638,-0.0751436369371616,0.114762315521465,0.68262753760279
CASQ2,Calsequestrin-2,Diet and food preferences,X20734.Liking for tea with sugar,35142,-0.056403665526383,0.0592151080801531,-0.172465277363483,0.059657946310717,0.340871314416686
CASQ2,Calsequestrin-2,Diet and food preferences,X20735.Liking for tea without sugar,35142,-0.0887295045656662,0.0490400916978902,-0.184848084293531,0.00738907516219858,0.0704509373775745
CASQ2,Calsequestrin-2,Diet and food preferences,X20736.Liking for tomato ketchup,35142,-0.0428594359076716,0.0481153992005186,-0.137165618340688,0.0514467465253449,0.373092204891302
CASQ2,Calsequestrin-2,Diet and food preferences,X20737.Liking for tinned tuna,35142,0.0570874220309022,0.0500820832513173,-0.0410734611416798,0.155248305203484,0.254383456923739
CASQ2,Calsequestrin-2,Diet and food preferences,X20738.Liking for turnip (white),35142,0.0363273467228966,0.0465390548882355,-0.054889200858045,0.127543894303838,0.435082043063589
CASQ2,Calsequestrin-2,Diet and food preferences,X20739.Liking for vegetables,35142,-0.00313444867186235,0.052646134903338,-0.106320873082405,0.10005197573868,0.952525555920512
CASQ2,Calsequestrin-2,Diet and food preferences,X20740.Liking for vinegar,35142,0.0123211738991557,0.0488094808062433,-0.0833454084810812,0.107987756279393,0.800714335839602
CASQ2,Calsequestrin-2,Diet and food preferences,X20741.Liking for watching television,35142,0.0555777075873503,0.0478889195367146,-0.0382845747046104,0.149439989879311,0.24586971055049
CASQ2,Calsequestrin-2,Diet and food preferences,X20742.Liking for whisky,35142,-0.0427301185701641,0.0491981427371715,-0.13915847833502,0.0536982411946919,0.385138732542122
CASQ2,Calsequestrin-2,Diet and food preferences,X20743.Liking for white bread,35142,0.0106277476919115,0.046817916186013,-0.081135368032674,0.102390863416497,0.820430214554757
CASQ2,Calsequestrin-2,Diet and food preferences,X20744.Liking for white rice,35142,0.0442859853083945,0.0484366278051351,-0.0506498051896703,0.139221775806459,0.360592264782352
CASQ2,Calsequestrin-2,Diet and food preferences,X20745.Liking for white wine,35142,-0.0494505878434908,0.0484938681485706,-0.144498569414689,0.0455973937277077,0.307898695445403
CASQ2,Calsequestrin-2,Diet and food preferences,X20746.Liking for whole grain breakfast cereal,35142,0.16778416027947,0.0502320592129604,0.0693293242220676,0.266238996336873,0.000842401547430676
CASQ2,Calsequestrin-2,Diet and food preferences,X20747.Liking for whole milk,35142,-0.0168471454614111,0.0479437471097376,-0.110816889796497,0.0771225988736746,0.725305242274521
CASQ2,Calsequestrin-2,Diet and food preferences,X20748.Liking for wholemeal bread,35142,0.0809180387148817,0.0506405131935615,-0.0183373671444988,0.180173444574262,0.110120354655189
CASQ2,Calsequestrin-2,Diet and food preferences,X20749.Liking for working up a sweat,35142,0.0603072702627948,0.0482514615931023,-0.0342655944596858,0.154880134985275,0.211402225451459
CASQ2,Calsequestrin-2,Physical measures,X21001.Body mass index (BMI),48565,-0.00718953830477773,0.0168360705351983,-0.0401882365537664,0.025809159944211,0.669360877417429
CASQ2,Calsequestrin-2,Physical measures,X21002.Weight,48579,0.00319206039808431,0.00902834340325981,-0.0145034926723049,0.0208876134684735,0.723672558440462
CASQ2,Calsequestrin-2,Physical measures,X21021.Pulse wave Arterial Stiffness index,35895,0.00382424023277345,0.00600729991737432,-0.00795006760528023,0.0155985480708271,0.524407917516957
CASQ2,Calsequestrin-2,Health and medical history,X21025.Frequency of discomfort or pain in abdomen in last 3 months,34972,0.104760833225849,0.0497560562454011,0.00723896298486336,0.202282703466836,0.0352918393355519
CASQ2,Calsequestrin-2,Health and medical history,X21033.Frequency of hard or lumpy stools in the last 3 months,34987,0.000838138509841535,0.0501903341452824,-0.097534916414912,0.099211193434595,0.986677159450318
CASQ2,Calsequestrin-2,Health and medical history,X21034.Frequency of loose or mushy or watery stools in the last 3 months,34989,0.0407168061851383,0.0509943853142019,-0.0592321890306975,0.140665801400974,0.424638275610072
CASQ2,Calsequestrin-2,Health and medical history,X21040.Satisfaction with bowel habits,34945,-0.0213216478791455,0.045500752218765,-0.110503122227925,0.0678598264696338,0.639373438169072
CASQ2,Calsequestrin-2,Health and medical history,X21041.Degree to which abdominal pain or discomfort or altered bowel habits affect or interfere with life in general,34926,-0.0435748010465271,0.0506517011106742,-0.142852135223449,0.0557025331303943,0.389669058344778
CASQ2,Calsequestrin-2,Health and medical history,X21042.Greatest number of times bowels opened per day,34947,-0.020363566834584,0.0491902998629213,-0.11677655456591,0.0760494208967418,0.678907665487708
CASQ2,Calsequestrin-2,Health and medical history,X21043.Least number of times bowels opened per week,34889,0.0381846680759818,0.0491374887622437,-0.0581248098980159,0.134494146049979,0.437132949993384
CASQ2,Calsequestrin-2,Health and medical history,X21044.Average number of times bowels opened per day,34916,-0.0724419222258868,0.0584847060773084,-0.187071946137411,0.0421881016856378,0.215527031142929
CASQ2,Calsequestrin-2,Health and medical history,X21048.Degree bothered by back pain in the past 3 months,34990,0.0217804627530138,0.0497406471508202,-0.0757112056625937,0.119272131168621,0.661489183619128
CASQ2,Calsequestrin-2,Health and medical history,X21049.Degree bothered by pain in arms or legs or joints in the past 3 months,34987,0.00734359134104708,0.0497660316447302,-0.0901978306826242,0.104885013364718,0.882693325958332
CASQ2,Calsequestrin-2,Health and medical history,X21050.Degree bothered by menstrual cramps or other problems with period in the last 3 months,32244,0.0921094713222221,0.0930816642243317,-0.0903305905574681,0.274549533201912,0.322469958655749
CASQ2,Calsequestrin-2,Health and medical history,X21051.Degree bothered by headaches in the last 3 months,34989,0.0321014669879822,0.0585423250910599,-0.0826414901904952,0.14684442416646,0.583475272169761
CASQ2,Calsequestrin-2,Health and medical history,X21052.Degree bothered by chest pain in the last 3 months,34988,-0.108656550679564,0.0710280134141372,-0.247871456971273,0.0305583556121452,0.1261281772552
CASQ2,Calsequestrin-2,Health and medical history,X21053.Degree bothered by dizziness in the last 3 months,34985,0.0107641461757388,0.0586069993762841,-0.104105572601778,0.125633864953256,0.854281472446381
CASQ2,Calsequestrin-2,Health and medical history,X21054.Degree bothered by fainting spells in the last 3 months,34985,0.0226054770805561,0.150314707010204,-0.272011348659443,0.317222302820556,0.880464014775452
CASQ2,Calsequestrin-2,Health and medical history,X21055.Degree bothered by feeling heart pound or race in the last 3 months,34991,0.0721813963403903,0.0625591939558662,-0.0504346238131074,0.194797416493888,0.248625826767936
CASQ2,Calsequestrin-2,Health and medical history,X21056.Degree bothered by shortness of breath in the last 3 months,34988,0.0242644982648128,0.0551158757140774,-0.0837626181347789,0.132291614664405,0.659775970375774
CASQ2,Calsequestrin-2,Health and medical history,X21057.Degree bothered by pain or problems during intercourse in the last 3 months,34856,-0.0175004874648087,0.0523309368937851,-0.120069123776627,0.0850681488470101,0.738075392872406
CASQ2,Calsequestrin-2,Health and medical history,X21058.Degree bothered by urinary frequency or bladder irritability in the last 3 months,34985,0.00711482943382792,0.0515820530950584,-0.0939859946324865,0.108215653500142,0.890298746432828
CASQ2,Calsequestrin-2,Health and medical history,X21059.Degree bothered by nausea in the last 3 months,34987,0.144695437409289,0.0894354733110286,-0.0305980902803274,0.319988965098905,0.10574394000785
CASQ2,Calsequestrin-2,Health and medical history,X21060.Degree bothered by feeling tired all the time in the last 3 months,34992,0.0539944453308638,0.0505832366775318,-0.0451486985570985,0.153137589218826,0.285818758016301
CASQ2,Calsequestrin-2,Health and medical history,X21061.Degree bothered by trouble sleeping in the last 3 months,34991,-0.0186777799318075,0.050250124861356,-0.117168024660065,0.0798124647964502,0.710132649665039
CASQ2,Calsequestrin-2,Working and living environment,X21100.Water hardness (USGS classification),48533,-0.0130368729152572,0.0270600752083013,-0.0660746203235277,0.0400008744930133,0.629971106982389
CASQ2,Calsequestrin-2,Lifestyle factors,X2139.Age first had sexual intercourse,45382,-0.00131074682512766,0.0041983481063852,-0.00953950911364265,0.00691801546338734,0.754888472217546
CASQ2,Calsequestrin-2,Health and medical history,X2149.Lifetime number of sexual partners,44377,0.00666795163039694,0.0305328096372778,-0.0531763552586675,0.0665122585194613,0.827130964396736
CASQ2,Calsequestrin-2,Physical activities,X22032.IPAQ activity group,44360,-0.00849683278607683,0.0309284964643649,-0.069116685856232,0.0521230202840783,0.783531225414237
CASQ2,Calsequestrin-2,Physical activities,X22033.Summed days activity,44778,0.0012745446699141,0.00405638643495212,-0.00667597274259206,0.00922506208242025,0.753368096600812
CASQ2,Calsequestrin-2,Physical activities,X22034.Summed minutes activity,44360,-0.00181449683483547,0.00404672882124239,-0.00974608532447055,0.00611709165479961,0.653880998520642
CASQ2,Calsequestrin-2,Physical activities,X22037.MET minutes per week for walking,43540,-0.00108157606702953,0.00431671956086389,-0.00954234640632275,0.00737919427226369,0.802161693680808
CASQ2,Calsequestrin-2,Physical activities,X22038.MET minutes per week for moderate activity,44360,0.00204820474502422,0.00394408904721183,-0.00568220978751096,0.00977861927755941,0.603552183611726
CASQ2,Calsequestrin-2,Physical activities,X22039.MET minutes per week for vigorous activity,44360,0.0155519775520223,0.0308251104355997,-0.0448652389017531,0.0759691940057977,0.613901226008172
CASQ2,Calsequestrin-2,Physical activities,X22040.Summed MET minutes per week for all activity,43540,0.000638266132903518,0.00419253131275912,-0.00757909524010435,0.00885562750591139,0.879000696456764
CASQ2,Calsequestrin-2,Eye measures,X2217.Age started wearing glasses or contact lenses,46983,0.000908228915781481,0.00342729436945732,-0.00580926804835487,0.00762572587991783,0.791013452004931
CASQ2,Calsequestrin-2,Working and living environment,X22501.Year ended full time education,33352,0.0060958536175354,0.0176471882037096,-0.0284926352617354,0.0406843424968062,0.729789222561013
CASQ2,Calsequestrin-2,Lifestyle factors,X22506.Tobacco smoking,33329,0.155988742706615,0.123004099654895,-0.0850992926169788,0.397076778030209,0.204812644466926
CASQ2,Calsequestrin-2,Lifestyle factors,X2277.Frequency of solarium or sunlamp use,47551,-0.210867174913471,0.120610646213318,-0.447264041491574,0.0255296916646325,0.0804236699064164
CASQ2,Calsequestrin-2,Physical measures,X23098.Weight,48170,0.00195043992038903,0.00914515768118842,-0.0159740691347403,0.0198749489755183,0.831114216052081
CASQ2,Calsequestrin-2,Physical measures,X23099.Body fat percentage,48162,0.00276780120166219,0.00873527911899691,-0.0143533458715717,0.0198889482748961,0.751358476464413
CASQ2,Calsequestrin-2,Physical measures,X23100.Whole body fat mass,48149,0.000708461749787442,0.00860830406450094,-0.0161638142166344,0.0175807377162093,0.934409178109886
CASQ2,Calsequestrin-2,Physical measures,X23101.Whole body fat-free mass,48169,0.00141645588930464,0.00744273518543757,-0.013171305074153,0.0160042168527623,0.849065205385263
CASQ2,Calsequestrin-2,Physical measures,X23102.Whole body water mass,48170,0.0019307868895513,0.00746562118587725,-0.0127018306347681,0.0165634044138707,0.795928367657573
CASQ2,Calsequestrin-2,Physical measures,X23104.Body mass index (BMI),48170,-0.014692080772221,0.0168249389980826,-0.0476689612084629,0.0182847996640208,0.382547503272424
CASQ2,Calsequestrin-2,Physical measures,X23105.Basal metabolic rate,48170,0.0020182012983027,0.0079484201569134,-0.0135607022092476,0.017597104805853,0.799566096653763
CASQ2,Calsequestrin-2,Physical measures,X23106.Impedance of whole body,48167,0.0025695242710536,0.00609660474324864,-0.00937982102571373,0.0145188695678209,0.673418092618546
CASQ2,Calsequestrin-2,Physical measures,X23107.Impedance of leg (right),48170,-0.000891481775809595,0.00493941826123533,-0.0105727415678308,0.00878977801621165,0.856775207460685
CASQ2,Calsequestrin-2,Physical measures,X23108.Impedance of leg (left),48170,0.000612179897087064,0.0049071913573259,-0.00900591516327171,0.0102302749574458,0.900721539290242
CASQ2,Calsequestrin-2,Physical measures,X23109.Impedance of arm (right),48168,0.00647417359773983,0.0060118981432045,-0.00530914676294099,0.0182574939584207,0.281541571310731
CASQ2,Calsequestrin-2,Physical measures,X23110.Impedance of arm (left),48170,0.00220395683808906,0.00602692469900782,-0.00960881557196626,0.0140167292481444,0.714604107534666
CASQ2,Calsequestrin-2,Physical measures,X23111.Leg fat percentage (right),48170,-0.00319370464264664,0.0102703750532174,-0.0233236397469526,0.0169362304616594,0.755832313106634
CASQ2,Calsequestrin-2,Physical measures,X23112.Leg fat mass (right),48170,0.00183991770118879,0.011267664021613,-0.0202447037811726,0.0239245391835502,0.870290389585516
CASQ2,Calsequestrin-2,Physical measures,X23113.Leg fat-free mass (right),48169,0.00406625257474873,0.0075909520627173,-0.0108120134681772,0.0189445186176746,0.592192255863222
CASQ2,Calsequestrin-2,Physical measures,X23114.Leg predicted mass (right),48169,0.00369411245245233,0.0076348101757548,-0.0112701154920271,0.0186583403969317,0.628497023347203
CASQ2,Calsequestrin-2,Physical measures,X23115.Leg fat percentage (left),48167,-0.00157133034249099,0.0108083262188636,-0.0227556497314637,0.0196129890464817,0.884411239203934
CASQ2,Calsequestrin-2,Physical measures,X23116.Leg fat mass (left),48167,0.000261389185659587,0.011807211046589,-0.0228807444656549,0.0234035228369741,0.982338029557091
CASQ2,Calsequestrin-2,Physical measures,X23117.Leg fat-free mass (left),48166,0.00272343501345023,0.00797585859632367,-0.0129092478353442,0.0183561178622446,0.732761251225625
CASQ2,Calsequestrin-2,Physical measures,X23118.Leg predicted mass (left),48166,0.00204196889501528,0.0080269068778622,-0.0136907685855946,0.0177747063756252,0.799196642638118
CASQ2,Calsequestrin-2,Physical measures,X23119.Arm fat percentage (right),48166,0.00509702360445554,0.00979271446821562,-0.0140966967532471,0.0242907439621582,0.60272719846901
CASQ2,Calsequestrin-2,Physical measures,X23120.Arm fat mass (right),48164,4.04447334796416e-05,0.00980812412148928,-0.0191834785446393,0.0192643680115986,0.996709899744833
CASQ2,Calsequestrin-2,Physical measures,X23121.Arm fat-free mass (right),48165,-0.00353538257360452,0.00759570395688094,-0.0184229623290912,0.0113521971818821,0.641618144159395
CASQ2,Calsequestrin-2,Physical measures,X23122.Arm predicted mass (right),48165,-0.00660793841803474,0.00761393078711973,-0.0215312427607894,0.00831536592471993,0.385473870995813
CASQ2,Calsequestrin-2,Physical measures,X23123.Arm fat percentage (left),48164,0.000518278207466878,0.0100281845525432,-0.0191369635155178,0.0201735199304515,0.958782499130916
CASQ2,Calsequestrin-2,Physical measures,X23124.Arm fat mass (left),48164,-0.00208157798414159,0.00980230654983674,-0.0212940988218216,0.0171309428535384,0.831831641194779
CASQ2,Calsequestrin-2,Physical measures,X23125.Arm fat-free mass (left),48164,0.000320200180332891,0.00776193082385643,-0.0148931842344257,0.0155335845950915,0.967094918499075
CASQ2,Calsequestrin-2,Physical measures,X23126.Arm predicted mass (left),48162,0.0010419793967202,0.00776601161369544,-0.0141794033661229,0.0162633621595633,0.893268184780249
CASQ2,Calsequestrin-2,Physical measures,X23127.Trunk fat percentage,48162,0.00263156433172069,0.0062417986132718,-0.00960236095029202,0.0148654896137334,0.673319206591402
CASQ2,Calsequestrin-2,Physical measures,X23128.Trunk fat mass,48162,0.00212976310119726,0.00698321063606564,-0.0115573297454914,0.0158168559478859,0.760382165709465
CASQ2,Calsequestrin-2,Physical measures,X23129.Trunk fat-free mass,48161,0.00102522060406809,0.00671756267466011,-0.0121412022382657,0.0141916434464019,0.878701196917457
CASQ2,Calsequestrin-2,Physical measures,X23130.Trunk predicted mass,48158,0.000720273656653674,0.00674931551339278,-0.0125083847495962,0.0139489320629035,0.91501380711216
CASQ2,Calsequestrin-2,NMR metabolomics,X23400.Total Cholesterol,40116,0.00182545733700192,0.00489892845539927,-0.00777644243558066,0.0114273571095845,0.709435687057901
CASQ2,Calsequestrin-2,NMR metabolomics,X23401.Total Cholesterol Minus HDL-C,40116,0.00379720871198157,0.0047467847199202,-0.00550648933906203,0.0131009067630252,0.423754934220523
CASQ2,Calsequestrin-2,NMR metabolomics,"X23402.Remnant Cholesterol (Non-HDL, Non-LDL -Cholesterol)",40116,0.00318140965822532,0.00473968106232787,-0.00610836522393729,0.0124711845403879,0.502089083409772
CASQ2,Calsequestrin-2,NMR metabolomics,X23403.VLDL Cholesterol,40116,0.00244700583748902,0.0048109576463737,-0.00698247114940344,0.0118764828243815,0.611020638874187
CASQ2,Calsequestrin-2,NMR metabolomics,X23404.Clinical LDL Cholesterol,40116,0.00484765764513265,0.00474195444126937,-0.00444657305975532,0.0141418883500206,0.306665804034862
CASQ2,Calsequestrin-2,NMR metabolomics,X23405.LDL Cholesterol,40116,0.00430699856707705,0.00476219849162816,-0.00502691047651414,0.0136409076106682,0.36579591220284
CASQ2,Calsequestrin-2,NMR metabolomics,X23406.HDL Cholesterol,40116,-0.00756556049812612,0.00551122842195193,-0.0183675682051519,0.00323644720889967,0.169857041154115
CASQ2,Calsequestrin-2,NMR metabolomics,X23407.Total Triglycerides,40116,-0.0027879734730732,0.00518070210356394,-0.0129421495960585,0.00736620264991213,0.590487308341666
CASQ2,Calsequestrin-2,NMR metabolomics,X23408.Triglycerides in VLDL,40116,-0.00279588287543893,0.00515999268530708,-0.0129094685386408,0.00731770278776295,0.587940795786664
CASQ2,Calsequestrin-2,NMR metabolomics,X23409.Triglycerides in LDL,40116,-0.000927553566641348,0.00516378866695394,-0.0110485793538711,0.00919347222058838,0.857449088422203
CASQ2,Calsequestrin-2,NMR metabolomics,X23410.Triglycerides in HDL,40116,-0.00557422737463408,0.00506793871689595,-0.0155073872597501,0.00435893251048198,0.271399800931435
CASQ2,Calsequestrin-2,NMR metabolomics,X23411.Total Phospholipids in Lipoprotein Particles,40116,-0.00373291397197364,0.00508175690213512,-0.0136931575001585,0.00622732955621119,0.462616248848735
CASQ2,Calsequestrin-2,NMR metabolomics,X23412.Phospholipids in VLDL,40116,0.000300838463480974,0.00496287727696753,-0.00942640099937538,0.0100280779263373,0.951664744643272
CASQ2,Calsequestrin-2,NMR metabolomics,X23413.Phospholipids in LDL,40116,0.0044167764694145,0.00473688584725165,-0.00486751979119873,0.0137010727300277,0.351139101996636
CASQ2,Calsequestrin-2,NMR metabolomics,X23414.Phospholipids in HDL,40116,-0.0114803096479124,0.00545377006080982,-0.0221696989670997,-0.000790920328725193,0.035312113949929
CASQ2,Calsequestrin-2,NMR metabolomics,X23415.Total Esterified Cholesterol,40116,0.00167791745918945,0.00492488166489316,-0.00797485060400115,0.01133068552238,0.733334420659503
CASQ2,Calsequestrin-2,NMR metabolomics,X23416.Cholesteryl Esters in VLDL,40116,0.00334521222457253,0.00475454031953212,-0.00597368680171042,0.0126641112508555,0.481707698296511
CASQ2,Calsequestrin-2,NMR metabolomics,X23417.Cholesteryl Esters in LDL,40116,0.00382527602420339,0.00476721042559188,-0.0055184564099567,0.0131690084583635,0.422331020350796
CASQ2,Calsequestrin-2,NMR metabolomics,X23418.Cholesteryl Esters in HDL,40116,-0.0074949371339344,0.00548105894690538,-0.0182378126698689,0.00324793840200014,0.171520263060679
CASQ2,Calsequestrin-2,NMR metabolomics,X23419.Total Free Cholesterol,40116,0.00215140984058328,0.00484073032084107,-0.00733642158826522,0.0116392412694318,0.656733953746385
CASQ2,Calsequestrin-2,NMR metabolomics,X23420.Free Cholesterol in VLDL,40116,0.00109178347677957,0.00490742166028198,-0.00852676297737311,0.0107103299309323,0.823947524551212
CASQ2,Calsequestrin-2,NMR metabolomics,X23421.Free Cholesterol in LDL,40116,0.00543055048745891,0.00477238618458192,-0.00392332643432166,0.0147844274092395,0.255182630000457
CASQ2,Calsequestrin-2,NMR metabolomics,X23422.Free Cholesterol in HDL,40116,-0.00705508453637375,0.0055607551624428,-0.0179541646547616,0.00384399558201415,0.204565210593142
CASQ2,Calsequestrin-2,NMR metabolomics,X23423.Total Lipids in Lipoprotein Particles,40116,-0.0010608782245176,0.00488806295238689,-0.0106414816111959,0.0085197251621607,0.828185524216164
CASQ2,Calsequestrin-2,NMR metabolomics,X23424.Total Lipids in VLDL,40116,-0.000596401340880323,0.00502493459422447,-0.0104452731455603,0.00925247046379963,0.905524426504827
CASQ2,Calsequestrin-2,NMR metabolomics,X23425.Total Lipids in LDL,40116,0.00402435326236527,0.00476008068509489,-0.00530540488042071,0.0133541114051512,0.397884835972061
CASQ2,Calsequestrin-2,NMR metabolomics,X23426.Total Lipids in HDL,40116,-0.0102405847198665,0.00549025018440531,-0.021001475081301,0.000520305641567863,0.0621758289353178
CASQ2,Calsequestrin-2,NMR metabolomics,X23427.Total Concentration of Lipoprotein Particles,40116,-0.00690228937924448,0.00517552358386855,-0.0170463156036268,0.00324173684513787,0.182349417861169
CASQ2,Calsequestrin-2,NMR metabolomics,X23428.Concentration of VLDL Particles,40116,0.00194136513613691,0.00489596618411773,-0.00765472858473384,0.0115374588570076,0.691726698828175
CASQ2,Calsequestrin-2,NMR metabolomics,X23429.Concentration of LDL Particles,40116,0.00467921176387708,0.00471688836173797,-0.00456588942512934,0.0139243129528835,0.321213450818102
CASQ2,Calsequestrin-2,NMR metabolomics,X23430.Concentration of HDL Particles,40116,-0.00832816867027439,0.00518547718018854,-0.0184917039434439,0.00183536660289515,0.108290433395478
CASQ2,Calsequestrin-2,NMR metabolomics,X23431.Average Diameter for VLDL Particles,40116,-0.00394216414535049,0.00526582337944615,-0.014263177969065,0.00637884967836396,0.454095130735611
CASQ2,Calsequestrin-2,NMR metabolomics,X23432.Average Diameter for LDL Particles,40116,0.00471669833119301,0.00499947556108883,-0.00508227376854109,0.0145156704309271,0.345477464434577
CASQ2,Calsequestrin-2,NMR metabolomics,X23433.Average Diameter for HDL Particles,40116,-0.00563727399157141,0.0056572265842875,-0.0167254380967749,0.0054508901136321,0.319042416813461
CASQ2,Calsequestrin-2,NMR metabolomics,X23434.Phosphoglycerides,40105,-0.0066652856810182,0.00518412655122168,-0.0168261737214127,0.00349560235937629,0.198571418738284
CASQ2,Calsequestrin-2,NMR metabolomics,X23435.Triglycerides to Phosphoglycerides ratio,40105,-0.00073686983424804,0.00540717669232119,-0.0113349361511976,0.0098611964827015,0.891605402148933
CASQ2,Calsequestrin-2,NMR metabolomics,X23436.Total Cholines,40105,-0.0055176448266312,0.00519415741075732,-0.0156981933517156,0.00466290369845315,0.288132513264683
CASQ2,Calsequestrin-2,NMR metabolomics,X23437.Phosphatidylcholines,40105,-0.0070453602948995,0.0052326661003123,-0.0173013858515116,0.00321066526171261,0.178195442832104
CASQ2,Calsequestrin-2,NMR metabolomics,X23438.Sphingomyelins,40105,0.00154335690067028,0.00509948497399839,-0.00845163364836657,0.0115383474497071,0.762162707935102
CASQ2,Calsequestrin-2,NMR metabolomics,X23439.Apolipoprotein B,40116,0.00447609717278557,0.00471700696731539,-0.0047692364831526,0.0137214308287237,0.342678531665578
CASQ2,Calsequestrin-2,NMR metabolomics,X23440.Apolipoprotein A1,40116,-0.0104376771627386,0.00535395377743661,-0.0209314265665144,5.60722410371459e-05,0.0512580855567811
CASQ2,Calsequestrin-2,NMR metabolomics,X23441.Apolipoprotein B to Apolipoprotein A1 ratio,40116,0.00973015558602778,0.00483311893798545,0.00025724246757629,0.0192030687044793,0.0441154573992052
CASQ2,Calsequestrin-2,NMR metabolomics,X23442.Total Fatty Acids,40105,-0.00427075474557652,0.00503602327652535,-0.0141413603675662,0.00559985087641317,0.396433681742691
CASQ2,Calsequestrin-2,NMR metabolomics,X23443.Degree of Unsaturation,40105,0.00248034326962144,0.00507390124556351,-0.00746450317168305,0.0124251897109259,0.624962376114483
CASQ2,Calsequestrin-2,NMR metabolomics,X23444.Omega-3 Fatty Acids,40105,0.00237925201334244,0.00504839079274032,-0.00751559394042858,0.0122740979671135,0.637443656090011
CASQ2,Calsequestrin-2,NMR metabolomics,X23445.Omega-6 Fatty Acids,40105,-0.00499897010532372,0.00496818170917375,-0.0147366062553043,0.00473866604465683,0.314343072682122
CASQ2,Calsequestrin-2,NMR metabolomics,X23446.Polyunsaturated Fatty Acids,40105,-0.00374344416881088,0.00504019825868174,-0.0136222327558271,0.00613534441820534,0.457668635586085
CASQ2,Calsequestrin-2,NMR metabolomics,X23447.Monounsaturated Fatty Acids,40105,-0.00537523092426463,0.00515017296763408,-0.0154695699408274,0.00471910809229816,0.29664774633209
CASQ2,Calsequestrin-2,NMR metabolomics,X23448.Saturated Fatty Acids,40105,-0.00312175874262868,0.00503167783705492,-0.0129838473032563,0.00674032981799895,0.534993588886863
CASQ2,Calsequestrin-2,NMR metabolomics,X23449.Linoleic Acid,40105,-0.003758024966428,0.00486121351967514,-0.0132860034649913,0.00576995353213526,0.439501763269416
CASQ2,Calsequestrin-2,NMR metabolomics,X23450.Docosahexaenoic Acid,40105,0.00561849184532048,0.00504811180116194,-0.00427580728495692,0.0155127909755979,0.265737763442674
CASQ2,Calsequestrin-2,NMR metabolomics,X23451.Omega-3 Fatty Acids to Total Fatty Acids percentage,40105,0.00530176389695178,0.00497050209374725,-0.00444042020679284,0.0150439480006964,0.286155527918249
CASQ2,Calsequestrin-2,NMR metabolomics,X23452.Omega-6 Fatty Acids to Total Fatty Acids percentage,40105,0.000614347154538679,0.0053740551286206,-0.00991880089755771,0.0111474952066351,0.908988419269525
CASQ2,Calsequestrin-2,NMR metabolomics,X23453.Polyunsaturated Fatty Acids to Total Fatty Acids percentage,40105,0.00353700277436539,0.00529843696512361,-0.00684793367727689,0.0139219392260077,0.504431244253831
CASQ2,Calsequestrin-2,NMR metabolomics,X23454.Monounsaturated Fatty Acids to Total Fatty Acids percentage,40105,-0.00616752962697965,0.0053878924806596,-0.0167277988890725,0.00439273963511316,0.252357860634408
CASQ2,Calsequestrin-2,NMR metabolomics,X23455.Saturated Fatty Acids to Total Fatty Acids percentage,40105,0.00096027718649087,0.00487885349100232,-0.00860227565587368,0.0105228300288554,0.843968658106576
CASQ2,Calsequestrin-2,NMR metabolomics,X23456.Linoleic Acid to Total Fatty Acids percentage,40105,0.000634166759003385,0.00515095349159638,-0.00946170208452552,0.0107300356025323,0.902017206426039
CASQ2,Calsequestrin-2,NMR metabolomics,X23457.Docosahexaenoic Acid to Total Fatty Acids percentage,40105,0.00776485210604638,0.00496674691819036,-0.00196997185360672,0.0174996760656995,0.117995115079514
CASQ2,Calsequestrin-2,NMR metabolomics,X23458.Polyunsaturated Fatty Acids to Monounsaturated Fatty Acids ratio,40105,0.00476392064199915,0.00538451289769428,-0.00578972463748163,0.0153175659214799,0.376313697425382
CASQ2,Calsequestrin-2,NMR metabolomics,X23459.Omega-6 Fatty Acids to Omega-3 Fatty Acids ratio,40105,-0.00464065409170972,0.00492163514140551,-0.0142870589688645,0.00500575078544507,0.345748325578836
CASQ2,Calsequestrin-2,NMR metabolomics,X23460.Alanine,40110,-0.00937497334314102,0.00489539117946171,-0.018969940054886,0.000219993368603934,0.0555108130349791
CASQ2,Calsequestrin-2,NMR metabolomics,X23461.Glutamine,40077,0.00881672681634869,0.00488382565902403,-0.000755571475338401,0.0183890251080358,0.0710567721445593
CASQ2,Calsequestrin-2,NMR metabolomics,X23462.Glycine,40101,0.00238420636490799,0.00518806901268552,-0.00778440889995562,0.0125528216297716,0.645844366786966
CASQ2,Calsequestrin-2,NMR metabolomics,X23463.Histidine,40098,-0.00255209302565974,0.00479926846639844,-0.0119586592198007,0.00685447316848119,0.594898152156368
CASQ2,Calsequestrin-2,NMR metabolomics,X23464.Total Concentration of Branched-Chain Amino Acids (Leucine + Isoleucine + Valine),40108,-0.00443300875562307,0.0050970995407756,-0.0144233238555432,0.00555730634429711,0.384476926383102
CASQ2,Calsequestrin-2,NMR metabolomics,X23465.Isoleucine,40112,-0.00153685971344867,0.00496514464564351,-0.01126854321891,0.00819482379201262,0.756924533221893
CASQ2,Calsequestrin-2,NMR metabolomics,X23466.Leucine,40112,-0.0038927985856705,0.00501367947022306,-0.0137196103473077,0.0059340131759667,0.437508726988942
CASQ2,Calsequestrin-2,NMR metabolomics,X23467.Valine,40108,-0.00552447904061013,0.00515725040678081,-0.0156326898379005,0.00458373175668025,0.284100374310836
CASQ2,Calsequestrin-2,NMR metabolomics,X23468.Phenylalanine,40110,0.00187980140905023,0.00487120985636381,-0.00766776990942284,0.0114273727275233,0.699578019036921
CASQ2,Calsequestrin-2,NMR metabolomics,X23469.Tyrosine,40100,-0.001354826194035,0.00495856088234636,-0.0110736055234339,0.00836395313536387,0.784681810368626
CASQ2,Calsequestrin-2,NMR metabolomics,X23470.Glucose,40093,-0.0089467118989059,0.00484803306495209,-0.018448856706212,0.00055543290840019,0.0650019325679403
CASQ2,Calsequestrin-2,NMR metabolomics,X23471.Lactate,40095,0.000660842955729469,0.0048714278374266,-0.00888715560562667,0.0102088415170856,0.892095000842827
CASQ2,Calsequestrin-2,NMR metabolomics,X23472.Pyruvate,40079,-0.00543174592915947,0.00486020245435691,-0.014957742739699,0.00409425088138007,0.263763970747018
CASQ2,Calsequestrin-2,NMR metabolomics,X23473.Citrate,40113,-0.00427288149503116,0.00486425936454647,-0.0138068298495422,0.00526106685947994,0.379733068739246
CASQ2,Calsequestrin-2,NMR metabolomics,X23474.3-Hydroxybutyrate,39941,-0.00659890821779006,0.00512223003089101,-0.0166384790783364,0.00344066264275631,0.197673413849364
CASQ2,Calsequestrin-2,NMR metabolomics,X23475.Acetate,40104,0.00199465617855839,0.00480182609883626,-0.00741692297516067,0.0114062353322774,0.677860687544861
CASQ2,Calsequestrin-2,NMR metabolomics,X23476.Acetoacetate,40114,-0.00982645337908955,0.00493471834851981,-0.0194985013421884,-0.00015440541599073,0.0464739289466215
CASQ2,Calsequestrin-2,NMR metabolomics,X23477.Acetone,40114,-0.00358182009668063,0.00487906193504641,-0.0131447814893716,0.00598114129601034,0.462890973783746
CASQ2,Calsequestrin-2,NMR metabolomics,X23478.Creatinine,39855,-0.00104706442744897,0.00568177488690399,-0.0121833432057808,0.0100892143508829,0.853793586971357
CASQ2,Calsequestrin-2,NMR metabolomics,X23479.Albumin,40113,0.000127653314528027,0.00488547858097582,-0.00944788470418459,0.00970319133324064,0.979154818538575
CASQ2,Calsequestrin-2,NMR metabolomics,X23480.Glycoprotein Acetyls,40116,-0.00889967826251982,0.0051956745249836,-0.0190832003314877,0.00128384380644804,0.0867590585085047
CASQ2,Calsequestrin-2,NMR metabolomics,X23481.Concentration of Chylomicrons and Extremely Large VLDL Particles,40116,-0.00657327533891333,0.00521116027269814,-0.0167871494734017,0.00364059879557502,0.207197390579323
CASQ2,Calsequestrin-2,NMR metabolomics,X23482.Total Lipids in Chylomicrons and Extremely Large VLDL,40116,-0.00688859283360691,0.00514591273806395,-0.0169745818002123,0.00319739613299844,0.180711443460857
CASQ2,Calsequestrin-2,NMR metabolomics,X23483.Phospholipids in Chylomicrons and Extremely Large VLDL,40116,-0.00696940514815287,0.00522569780156541,-0.0172117728392211,0.00327296254291532,0.182336782689401
CASQ2,Calsequestrin-2,NMR metabolomics,X23484.Cholesterol in Chylomicrons and Extremely Large VLDL,40116,-0.0051750311242668,0.00516813187425122,-0.0153045695977992,0.00495450734926559,0.316687080022941
CASQ2,Calsequestrin-2,NMR metabolomics,X23485.Cholesteryl Esters in Chylomicrons and Extremely Large VLDL,40116,-0.00368507854477906,0.00510032510597212,-0.0136817157524844,0.0063115586629263,0.469991309656336
CASQ2,Calsequestrin-2,NMR metabolomics,X23486.Free Cholesterol in Chylomicrons and Extremely Large VLDL,40116,-0.00662235712255932,0.00521949883650464,-0.0168525748421084,0.00360786059698978,0.204549218692762
CASQ2,Calsequestrin-2,NMR metabolomics,X23487.Triglycerides in Chylomicrons and Extremely Large VLDL,40116,-0.00778451478445963,0.00510035809023006,-0.0177812166413105,0.00221218707239129,0.126972020030123
CASQ2,Calsequestrin-2,NMR metabolomics,X23488.Concentration of Very Large VLDL Particles,40116,-0.0024345480628551,0.0051894195309059,-0.0126058103434307,0.00773671421772046,0.638981166870783
CASQ2,Calsequestrin-2,NMR metabolomics,X23489.Total Lipids in Very Large VLDL,40116,-0.00233543756694316,0.00516075209920188,-0.0124505116813789,0.00777963654749253,0.650890282260643
CASQ2,Calsequestrin-2,NMR metabolomics,X23490.Phospholipids in Very Large VLDL,40116,-0.00213032787318846,0.00515080628578161,-0.0122259081933204,0.0079652524469435,0.679181679192406
CASQ2,Calsequestrin-2,NMR metabolomics,X23491.Cholesterol in Very Large VLDL,40116,-2.92059758956179e-05,0.00503453851242956,-0.00989690146025755,0.00983848950846631,0.995371505632146
CASQ2,Calsequestrin-2,NMR metabolomics,X23492.Cholesteryl Esters in Very Large VLDL,40116,0.0016182392764219,0.0049551298948486,-0.00809381531748135,0.0113302938703251,0.743992905592964
CASQ2,Calsequestrin-2,NMR metabolomics,X23493.Free Cholesterol in Very Large VLDL,40116,-0.00170725106140359,0.00511255138871072,-0.0117278517832766,0.00831334966046942,0.738436316100557
CASQ2,Calsequestrin-2,NMR metabolomics,X23494.Triglycerides in Very Large VLDL,40116,-0.0035514082157464,0.00518903660090209,-0.0137219199535145,0.00661910352202169,0.493733297470447
CASQ2,Calsequestrin-2,NMR metabolomics,X23495.Concentration of Large VLDL Particles,40116,-0.000809242026362896,0.00512737855553798,-0.0108589039952173,0.00924041994249155,0.874595540372337
CASQ2,Calsequestrin-2,NMR metabolomics,X23496.Total Lipids in Large VLDL,40116,-0.000714705984997721,0.00509609889026835,-0.0107030598099237,0.00927364783992824,0.888468446959875
CASQ2,Calsequestrin-2,NMR metabolomics,X23497.Phospholipids in Large VLDL,40116,-0.0011467813532729,0.00512424271745503,-0.0111902970794848,0.00889673437293896,0.822920785615905
CASQ2,Calsequestrin-2,NMR metabolomics,X23498.Cholesterol in Large VLDL,40116,0.000998840125191972,0.00502748974988964,-0.00885503978459171,0.0108527200349757,0.842520119172965
CASQ2,Calsequestrin-2,NMR metabolomics,X23499.Cholesteryl Esters in Large VLDL,40116,0.00235732348205114,0.00494219782163209,-0.00732938424834776,0.01204403121245,0.633386776142395
CASQ2,Calsequestrin-2,NMR metabolomics,X23500.Free Cholesterol in Large VLDL,40116,-0.000424674358618564,0.00511384618863311,-0.0104478128883395,0.00959846417110233,0.933818057319967
CASQ2,Calsequestrin-2,NMR metabolomics,X23501.Triglycerides in Large VLDL,40116,-0.00184890170457341,0.00508076955118217,-0.0118072100248905,0.00810940661574364,0.715938307972451
CASQ2,Calsequestrin-2,NMR metabolomics,X23502.Concentration of Medium VLDL Particles,40116,0.00300701816748505,0.00481603868715965,-0.00643241765934786,0.012446453994318,0.532393833984234
CASQ2,Calsequestrin-2,NMR metabolomics,X23503.Total Lipids in Medium VLDL,40116,0.00199786063674566,0.00486617089306455,-0.00753983431366085,0.0115355555871522,0.681402421856618
CASQ2,Calsequestrin-2,NMR metabolomics,X23504.Phospholipids in Medium VLDL,40116,0.00306863722927596,0.00479617540698324,-0.00633186656841119,0.0124691410269631,0.522310059967195
CASQ2,Calsequestrin-2,NMR metabolomics,X23505.Cholesterol in Medium VLDL,40116,0.00518541856331459,0.00471179719513162,-0.00404970393914338,0.0144205410657726,0.271130658773139
CASQ2,Calsequestrin-2,NMR metabolomics,X23506.Cholesteryl Esters in Medium VLDL,40116,0.00579531455373665,0.00472797112785432,-0.00347150885685782,0.0150621379643311,0.220318883180024
CASQ2,Calsequestrin-2,NMR metabolomics,X23507.Free Cholesterol in Medium VLDL,40116,0.00402694889956453,0.00476255673955554,-0.00530766230996433,0.0133615601090934,0.397825978217652
CASQ2,Calsequestrin-2,NMR metabolomics,X23508.Triglycerides in Medium VLDL,40116,-0.000594869986322395,0.00504307804206918,-0.010479302948778,0.00928956297613319,0.906103327783407
CASQ2,Calsequestrin-2,NMR metabolomics,X23509.Concentration of Small VLDL Particles,40116,0.00201829387863184,0.00496836195421982,-0.00771969555163901,0.0117562833089027,0.684582133520688
CASQ2,Calsequestrin-2,NMR metabolomics,X23510.Total Lipids in Small VLDL,40116,0.0016590251079111,0.00495426377769636,-0.00805133189637376,0.011369382112196,0.737730985379812
CASQ2,Calsequestrin-2,NMR metabolomics,X23511.Phospholipids in Small VLDL,40116,0.00324760855768186,0.00484171482541338,-0.00624215250012836,0.0127373696154921,0.502390258758171
CASQ2,Calsequestrin-2,NMR metabolomics,X23512.Cholesterol in Small VLDL,40116,0.00441262561217758,0.00479329091137945,-0.00498222457412614,0.0138074757984813,0.357288133520108
CASQ2,Calsequestrin-2,NMR metabolomics,X23513.Cholesteryl Esters in Small VLDL,40116,0.0043144175853132,0.00481568734476744,-0.005124329610431,0.0137531647810574,0.370321117036646
CASQ2,Calsequestrin-2,NMR metabolomics,X23514.Free Cholesterol in Small VLDL,40116,0.00442727615882055,0.00475981625359407,-0.00490196369822383,0.0137565160158649,0.352321262387979
CASQ2,Calsequestrin-2,NMR metabolomics,X23515.Triglycerides in Small VLDL,40116,-0.00200643846368257,0.0051353737071597,-0.0120717709297156,0.00805889400235043,0.696019715792146
CASQ2,Calsequestrin-2,NMR metabolomics,X23516.Concentration of Very Small VLDL Particles,40116,0.00292896407188629,0.0048377692929284,-0.00655306374225338,0.012410991886026,0.544901315075063
CASQ2,Calsequestrin-2,NMR metabolomics,X23517.Total Lipids in Very Small VLDL,40116,0.00229378130594493,0.00488342366829513,-0.00727772908391353,0.0118652916958034,0.638573300609135
CASQ2,Calsequestrin-2,NMR metabolomics,X23518.Phospholipids in Very Small VLDL,40116,0.00228028708504787,0.00488609249959806,-0.00729645421416434,0.0118570283842601,0.640731495237742
CASQ2,Calsequestrin-2,NMR metabolomics,X23519.Cholesterol in Very Small VLDL,40116,0.00373407875607982,0.00482176186919946,-0.00571657450755112,0.0131847320197108,0.438698006304003
CASQ2,Calsequestrin-2,NMR metabolomics,X23520.Cholesteryl Esters in Very Small VLDL,40116,0.00382060103621598,0.00482905742040711,-0.00564435150778196,0.0132855535802139,0.428862497640756
CASQ2,Calsequestrin-2,NMR metabolomics,X23521.Free Cholesterol in Very Small VLDL,40116,0.00337545678287528,0.00484513625692137,-0.00612101028069059,0.0128719238464412,0.486024718436283
CASQ2,Calsequestrin-2,NMR metabolomics,X23522.Triglycerides in Very Small VLDL,40116,-0.00166595121161642,0.00513251983531731,-0.0117256900888384,0.0083937876656055,0.745499589353973
CASQ2,Calsequestrin-2,NMR metabolomics,X23523.Concentration of IDL Particles,40116,0.00466315394613941,0.00470120106516046,-0.0045512001415751,0.0138775080338539,0.321264899034256
CASQ2,Calsequestrin-2,NMR metabolomics,X23524.Total Lipids in IDL,40116,0.00343800824794417,0.00484359684964615,-0.00605544157736228,0.0129314580732506,0.477840351013441
CASQ2,Calsequestrin-2,NMR metabolomics,X23525.Phospholipids in IDL,40116,0.00416759471905362,0.00485039633519873,-0.00533918209793588,0.0136743715360431,0.390233780311703
CASQ2,Calsequestrin-2,NMR metabolomics,X23526.Cholesterol in IDL,40116,0.00355560001457898,0.00484297632165121,-0.00593663357585738,0.0130478336050153,0.46285685777828
CASQ2,Calsequestrin-2,NMR metabolomics,X23527.Cholesteryl Esters in IDL,40116,0.00319291486750512,0.00484929148585173,-0.00631169644476427,0.0126975261797745,0.510276288588332
CASQ2,Calsequestrin-2,NMR metabolomics,X23528.Free Cholesterol in IDL,40116,0.0045670262646199,0.00482056577577263,-0.00488128265589446,0.0140153351851343,0.343453600464302
CASQ2,Calsequestrin-2,NMR metabolomics,X23529.Triglycerides in IDL,40116,-0.000811661103591006,0.00514357200662524,-0.0108930622365765,0.00926974002939447,0.874616482228122
CASQ2,Calsequestrin-2,NMR metabolomics,X23530.Concentration of Large LDL Particles,40116,0.00511010161243288,0.00471971775857531,-0.00414054519437473,0.0143607484192405,0.278959561266464
CASQ2,Calsequestrin-2,NMR metabolomics,X23531.Total Lipids in Large LDL,40116,0.00411628390767961,0.00478989059836089,-0.00527190166510774,0.0135044694804669,0.390155780251668
CASQ2,Calsequestrin-2,NMR metabolomics,X23532.Phospholipids in Large LDL,40116,0.0041154254116718,0.00475704675344859,-0.00520838622508743,0.013439237048431,0.386990876774904
CASQ2,Calsequestrin-2,NMR metabolomics,X23533.Cholesterol in Large LDL,40116,0.00444304348953707,0.00479900716500815,-0.0049630105538789,0.013849097532953,0.354557098221605
CASQ2,Calsequestrin-2,NMR metabolomics,X23534.Cholesteryl Esters in Large LDL,40116,0.00419547053419996,0.00479756173881705,-0.00520775047388145,0.0135986915422814,0.3818649318948
CASQ2,Calsequestrin-2,NMR metabolomics,X23535.Free Cholesterol in Large LDL,40116,0.00506366979423348,0.00480895694441631,-0.0043618858168225,0.0144892254052895,0.292379713225919
CASQ2,Calsequestrin-2,NMR metabolomics,X23536.Triglycerides in Large LDL,40116,-0.000485170964329652,0.00515283649160575,-0.0105847304878769,0.00961438855921762,0.924986887709562
CASQ2,Calsequestrin-2,NMR metabolomics,X23537.Concentration of Medium LDL Particles,40116,0.00383724540069403,0.00473916667543956,-0.0054515212831675,0.0131260120845556,0.418137275513085
CASQ2,Calsequestrin-2,NMR metabolomics,X23538.Total Lipids in Medium LDL,40116,0.00363850699382216,0.00477164849449042,-0.00571392405537906,0.0129909380430234,0.445762479410562
CASQ2,Calsequestrin-2,NMR metabolomics,X23539.Phospholipids in Medium LDL,40116,0.00403611276766341,0.00476026648549271,-0.00529400954390231,0.0133662350792291,0.396525955592095
CASQ2,Calsequestrin-2,NMR metabolomics,X23540.Cholesterol in Medium LDL,40116,0.00388551460665367,0.00476061946361092,-0.00544529954202373,0.0132163287553311,0.414415929125464
CASQ2,Calsequestrin-2,NMR metabolomics,X23541.Cholesteryl Esters in Medium LDL,40116,0.0033014367527318,0.00478531197465798,-0.00607777471759784,0.0126806482230614,0.490265160207304
CASQ2,Calsequestrin-2,NMR metabolomics,X23542.Free Cholesterol in Medium LDL,40116,0.00547005862372093,0.00474801416371046,-0.00383604913715157,0.0147761663845934,0.249316319083564
CASQ2,Calsequestrin-2,NMR metabolomics,X23543.Triglycerides in Medium LDL,40116,-0.00146078696126393,0.00517268280555795,-0.0115992452601575,0.00867767133762966,0.77763900361272
CASQ2,Calsequestrin-2,NMR metabolomics,X23544.Concentration of Small LDL Particles,40116,0.00374827371946657,0.00471413356809464,-0.00549142807399891,0.0129879755129321,0.426564454528643
CASQ2,Calsequestrin-2,NMR metabolomics,X23545.Total Lipids in Small LDL,40116,0.00434307230072457,0.00472440417199855,-0.00491675987639259,0.0136029044778417,0.357966998799419
CASQ2,Calsequestrin-2,NMR metabolomics,X23546.Phospholipids in Small LDL,40116,0.00614621433660045,0.00469210700456626,-0.00305031539234943,0.0153427440655503,0.19025553186502
CASQ2,Calsequestrin-2,NMR metabolomics,X23547.Cholesterol in Small LDL,40116,0.00419066056461515,0.00472075063610817,-0.00506201068215687,0.0134433318113872,0.374715969224962
CASQ2,Calsequestrin-2,NMR metabolomics,X23548.Cholesteryl Esters in Small LDL,40116,0.00298409838087856,0.00475085335845385,-0.00632757420169098,0.0122957709634481,0.52993951747173
CASQ2,Calsequestrin-2,NMR metabolomics,X23549.Free Cholesterol in Small LDL,40116,0.00732639971091084,0.00471154303264539,-0.00190822463307412,0.0165610240548958,0.119977555928762
CASQ2,Calsequestrin-2,NMR metabolomics,X23550.Triglycerides in Small LDL,40116,-0.0027555554787742,0.00518737518869006,-0.0129228108486067,0.00741169989105831,0.59528808602855
CASQ2,Calsequestrin-2,NMR metabolomics,X23551.Concentration of Very Large HDL Particles,40116,0.00132001145138742,0.00540955787168245,-0.00928272197711017,0.011922744879885,0.80722404550335
CASQ2,Calsequestrin-2,NMR metabolomics,X23552.Total Lipids in Very Large HDL,40116,0.0011837950541491,0.00543468898849867,-0.00946819536330829,0.0118357854716065,0.827571838860224
CASQ2,Calsequestrin-2,NMR metabolomics,X23553.Phospholipids in Very Large HDL,40116,0.000363366328589692,0.00546674347256257,-0.010351450877633,0.0110781835348123,0.947006039060071
CASQ2,Calsequestrin-2,NMR metabolomics,X23554.Cholesterol in Very Large HDL,40116,0.00286752273177116,0.00538006069202356,-0.00767739622459502,0.0134124416881373,0.594050808515853
CASQ2,Calsequestrin-2,NMR metabolomics,X23555.Cholesteryl Esters in Very Large HDL,40116,0.00230595114309639,0.00543955360912016,-0.00835557393077912,0.0129674762169719,0.671630417755186
CASQ2,Calsequestrin-2,NMR metabolomics,X23556.Free Cholesterol in Very Large HDL,40116,0.00505797697824218,0.00513560714639469,-0.00500781302869141,0.0151237669851758,0.324702901610664
CASQ2,Calsequestrin-2,NMR metabolomics,X23557.Triglycerides in Very Large HDL,40116,-0.0021733543609008,0.00506168737046768,-0.0120942616070174,0.00774755288521585,0.66765991400567
CASQ2,Calsequestrin-2,NMR metabolomics,X23558.Concentration of Large HDL Particles,40116,-0.0051912673145608,0.00567563855174931,-0.0163155188759894,0.00593298424686785,0.360391474197354
CASQ2,Calsequestrin-2,NMR metabolomics,X23559.Total Lipids in Large HDL,40116,-0.0062745100495977,0.00568536974109426,-0.0174178347421425,0.00486881464294705,0.269780624320054
CASQ2,Calsequestrin-2,NMR metabolomics,X23560.Phospholipids in Large HDL,40116,-0.00769445832728949,0.00568074598911039,-0.0188287204659459,0.00343980381136688,0.175611224725157
CASQ2,Calsequestrin-2,NMR metabolomics,X23561.Cholesterol in Large HDL,40116,-0.00377846041568611,0.00562948203139802,-0.0148122451972262,0.007255324365854,0.502112745308788
CASQ2,Calsequestrin-2,NMR metabolomics,X23562.Cholesteryl Esters in Large HDL,40116,-0.00353841453578614,0.00561833882790819,-0.0145503586384862,0.00747352956691392,0.528840397009497
CASQ2,Calsequestrin-2,NMR metabolomics,X23563.Free Cholesterol in Large HDL,40116,-0.00430401203800699,0.00563544980839907,-0.0153494936624692,0.00674146958645519,0.445039372835628
CASQ2,Calsequestrin-2,NMR metabolomics,X23564.Triglycerides in Large HDL,40116,-0.00668882454916577,0.00520950850827501,-0.0168994612253848,0.00352181212705326,0.19918157565703
CASQ2,Calsequestrin-2,NMR metabolomics,X23565.Concentration of Medium HDL Particles,40116,-0.011348460776956,0.00530607221412583,-0.0217483623166426,-0.000948559237269348,0.0324765254940034
CASQ2,Calsequestrin-2,NMR metabolomics,X23566.Total Lipids in Medium HDL,40116,-0.0119932527914918,0.00525922923575078,-0.0223013420935634,-0.00168516348942031,0.0226019554106343
CASQ2,Calsequestrin-2,NMR metabolomics,X23567.Phospholipids in Medium HDL,40116,-0.012539507155993,0.00522703527102728,-0.0227844962872065,-0.00229451802477955,0.0164578646573224
CASQ2,Calsequestrin-2,NMR metabolomics,X23568.Cholesterol in Medium HDL,40116,-0.0103478825402711,0.00530061964070399,-0.0207370970360509,4.13319555086916e-05,0.0509396906966794
CASQ2,Calsequestrin-2,NMR metabolomics,X23569.Cholesteryl Esters in Medium HDL,40116,-0.0102658088651636,0.00527187351162326,-0.0205986809479452,6.70632176179749e-05,0.0515268818642883
CASQ2,Calsequestrin-2,NMR metabolomics,X23570.Free Cholesterol in Medium HDL,40116,-0.010080049537609,0.00539299362775791,-0.0206503170480145,0.000490217972796539,0.0616355123210306
CASQ2,Calsequestrin-2,NMR metabolomics,X23571.Triglycerides in Medium HDL,40116,-0.00667737822958563,0.00504139019218587,-0.0165585030062699,0.00320374654709868,0.185361009331378
CASQ2,Calsequestrin-2,NMR metabolomics,X23572.Concentration of Small HDL Particles,40116,-0.00522602734281415,0.00485310414894558,-0.0147381114747475,0.00428605678911919,0.281574553615231
CASQ2,Calsequestrin-2,NMR metabolomics,X23573.Total Lipids in Small HDL,40116,-0.00776608795805119,0.00488706353413132,-0.0173447324849486,0.0018125565688462,0.112064208038168
CASQ2,Calsequestrin-2,NMR metabolomics,X23574.Phospholipids in Small HDL,40116,-0.00930796565487747,0.00491603003877167,-0.0189433845308699,0.000327453221115005,0.0583323346522094
CASQ2,Calsequestrin-2,NMR metabolomics,X23575.Cholesterol in Small HDL,40116,-0.00500733053780434,0.00485187423957022,-0.014517004047362,0.0045023429717533,0.30207601434786
CASQ2,Calsequestrin-2,NMR metabolomics,X23576.Cholesteryl Esters in Small HDL,40116,-0.00461534926966154,0.00482179726775311,-0.0140660719144576,0.00483537337513456,0.338495360627374
CASQ2,Calsequestrin-2,NMR metabolomics,X23577.Free Cholesterol in Small HDL,40116,-0.00556727467878345,0.00498002783033294,-0.015328129226236,0.00419357986866911,0.263625582202026
CASQ2,Calsequestrin-2,NMR metabolomics,X23578.Triglycerides in Small HDL,40116,-0.0034679663210121,0.00514384284045578,-0.0135498982883054,0.00661396564628122,0.50019998572217
CASQ2,Calsequestrin-2,NMR metabolomics,X23579.Phospholipids to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39706,-0.00219824866077748,0.00492612009182812,-0.0118534440407606,0.00745694671920562,0.655430615613642
CASQ2,Calsequestrin-2,NMR metabolomics,X23580.Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39706,0.00931680661243882,0.00507998087378068,-0.000639955900171321,0.019273569125049,0.0666786903480117
CASQ2,Calsequestrin-2,NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39706,0.00903286210875161,0.0050158626651504,-0.000798228714943169,0.0188639529324464,0.0717537356245669
CASQ2,Calsequestrin-2,NMR metabolomics,X23582.Free Cholesterol to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39706,0.00299218757605264,0.00510990258803243,-0.00702322149649093,0.0130075966485962,0.558179462389389
CASQ2,Calsequestrin-2,NMR metabolomics,X23583.Triglycerides to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,39706,-0.00805021055010963,0.0050385406285963,-0.0179257501821584,0.00182532908193911,0.110133885285848
CASQ2,Calsequestrin-2,NMR metabolomics,X23584.Phospholipids to Total Lipids in Very Large VLDL percentage,40019,0.00333779844457225,0.00490319288984418,-0.00627245961952234,0.0129480565086668,0.496050721202486
CASQ2,Calsequestrin-2,NMR metabolomics,X23585.Cholesterol to Total Lipids in Very Large VLDL percentage,40019,0.00856454358892835,0.00515140695368606,-0.00153221404029633,0.018661301218153,0.0964287000547563
CASQ2,Calsequestrin-2,NMR metabolomics,X23586.Cholesteryl Esters to Total Lipids in Very Large VLDL percentage,40019,0.00880883812850923,0.00516381868951867,-0.00131224650294737,0.0189299227599658,0.088059719921585
CASQ2,Calsequestrin-2,NMR metabolomics,X23587.Free Cholesterol to Total Lipids in Very Large VLDL percentage,40019,0.0075623072901473,0.00507840108804125,-0.00239135884241354,0.0175159734227082,0.136487047175676
CASQ2,Calsequestrin-2,NMR metabolomics,X23588.Triglycerides to Total Lipids in Very Large VLDL percentage,40019,-0.00913160483052238,0.0050638241726737,-0.0190567002089628,0.00079349054791808,0.0713685759739823
CASQ2,Calsequestrin-2,NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,40115,-0.00131866998702586,0.00504498695732032,-0.0112068444233737,0.00856950444932197,0.793802681203266
CASQ2,Calsequestrin-2,NMR metabolomics,X23590.Cholesterol to Total Lipids in Large VLDL percentage,40115,0.00806047498751465,0.0048830092238564,-0.0015102230912439,0.0176311730662732,0.0988247671037736
CASQ2,Calsequestrin-2,NMR metabolomics,X23591.Cholesteryl Esters to Total Lipids in Large VLDL percentage,40115,0.00845358943214963,0.00501992442722676,-0.00138546244521482,0.0182926413095141,0.092208833255125
CASQ2,Calsequestrin-2,NMR metabolomics,X23592.Free Cholesterol to Total Lipids in Large VLDL percentage,40115,0.00470589101665866,0.0048244337061544,-0.00474999904740397,0.0141617810807213,0.329369266626102
CASQ2,Calsequestrin-2,NMR metabolomics,X23593.Triglycerides to Total Lipids in Large VLDL percentage,40115,-0.00737349158293019,0.00480350688969787,-0.016788365086738,0.00204138192087764,0.124807247686205
CASQ2,Calsequestrin-2,NMR metabolomics,X23594.Phospholipids to Total Lipids in Medium VLDL percentage,40116,0.00652546116647797,0.00488774328617781,-0.00305451567443053,0.0161054380073865,0.181882485633225
CASQ2,Calsequestrin-2,NMR metabolomics,X23595.Cholesterol to Total Lipids in Medium VLDL percentage,40116,0.00693322709342144,0.00507744313456457,-0.00301856145032512,0.016885015637168,0.172125404504721
CASQ2,Calsequestrin-2,NMR metabolomics,X23596.Cholesteryl Esters to Total Lipids in Medium VLDL percentage,40116,0.00647086256756499,0.00512977512747238,-0.00358349668228089,0.0165252218174109,0.207180180900916
CASQ2,Calsequestrin-2,NMR metabolomics,X23597.Free Cholesterol to Total Lipids in Medium VLDL percentage,40116,0.00728209091684928,0.0049491567043208,-0.00241825622361948,0.016982438057318,0.141217149766904
CASQ2,Calsequestrin-2,NMR metabolomics,X23598.Triglycerides to Total Lipids in Medium VLDL percentage,40116,-0.00692982946008628,0.0050289748671673,-0.0167866201997342,0.00292696127956162,0.16823752890414
CASQ2,Calsequestrin-2,NMR metabolomics,X23599.Phospholipids to Total Lipids in Small VLDL percentage,40116,0.00634893101304337,0.00506604845468306,-0.00358052395813542,0.0162783859842222,0.210148332170455
CASQ2,Calsequestrin-2,NMR metabolomics,X23600.Cholesterol to Total Lipids in Small VLDL percentage,40116,0.00821928189764956,0.00493657330587766,-0.00145640178187066,0.0178949655771698,0.095945990708112
CASQ2,Calsequestrin-2,NMR metabolomics,X23601.Cholesteryl Esters to Total Lipids in Small VLDL percentage,40116,0.00872128341834629,0.0048411757712168,-0.000767421093238647,0.0182099879299312,0.0716547570308439
CASQ2,Calsequestrin-2,NMR metabolomics,X23602.Free Cholesterol to Total Lipids in Small VLDL percentage,40116,0.00659412469532651,0.00508542793902187,-0.00337331406515636,0.0165615634558094,0.194771956581916
CASQ2,Calsequestrin-2,NMR metabolomics,X23603.Triglycerides to Total Lipids in Small VLDL percentage,40116,-0.00774053195830368,0.00498050634544274,-0.0175023243953715,0.00202126047876409,0.120173879222123
CASQ2,Calsequestrin-2,NMR metabolomics,X23604.Phospholipids to Total Lipids in Very Small VLDL percentage,40116,0.00113882662052255,0.00494910546687276,-0.00856142009454806,0.0108390733355932,0.818012493980863
CASQ2,Calsequestrin-2,NMR metabolomics,X23605.Cholesterol to Total Lipids in Very Small VLDL percentage,40116,0.00499646008754341,0.00512263250812661,-0.00504389962838475,0.0150368198034716,0.329398552830079
CASQ2,Calsequestrin-2,NMR metabolomics,X23606.Cholesteryl Esters to Total Lipids in Very Small VLDL percentage,40116,0.00461730588080466,0.00516462661846322,-0.00550536229138325,0.0147399740529926,0.371328155908596
CASQ2,Calsequestrin-2,NMR metabolomics,X23607.Free Cholesterol to Total Lipids in Very Small VLDL percentage,40116,0.006705076407126,0.00486240479288427,-0.00282523698692717,0.0162353898011792,0.167934393402121
CASQ2,Calsequestrin-2,NMR metabolomics,X23608.Triglycerides to Total Lipids in Very Small VLDL percentage,40116,-0.0056640052268876,0.00510482200286252,-0.0156694563524981,0.00434144589872294,0.267221640978508
CASQ2,Calsequestrin-2,NMR metabolomics,X23609.Phospholipids to Total Lipids in IDL percentage,40116,0.00273874621579588,0.00468662718079537,-0.00644704305856305,0.0119245354901548,0.55898033390788
CASQ2,Calsequestrin-2,NMR metabolomics,X23610.Cholesterol to Total Lipids in IDL percentage,40116,0.00318301553183515,0.00495414183766207,-0.0065271024699825,0.0128931335336528,0.520564774154499
CASQ2,Calsequestrin-2,NMR metabolomics,X23611.Cholesteryl Esters to Total Lipids in IDL percentage,40116,0.00130331504520684,0.00496413995328511,-0.00842639926323197,0.0110330293536456,0.792905484299929
CASQ2,Calsequestrin-2,NMR metabolomics,X23612.Free Cholesterol to Total Lipids in IDL percentage,40116,0.00559359346337241,0.00474871806786209,-0.00371389394963729,0.0149010808763821,0.238855552788545
CASQ2,Calsequestrin-2,NMR metabolomics,X23613.Triglycerides to Total Lipids in IDL percentage,40116,-0.00464194253943493,0.00510726834524992,-0.0146521884961248,0.00536830341725491,0.363428515065654
CASQ2,Calsequestrin-2,NMR metabolomics,X23614.Phospholipids to Total Lipids in Large LDL percentage,40116,-0.000653696557997449,0.00474381122651184,-0.00995156656196066,0.00864417344596576,0.890401129356207
CASQ2,Calsequestrin-2,NMR metabolomics,X23615.Cholesterol to Total Lipids in Large LDL percentage,40116,0.00675294513304004,0.00514216903561576,-0.00332570617676684,0.0168315964428469,0.189126856135383
CASQ2,Calsequestrin-2,NMR metabolomics,X23616.Cholesteryl Esters to Total Lipids in Large LDL percentage,40116,0.0027008303630738,0.00476394397862643,-0.006636499835034,0.0120381605611816,0.570772307178313
CASQ2,Calsequestrin-2,NMR metabolomics,X23617.Free Cholesterol to Total Lipids in Large LDL percentage,40116,0.00571067566912785,0.00512297709608025,-0.00433035943918945,0.0157517107774452,0.264995738598035
CASQ2,Calsequestrin-2,NMR metabolomics,X23618.Triglycerides to Total Lipids in Large LDL percentage,40116,-0.00554898016736698,0.00512198978639976,-0.0155880801487105,0.00449011981397655,0.278670732100132
CASQ2,Calsequestrin-2,NMR metabolomics,X23619.Phospholipids to Total Lipids in Medium LDL percentage,40116,0.00156208941762434,0.0048401776398444,-0.00792465875647069,0.0110488375917194,0.746902952299944
CASQ2,Calsequestrin-2,NMR metabolomics,X23620.Cholesterol to Total Lipids in Medium LDL percentage,40116,0.00455013245427596,0.00472448677019493,-0.0047098616153061,0.013810126523858,0.335520868112687
CASQ2,Calsequestrin-2,NMR metabolomics,X23621.Cholesteryl Esters to Total Lipids in Medium LDL percentage,40116,-0.00118560047596588,0.00489083674454274,-0.0107716404952696,0.00840043954333789,0.808465019842512
CASQ2,Calsequestrin-2,NMR metabolomics,X23622.Free Cholesterol to Total Lipids in Medium LDL percentage,40116,0.0043528730258598,0.00523790280346217,-0.00591341646892605,0.0146191625206457,0.40597283595002
CASQ2,Calsequestrin-2,NMR metabolomics,X23623.Triglycerides to Total Lipids in Medium LDL percentage,40116,-0.00622602447341471,0.00503104502991648,-0.016086872732051,0.00363482378522158,0.215920282450222
CASQ2,Calsequestrin-2,NMR metabolomics,X23624.Phospholipids to Total Lipids in Small LDL percentage,40116,0.00589995881803096,0.00480035662370709,-0.00350874016443493,0.0153086578004969,0.219073251011363
CASQ2,Calsequestrin-2,NMR metabolomics,X23625.Cholesterol to Total Lipids in Small LDL percentage,40116,-0.000624588604789377,0.00482400978333652,-0.010079647780129,0.0088304705705502,0.896984199869964
CASQ2,Calsequestrin-2,NMR metabolomics,X23626.Cholesteryl Esters to Total Lipids in Small LDL percentage,40116,-0.00567338718120055,0.00480704451414807,-0.0150951944289308,0.00374842006652965,0.237937015057196
CASQ2,Calsequestrin-2,NMR metabolomics,X23627.Free Cholesterol to Total Lipids in Small LDL percentage,40116,0.00690944880710172,0.00512762021631935,-0.0031406868168842,0.0169595844310876,0.177848424756026
CASQ2,Calsequestrin-2,NMR metabolomics,X23628.Triglycerides to Total Lipids in Small LDL percentage,40116,-0.00696665443051609,0.00512462877553402,-0.0170109268305628,0.00307761796953059,0.174033471273538
CASQ2,Calsequestrin-2,NMR metabolomics,X23629.Phospholipids to Total Lipids in Very Large HDL percentage,40107,-0.00230250071298342,0.00533731753791461,-0.0127636430872961,0.00815864166132921,0.666188533130193
CASQ2,Calsequestrin-2,NMR metabolomics,X23630.Cholesterol to Total Lipids in Very Large HDL percentage,40107,0.00550309886038908,0.00505465791224738,-0.00440403064761579,0.0154102283683939,0.276302145705733
CASQ2,Calsequestrin-2,NMR metabolomics,X23631.Cholesteryl Esters to Total Lipids in Very Large HDL percentage,40107,0.00384153626115569,0.00491428842698696,-0.00579046905573876,0.0134735415780501,0.434403434913427
CASQ2,Calsequestrin-2,NMR metabolomics,X23632.Free Cholesterol to Total Lipids in Very Large HDL percentage,40107,0.00573385312692738,0.00560473865041977,-0.00525143462789536,0.0167191408817501,0.306313188219896
CASQ2,Calsequestrin-2,NMR metabolomics,X23633.Triglycerides to Total Lipids in Very Large HDL percentage,40107,-0.00262368291665208,0.00532587934919061,-0.0130624064410657,0.00781504060776151,0.622284624515756
CASQ2,Calsequestrin-2,NMR metabolomics,X23634.Phospholipids to Total Lipids in Large HDL percentage,40116,-0.00926220331021463,0.00520015344712105,-0.0194545040665719,0.000930097446142628,0.0749173028135277
CASQ2,Calsequestrin-2,NMR metabolomics,X23635.Cholesterol to Total Lipids in Large HDL percentage,40116,0.00397827972170203,0.00537683042613589,-0.00656030791352432,0.0145168673569284,0.459380765661236
CASQ2,Calsequestrin-2,NMR metabolomics,X23636.Cholesteryl Esters to Total Lipids in Large HDL percentage,40116,0.00317682392856756,0.00540689025671045,-0.00742068097458492,0.01377432883172,0.556845836433113
CASQ2,Calsequestrin-2,NMR metabolomics,X23637.Free Cholesterol to Total Lipids in Large HDL percentage,40116,0.00625768131972327,0.00509649657537606,-0.00373145196801382,0.0162468146074604,0.219533573344585
CASQ2,Calsequestrin-2,NMR metabolomics,X23638.Triglycerides to Total Lipids in Large HDL percentage,40116,0.00016793606273235,0.00532785063330191,-0.0102746511785394,0.0106105233040041,0.974855087404547
CASQ2,Calsequestrin-2,NMR metabolomics,X23639.Phospholipids to Total Lipids in Medium HDL percentage,40116,0.000550045337919045,0.00528221014514561,-0.00980308654656634,0.0109031772224044,0.917066774305213
CASQ2,Calsequestrin-2,NMR metabolomics,X23640.Cholesterol to Total Lipids in Medium HDL percentage,40116,-0.000227687171257901,0.00523864342682439,-0.0104954282878337,0.0100400539453179,0.965333251051314
CASQ2,Calsequestrin-2,NMR metabolomics,X23641.Cholesteryl Esters to Total Lipids in Medium HDL percentage,40116,5.19408261393885e-05,0.00519550925105053,-0.0101312573059197,0.0102351389581984,0.992023660765173
CASQ2,Calsequestrin-2,NMR metabolomics,X23642.Free Cholesterol to Total Lipids in Medium HDL percentage,40116,-0.00157484561984634,0.00552430698665677,-0.0124024873136936,0.00925279607400092,0.775591560339448
CASQ2,Calsequestrin-2,NMR metabolomics,X23643.Triglycerides to Total Lipids in Medium HDL percentage,40116,0.000227375566105337,0.00516654834439362,-0.00989905918890616,0.0103538103211168,0.964897889346533
CASQ2,Calsequestrin-2,NMR metabolomics,X23644.Phospholipids to Total Lipids in Small HDL percentage,40116,-0.0118340299049259,0.00503148994417978,-0.0216957501955183,-0.00197230961433355,0.0186907743980463
CASQ2,Calsequestrin-2,NMR metabolomics,X23645.Cholesterol to Total Lipids in Small HDL percentage,40116,0.00725444530459518,0.00502608860682544,-0.00259668836478269,0.017105578973973,0.1489483229872
CASQ2,Calsequestrin-2,NMR metabolomics,X23646.Cholesteryl Esters to Total Lipids in Small HDL percentage,40116,0.00570617057284621,0.00507717493002947,-0.00424509229001154,0.015657433435704,0.261085695371546
CASQ2,Calsequestrin-2,NMR metabolomics,X23647.Free Cholesterol to Total Lipids in Small HDL percentage,40116,0.00714141685419853,0.00504606157856258,-0.00274886383978414,0.0170316975481812,0.157024986397121
CASQ2,Calsequestrin-2,NMR metabolomics,X23648.Triglycerides to Total Lipids in Small HDL percentage,40116,0.000395286053796532,0.00521282757288136,-0.00982185598905094,0.010612428096644,0.939556143260947
CASQ2,Calsequestrin-2,Working and living environment,X24003.Nitrogen dioxide air pollution; 2010,48408,0.00284624841367336,0.00411707012553526,-0.00522320903237576,0.0109157058597225,0.489367401750396
CASQ2,Calsequestrin-2,Working and living environment,X24004.Nitrogen oxides air pollution; 2010,48408,0.000497293547223085,0.00401953366234123,-0.00738099243096572,0.00837557952541189,0.901538891707087
CASQ2,Calsequestrin-2,Working and living environment,X24005.Particulate matter air pollution (pm10); 2010,47104,-0.000491900456004529,0.00382131217962003,-0.00798167232805978,0.00699787141605072,0.897576274624378
CASQ2,Calsequestrin-2,Working and living environment,X24006.Particulate matter air pollution (pm2.5); 2010,47104,0.00388243898917885,0.00420888320734136,-0.00436697209721021,0.0121318500755679,0.356311940297496
CASQ2,Calsequestrin-2,Working and living environment,X24007.Particulate matter air pollution (pm2.5) absorbance; 2010,47104,0.00264571582061484,0.00408218853392447,-0.00535537370587713,0.0106468053471068,0.516920751023938
CASQ2,Calsequestrin-2,Working and living environment,X24008.Particulate matter air pollution 2.5-10um; 2010,47104,0.000337372975817933,0.00374687636684805,-0.00700650470320423,0.0076812506548401,0.928255538717125
CASQ2,Calsequestrin-2,Working and living environment,X24009.Traffic intensity on the nearest road,48408,-0.0566468837920862,0.0633727905967145,-0.180857553361647,0.0675637857774742,0.371403935235366
CASQ2,Calsequestrin-2,Working and living environment,X24010.Inverse distance to the nearest road,48408,0.00196146161070606,0.0036158175872167,-0.00512554086023868,0.00904846408165079,0.587503147056668
CASQ2,Calsequestrin-2,Working and living environment,X24011.Traffic intensity on the nearest major road,48408,0.00151154955057618,0.00355235309802454,-0.00545106252155193,0.00847416162270429,0.670472205319569
CASQ2,Calsequestrin-2,Working and living environment,X24012.Inverse distance to the nearest major road,48408,0.000992906489828901,0.00364851425427414,-0.00615818144854841,0.00814399442820622,0.785517336142315
CASQ2,Calsequestrin-2,Working and living environment,X24013.Total traffic load on major roads,48408,-0.00685457335875759,0.0426936007907551,-0.0905340309086375,0.0768248841911223,0.872447390497173
CASQ2,Calsequestrin-2,Working and living environment,X24015.Sum of road length of major roads within 100m,48408,-0.0106869141984588,0.0416397735109785,-0.0923008702799766,0.0709270418830591,0.797450491336689
CASQ2,Calsequestrin-2,Working and living environment,X24016.Nitrogen dioxide air pollution; 2005,48408,0.00380910856376509,0.00410185977215243,-0.00423053658965367,0.0118487537171839,0.353092721156877
CASQ2,Calsequestrin-2,Working and living environment,X24017.Nitrogen dioxide air pollution; 2006,48408,0.00389873369070965,0.00409431480327064,-0.0041261233237008,0.0119235907051201,0.340991794633252
CASQ2,Calsequestrin-2,Working and living environment,X24018.Nitrogen dioxide air pollution; 2007,48408,0.00366259864063804,0.00404704589526214,-0.00426961131407575,0.0115948085953518,0.365473840955616
CASQ2,Calsequestrin-2,Working and living environment,X24019.Particulate matter air pollution (pm10); 2007,48358,0.00233125188020561,0.00401480156063945,-0.00553775917864771,0.0102002629390589,0.561473564414078
CASQ2,Calsequestrin-2,Working and living environment,X24020.Average daytime sound level of noise pollution,48408,0.00113242598952043,0.00362668195352312,-0.00597587063938488,0.00824072261842574,0.754855066231062
CASQ2,Calsequestrin-2,Working and living environment,X24021.Average evening sound level of noise pollution,48408,0.00116061476522348,0.0036277080011009,-0.00594969291693429,0.00827092244738125,0.749024425949814
CASQ2,Calsequestrin-2,Working and living environment,X24022.Average night-time sound level of noise pollution,48408,0.00112987333737608,0.00362654859364423,-0.00597816190616662,0.00823790858091878,0.755381281782104
CASQ2,Calsequestrin-2,Working and living environment,X24023.Average 16-hour sound level of noise pollution,48408,0.00112409329178128,0.00362698265520382,-0.0059847927124182,0.00823297929598076,0.756621206970714
CASQ2,Calsequestrin-2,Working and living environment,X24024.Average 24-hour sound level of noise pollution,48408,0.00112719841625182,0.00362700725833601,-0.00598173581008675,0.0082361326425904,0.755971853947004
CASQ2,Calsequestrin-2,Health and medical history,X2405.Number of children fathered,38266,0.0423069302460875,0.0492386255902887,-0.0542007759108783,0.138814636403053,0.390240527748007
CASQ2,Calsequestrin-2,Working and living environment,"X24500.Greenspace percentage, buffer 1000m",46347,-0.00584999658409183,0.0042166362990356,-0.0141146037302016,0.00241461056201794,0.165349747358943
CASQ2,Calsequestrin-2,Working and living environment,"X24501.Domestic garden percentage, buffer 1000m",46347,0.00210065141001372,0.00379265098421354,-0.00533294451904483,0.00953424733907226,0.579672184635635
CASQ2,Calsequestrin-2,Working and living environment,"X24502.Water percentage, buffer 1000m",46347,-0.00916076525479743,0.00384851195075363,-0.0167038486782745,-0.00161768183132031,0.0173075486961082
CASQ2,Calsequestrin-2,Working and living environment,"X24503.Greenspace percentage, buffer 300m",46347,-0.0018465965565423,0.00393860901164721,-0.00956627021937084,0.00587307710628624,0.639186496535833
CASQ2,Calsequestrin-2,Working and living environment,"X24504.Domestic garden percentage, buffer 300m",46347,-0.000767230054371288,0.003806255989121,-0.00822749179304845,0.00669303168430587,0.840254667201654
CASQ2,Calsequestrin-2,Working and living environment,"X24505.Water percentage, buffer 300m",46347,-0.00747328277313328,0.00388906668975919,-0.0150958534850613,0.000149287938794733,0.054670967387865
CASQ2,Calsequestrin-2,Working and living environment,"X24506.Natural environment percentage, buffer 1000m",48533,-0.00380794807169113,0.00402406156113835,-0.0116951087315223,0.00407921258814004,0.344010126181659
CASQ2,Calsequestrin-2,Working and living environment,"X24507.Natural environment percentage, buffer 300m",48533,0.000447929491858234,0.00377526394079736,-0.00695158783210459,0.00784744681582106,0.905555053069517
CASQ2,Calsequestrin-2,Working and living environment,X24508.Distance (Euclidean) to coast,48533,0.00130005602807096,0.00355602241363444,-0.00566974790265255,0.00826985995879447,0.714672981222356
CASQ2,Calsequestrin-2,Health and medical history,X2684.Years since last breast cancer screening  or  mammogram,34554,0.0105792953194856,0.0544360572315263,-0.0961153768543059,0.117273967493277,0.845914271256765
CASQ2,Calsequestrin-2,Health and medical history,X2704.Years since last cervical smear test,37072,-0.0567795817839312,0.0462515523610258,-0.147432624411542,0.0338734608436793,0.219624291336667
CASQ2,Calsequestrin-2,Health and medical history,X2714.Age when periods started (menarche),39105,0.000425828767590681,0.0374867523203072,-0.0730482057802114,0.0738998633153928,0.990936896355149
CASQ2,Calsequestrin-2,Health and medical history,X2734.Number of live births,39412,-0.0105066468181151,0.0362667110705298,-0.0815894005163535,0.0605761068801233,0.77204782805757
CASQ2,Calsequestrin-2,Health and medical history,X2744.Birth weight of first child,37870,-0.0126611872934175,0.0387398588100218,-0.0885913105610603,0.0632689359742253,0.743807497856826
CASQ2,Calsequestrin-2,Health and medical history,X2754.Age at first live birth,36808,0.00831286254005872,0.00668630732287323,-0.0047922998127728,0.0214180248928902,0.213807885061994
CASQ2,Calsequestrin-2,Health and medical history,X2764.Age at last live birth,36783,0.0072688447237675,0.00612953527572212,-0.00474504441664786,0.0192827338641829,0.235709944586455
CASQ2,Calsequestrin-2,Health and medical history,X2794.Age started oral contraceptive pill,35877,0.00355794600349376,0.00950702839674718,-0.0150758296541307,0.0221917216611182,0.708234845098664
CASQ2,Calsequestrin-2,Health and medical history,X2804.Age when last used oral contraceptive pill,35231,0.0125069704690695,0.00729201989239197,-0.00178538852001878,0.0267993294581577,0.0863674647995641
CASQ2,Calsequestrin-2,Lifestyle factors,X2867.Age started smoking in former smokers,35137,-0.0060016253336216,0.00652032835897342,-0.0187814689172095,0.00677821824996631,0.357375877258763
CASQ2,Calsequestrin-2,Mental health,"X28735.Feeling anxious, nervous or on edge over the last 2 weeks",34989,-0.0799372346144716,0.0654186661692437,-0.208157820306189,0.048283351077246,0.221782639623664
CASQ2,Calsequestrin-2,Mental health,X28736.Not being able to stop or control worrying over the last 2 weeks,34987,-0.0998765922389161,0.0726657860131571,-0.242301532824704,0.0425483483468718,0.169350499583277
CASQ2,Calsequestrin-2,Mental health,X28737.Little interest or pleasure in doing things over the last 2 weeks,34999,-0.118642984075017,0.0772856437720552,-0.270122845868246,0.0328368777182107,0.124808087207641
CASQ2,Calsequestrin-2,Mental health,"X28738.Feeling down, depressed or hopeless over the last 2 weeks",34975,0.0072864765008174,0.070389852991326,-0.130677635362182,0.145250588363816,0.91755703807869
CASQ2,Calsequestrin-2,Mental health,X28739.Difficulty with standing for long periods,35003,0.0392509620524659,0.0526814977394937,-0.0640047735169418,0.142506697621874,0.456264627478752
CASQ2,Calsequestrin-2,Mental health,X28740.Difficulty with taking care of household responsibilities,35023,0.00589532229527528,0.0594712288209775,-0.110668286193841,0.122458930784391,0.921039272584997
CASQ2,Calsequestrin-2,Mental health,X28741.Difficulty learning a new task,34968,-0.00538610491505823,0.0690123509499035,-0.140650312776869,0.129878102946753,0.93779454824727
CASQ2,Calsequestrin-2,Mental health,X28742.Difficulty with joining in community activities,34748,-0.131123457989784,0.0793521554000891,-0.286653682573959,0.0244067665943906,0.0985045677616579
CASQ2,Calsequestrin-2,Mental health,X28743.Difficulty with being emotionally affected by health problems,34992,-0.0560449253049419,0.0629788362501104,-0.179483444355158,0.0673935937452746,0.373556022323259
CASQ2,Calsequestrin-2,Mental health,X28744.Difficulty with concentrating on doing something for ten minutes,35024,-0.0903536288142226,0.101012837630601,-0.2883387905702,0.107631532941755,0.37110383928699
CASQ2,Calsequestrin-2,Lifestyle factors,X2887.Number of cigarettes previously smoked daily,34746,0.0188668591106652,0.0566549238654123,-0.0921767916655429,0.129910509886873,0.739136605158736
CASQ2,Calsequestrin-2,Lifestyle factors,X2897.Age stopped smoking,35134,-0.00681098881809732,0.00613731946846431,-0.0188401349762874,0.00521815734009273,0.26714476707403
CASQ2,Calsequestrin-2,Mental health,X29001#0.Mental health conditions experienced by first degree blood relatives_None of the above,34406,-0.0136621732387785,0.0155988859524162,-0.0442359897055142,0.0169116432279571,0.381155815758324
CASQ2,Calsequestrin-2,Mental health,X29001#1.Mental health conditions experienced by first degree blood relatives_Depression,34406,0.0293341006586796,0.0174442331113813,-0.00485659623962763,0.0635247975569869,0.092707694458591
CASQ2,Calsequestrin-2,Mental health,X29001#3.Mental health conditions experienced by first degree blood relatives_Schizophrenia,34406,-0.0208054041606195,0.0571896555149123,-0.132897128969848,0.0912863206486086,0.716024632385488
CASQ2,Calsequestrin-2,Mental health,X29001#4.Mental health conditions experienced by first degree blood relatives_Any other type of psychosis or psychotic illness,34406,-0.106798935572269,0.0702494704818327,-0.244487897716661,0.0308900265721228,0.128501024798569
CASQ2,Calsequestrin-2,Mental health,X29001#5.Mental health conditions experienced by first degree blood relatives_A personality disorder,34406,0.033309070844578,0.0826164611960988,-0.128619193099776,0.195237334788932,0.686834432623767
CASQ2,Calsequestrin-2,Mental health,X29001#7.Mental health conditions experienced by first degree blood relatives_Attention deficit or attention deficit and hyperactivity disorder,34406,0.0735826526578438,0.0681848814142122,-0.0600597149140122,0.2072250202297,0.280564671904051
CASQ2,Calsequestrin-2,Mental health,X29001#8.Mental health conditions experienced by first degree blood relatives_An anxiety disorder,34406,0.0304650514980911,0.028562264626619,-0.0255169871700821,0.0864470901662642,0.286193362864786
CASQ2,Calsequestrin-2,Mental health,X29001#9.Mental health conditions experienced by first degree blood relatives_An eating disorder,34406,-0.025333819870623,0.0492808027190532,-0.121924193199967,0.0712565534587212,0.607224311500816
CASQ2,Calsequestrin-2,Mental health,X29002.Recent lack of interest or pleasure in doing things,34376,-0.139921088883721,0.0784487730418737,-0.293680684045793,0.0138385062783519,0.0745475092949946
CASQ2,Calsequestrin-2,Mental health,X29003.Recent feelings of depression,34365,0.0198259422785455,0.0692454801267962,-0.115895198769975,0.155547083327066,0.774649200277974
CASQ2,Calsequestrin-2,Mental health,"X29004.Trouble falling or staying asleep, or sleeping too much",34378,-0.0289713300393573,0.0548800994806763,-0.136536325021483,0.0785936649427682,0.597589760353272
CASQ2,Calsequestrin-2,Mental health,X29005.Recent feelings of tiredness or low energy,34381,0.0243497136632289,0.0534275666919204,-0.080368317052935,0.129067744379393,0.648587500260554
CASQ2,Calsequestrin-2,Mental health,X29006.Recent poor appetite or overeating,34390,0.0566026489684134,0.0828795546802583,-0.105841278204893,0.21904657614172,0.494668462260592
CASQ2,Calsequestrin-2,Mental health,X29007.Recent feelings of inadequacy,34362,0.0105490174179274,0.0786310575264023,-0.143567855333821,0.164665890169676,0.893282540954078
CASQ2,Calsequestrin-2,Mental health,X29008.Recent trouble concentrating on things,34389,-0.10695147130013,0.0827753655152162,-0.269191187709954,0.0552882451096934,0.196390797525721
CASQ2,Calsequestrin-2,Mental health,X29009.Recent changes in speed or amount of moving or speaking,34382,-0.0525026034534148,0.138276690077094,-0.323524916004519,0.21851970909769,0.704189335660272
CASQ2,Calsequestrin-2,Mental health,X29010.Recent thoughts of suicide or self-harm,34364,-0.0102681820482193,0.14921214438387,-0.302723985040604,0.282187620944165,0.945138749132306
CASQ2,Calsequestrin-2,Mental health,X29038#0.Substances taken for depression_None of options listed,35214,-0.00772260977688122,0.0309415397968736,-0.0683680277787535,0.0529228082249911,0.80291517647868
CASQ2,Calsequestrin-2,Mental health,X29038#1.Substances taken for depression_Drugs or alcohol (more than once),35214,-0.0919704497428573,0.0752038336782636,-0.239369963752254,0.0554290642665394,0.221396848945923
CASQ2,Calsequestrin-2,Mental health,X29038#2.Substances taken for depression_Medication prescribed to participant (for at least 2 weeks),35214,0.01874392282718,0.03115552053697,-0.0423208974252812,0.0798087430796412,0.547446806578367
CASQ2,Calsequestrin-2,Mental health,X29038#3.Substances taken for depression_Unprescribed medication (more than once),35214,-0.0559749085425765,0.0968284059063493,-0.245758584119021,0.133808767033868,0.563229335855936
CASQ2,Calsequestrin-2,Mental health,X29039#1.Use of specific medications_Citalopram (sometimes called Cipramil),35214,-0.0562291811966237,0.078713846906412,-0.210508321133191,0.0980499587399439,0.47503891320678
CASQ2,Calsequestrin-2,Mental health,X29039#2.Use of specific medications_Fluoxetine (Prozac or Oxactin),35214,-0.0634264750045729,0.0839625810799874,-0.227993133921348,0.101140183912202,0.450030414230543
CASQ2,Calsequestrin-2,Mental health,X29039#3.Use of specific medications_Sertraline (Lustral),35214,0.0453499512743042,0.0904565655888405,-0.131944917279823,0.222644819828432,0.61614663806722
CASQ2,Calsequestrin-2,Mental health,X29039#5.Use of specific medications_Amitriptyline (Elavil),35214,0.0389523918289768,0.0851747223245907,-0.127990063927221,0.205894847585175,0.647455130798657
CASQ2,Calsequestrin-2,Mental health,X29039#7.Use of specific medications_Other antidepressant(s),35214,0.101277167185382,0.0542789008699513,-0.00510947851972238,0.207663812890487,0.0621086827222414
CASQ2,Calsequestrin-2,Mental health,X29047#0.Activities undertaken to treat depression_None of options listed,35214,-0.0163514212303039,0.0281693184455173,-0.0715632853835178,0.03886044292291,0.561619990346138
CASQ2,Calsequestrin-2,Mental health,X29051#0.Manifestations of mania or irritability_None of options listed,35214,0.128747958502508,0.0494746087073988,0.0317777254360067,0.22571819156901,0.00928267256676026
CASQ2,Calsequestrin-2,Mental health,X29051#1.Manifestations of mania or irritability_More active than usual,35214,0.0131030970882711,0.0806531046505733,-0.144976988026852,0.171183182203395,0.870947186649256
CASQ2,Calsequestrin-2,Mental health,X29051#2.Manifestations of mania or irritability_More confident than usual,35214,0.0598830037137114,0.109638989367693,-0.155009415446967,0.27477542287439,0.584960067318409
CASQ2,Calsequestrin-2,Mental health,X29051#3.Manifestations of mania or irritability_Easily distracted,35214,-0.148136048059934,0.0776942992583327,-0.300416874606266,0.00414477848639769,0.0566131328984733
CASQ2,Calsequestrin-2,Mental health,X29051#4.Manifestations of mania or irritability_More creative or had more ideas than usual,35214,0.0549052683435353,0.115267634632236,-0.171019295535646,0.280829832222717,0.633857596523444
CASQ2,Calsequestrin-2,Mental health,X29051#5.Manifestations of mania or irritability_Neded less sleep than usual,35214,0.0267197651089622,0.109714185331565,-0.188320038140904,0.241759568358829,0.807595595201659
CASQ2,Calsequestrin-2,Mental health,X29051#6.Manifestations of mania or irritability_Thoughts were racing,35214,-0.0834538364362518,0.0617340734818153,-0.20445262046061,0.0375449475881061,0.176481197714823
CASQ2,Calsequestrin-2,Mental health,X29051#7.Manifestations of mania or irritability_More restless than usual,35214,-0.0730533482178443,0.0591210505046555,-0.188930607206969,0.0428239107712805,0.216634251095155
CASQ2,Calsequestrin-2,Mental health,X29051#8.Manifestations of mania or irritability_More talkative than usual,35214,0.00109925694018333,0.0862741282608523,-0.167998034451087,0.170196548331454,0.989834496135918
CASQ2,Calsequestrin-2,Mental health,X29058.Recent feelings or nervousness or anxiety,34301,0.0380125438184114,0.0643432315694942,-0.0881001900577972,0.16412527769462,0.554695558108514
CASQ2,Calsequestrin-2,Mental health,X29059.Recent inability to stop or control worrying,34311,0.00368439952698397,0.0666761567726558,-0.127000867747421,0.134369666801389,0.955934979268843
CASQ2,Calsequestrin-2,Mental health,X29060.Recent worrying too much about different things,34310,0.00701464883409729,0.0622565371705913,-0.115008164020262,0.129037461688456,0.910294000620453
CASQ2,Calsequestrin-2,Mental health,X29061.Recent trouble relaxing,34309,-0.00235053892477044,0.0670042556290015,-0.133678879957613,0.128977802108072,0.972016965965502
CASQ2,Calsequestrin-2,Mental health,X29062.Recent restlessness,34321,-0.0464709663820327,0.102045025270857,-0.246479215912911,0.153537283148846,0.648843170614898
CASQ2,Calsequestrin-2,Mental health,X29063.Recent easy annoyance or irritability,34295,-0.0750742408564009,0.0708305734122318,-0.213902164744375,0.0637536830315734,0.289234414286703
CASQ2,Calsequestrin-2,Mental health,X29064.Recent feelings of foreboding,34296,-0.0222620789133315,0.0778264269275263,-0.174801875691283,0.13027771786462,0.774853122136155
CASQ2,Calsequestrin-2,Mental health,X29065#1.Symptoms of panic attack_Heart was pounding or racing,35214,-0.0132894110862304,0.0356730324558528,-0.0832085546997018,0.0566297325272411,0.709508549895222
CASQ2,Calsequestrin-2,Mental health,X29065#11.Symptoms of panic attack_Felt like things weren't real or detached from self,35214,-0.0543074361722507,0.062186660397397,-0.176193290551149,0.0675784182066473,0.382535941117826
CASQ2,Calsequestrin-2,Mental health,X29065#12.Symptoms of panic attack_Afraid of losing control or 'going crazy',35214,0.0116861760192813,0.077803580347871,-0.140808841462546,0.164181193501108,0.88061106438418
CASQ2,Calsequestrin-2,Mental health,X29065#13.Symptoms of panic attack_Afraid I was going to die,35214,0.0035400629492907,0.0742967012308597,-0.142081471463194,0.149161597361776,0.961998639335678
CASQ2,Calsequestrin-2,Mental health,X29065#2.Symptoms of panic attack_Sweating,35214,-0.0138102834082423,0.0545988062711656,-0.120823943699727,0.0932033768832424,0.800322346830338
CASQ2,Calsequestrin-2,Mental health,X29065#3.Symptoms of panic attack_Trembling or shaking,35214,0.0867513821891928,0.0588328969417765,-0.0285610958166892,0.202063860195075,0.140388902888267
CASQ2,Calsequestrin-2,Mental health,X29065#6.Symptoms of panic attack_Pain or discomfort in chest,35214,-0.0504135599910905,0.0599719006653616,-0.167958485295199,0.0671313653130182,0.40059441563139
CASQ2,Calsequestrin-2,Mental health,X29065#7.Symptoms of panic attack_Nauseous or felt sick in the stomach,35214,-0.0311105460958599,0.0576721608003983,-0.144147981264641,0.0819268890729209,0.589604724378994
CASQ2,Calsequestrin-2,Mental health,X29065#9.Symptoms of panic attack_Felt hot or cold,35214,0.0232201333837198,0.0721102721696446,-0.118116000068784,0.164556266836223,0.747457301372517
CASQ2,Calsequestrin-2,Mental health,X29076.Felt loved as a child,34295,-0.00916432484272395,0.0563228953298097,-0.119557199689151,0.101228550003703,0.870752850860272
CASQ2,Calsequestrin-2,Mental health,X29077.Physically abused by family as a child,34315,-0.0793113294962824,0.0890811154326746,-0.253910315744325,0.0952876567517598,0.373332132738143
CASQ2,Calsequestrin-2,Mental health,X29078.Felt hated by family member as a child,34300,-0.0274960310676803,0.0858287953590153,-0.19572046997135,0.14072840783599,0.748709283493447
CASQ2,Calsequestrin-2,Mental health,X29079.Sexually molested as a child,34262,0.037515021456079,0.105271696407201,-0.168817503502036,0.243847546414194,0.721582981004936
CASQ2,Calsequestrin-2,Mental health,X29080.Someone to take to doctor when needed as a child,34281,-0.148575187505226,0.0716909526628692,-0.28908945472445,-0.00806092028600272,0.0382747239349835
CASQ2,Calsequestrin-2,Mental health,X29081.Stopped from seeing friends or family by partner or ex-partner as an adult,34304,0.0210171122625736,0.123764815038209,-0.221561925212315,0.263596149737463,0.865162415742833
CASQ2,Calsequestrin-2,Mental health,X29082.Belittlement by partner or ex-partner as an adult,34274,0.0420384151786193,0.0926333082308836,-0.139522868953913,0.223599699311151,0.649981140061876
CASQ2,Calsequestrin-2,Mental health,X29083.Physical violence by partner or ex-partner as an adult,34310,-0.00546319521270497,0.108679249462265,-0.218474524158744,0.207548133733334,0.959910004227052
CASQ2,Calsequestrin-2,Mental health,X29084.Sexual interference by partner or ex-partner without consent as an adult,34296,-0.198819014535547,0.171216468709144,-0.534403293205469,0.136765264134376,0.245609090028139
CASQ2,Calsequestrin-2,Mental health,X29085.Sexual intercourse by partner or ex-partner without consent as an adult,34298,-0.00214847065037523,0.138963847137628,-0.274517611040126,0.270220669739375,0.987665286209854
CASQ2,Calsequestrin-2,Mental health,X29086.Experienced a violent or sexual assault,34311,-0.0244932997242073,0.135168751564043,-0.289424052789732,0.240437453341318,0.856213580583877
CASQ2,Calsequestrin-2,Mental health,X29087.Experienced a life-threatening injury or illness,34308,-0.0840612142703678,0.065209985306496,-0.2118727854711,0.0437503569303645,0.197426851678515
CASQ2,Calsequestrin-2,Mental health,X29088.Experienced a marital separation or divorce,34309,-0.0158358620110302,0.0640710958898635,-0.141415209955163,0.109743485933102,0.804793718542437
CASQ2,Calsequestrin-2,Mental health,X29089.Experienced the death of a spouse or partner,34319,0.0102507262561664,0.0692006863594019,-0.125382619008261,0.145884071520594,0.88224567666253
CASQ2,Calsequestrin-2,Mental health,X29090.Experienced the death of a close friend or family member due to suicide,34309,-0.00620993169575367,0.0821449223256238,-0.167213979453976,0.154794116062469,0.939742467166177
CASQ2,Calsequestrin-2,Lifestyle factors,X29091.Frequency of drinking alcohol,34306,-0.0164247802484184,0.0507272322436245,-0.115850155445922,0.0830005949490857,0.746113120908782
CASQ2,Calsequestrin-2,Lifestyle factors,X29092.Amount of alcohol drunk on a typical drinking day,33681,0.0155033229612567,0.063531127430819,-0.109017686803149,0.140024332725662,0.807220920489969
CASQ2,Calsequestrin-2,Lifestyle factors,X29093.Frequency of consuming six or more units of alcohol,33702,0.0250420380537312,0.0641483663494147,-0.100688759991122,0.150772836098584,0.696276350834698
CASQ2,Calsequestrin-2,Mental health,X29104.Ever used cannabis,34308,0.114153803306197,0.0879405003661517,-0.0582095774114604,0.286517184023854,0.194318425461023
CASQ2,Calsequestrin-2,Mental health,X29108.Ever thought that life not worth living,34283,0.0228596607319944,0.0692503009488794,-0.112870929127809,0.158590250591798,0.741336505332307
CASQ2,Calsequestrin-2,Mental health,X29109.Ever contemplated self-harm,34302,0.0390047535249175,0.102584146934807,-0.162060174467303,0.240069681517138,0.70379641284399
CASQ2,Calsequestrin-2,Mental health,X29111.Ever self-harmed,34308,0.165698991716659,0.162960052541243,-0.153702711264178,0.485100694697496,0.309293159127792
CASQ2,Calsequestrin-2,Diet and food preferences,X29132.Ever had recurrent episodes of excessive overeating or binge eating,34296,-0.0456726474987148,0.110418172522395,-0.262092265642608,0.170746970645179,0.679159974994998
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#1.Actions and feelings during periods of overeating or binge eating_Eaten much more rapidly than normal,35748,0.0994817976753886,0.0868985031378811,-0.0708392684748583,0.269802863825635,0.252331953855261
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#2.Actions and feelings during periods of overeating or binge eating_Eaten until feeling uncomfortably full,35748,0.0152729041503122,0.0658781199140664,-0.113848210881258,0.144394019181882,0.816672817225628
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#3.Actions and feelings during periods of overeating or binge eating_Eaten large amounts of food when not physically hungry,35748,0.0598431352498269,0.0779219028532307,-0.0928837943425052,0.212570064842159,0.442521609580566
CASQ2,Calsequestrin-2,Diet and food preferences,X29136#4.Actions and feelings during periods of overeating or binge eating_Eaten alone because of feeling embarrassed by overeating,35748,0.120861619079828,0.116514309547613,-0.107506427633493,0.349229665793149,0.299629033087531
CASQ2,Calsequestrin-2,Diet and food preferences,X29149.Dependency of self-esteem on body shape or weight currently,34288,-0.0327295553671975,0.0595927676163993,-0.14953137989534,0.0840722691609451,0.582878380343026
CASQ2,Calsequestrin-2,Health and medical history,X29153.Pain or discomfort today,34300,0.0664829925030894,0.0530872840496263,-0.0375680842341782,0.170534069240357,0.210505701102156
CASQ2,Calsequestrin-2,Mental health,X29154.Anxiety or depression today,34300,-0.0578554141630284,0.0732447792936535,-0.201415181578589,0.0857043532525324,0.429627952591716
CASQ2,Calsequestrin-2,Mental health,X29166.Frequency of confiding in someone close,34147,0.0332616919941661,0.055366431695815,-0.0752565141296314,0.141779898117963,0.548030314355682
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#0.Sports and social activities attended in person at least once a week_None of the above,34288,-0.0175575057602475,0.0150930507591707,-0.047139885248222,0.012024873727727,0.244768747823219
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#1.Sports and social activities attended in person at least once a week_Sports club or gym or fitness class,34288,0.0157963877057,0.0155519749530254,-0.0146854832022297,0.0462782586136297,0.309812949735578
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#2.Sports and social activities attended in person at least once a week_Pub or social club,34288,0.00426109160350191,0.0193128222352269,-0.0335920399775429,0.0421142231845467,0.825385203597228
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#3.Sports and social activities attended in person at least once a week_Religious group,34288,-0.0118441492720612,0.0179400148161791,-0.0470065783117723,0.0233182797676499,0.509149924784034
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#4.Sports and social activities attended in person at least once a week_Adult education class,34288,-0.00775698552211577,0.0303897710803924,-0.0673209368396848,0.0518069657954533,0.798540410180698
CASQ2,Calsequestrin-2,Lifestyle factors,X29167#5.Sports and social activities attended in person at least once a week_Other group activity,34288,-0.00234170921147523,0.0146901656321332,-0.0311344338504562,0.0264510154275058,0.873354866849159
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#0.Sports and social activities attended virtually at least once a week_None of the above,34283,0.00401422280970039,0.015696197803061,-0.0267503248842991,0.0347787705036999,0.79815814526351
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#1.Sports and social activities attended virtually at least once a week_Sports club or gym or fitness class,34283,0.000209934021435726,0.024230137514453,-0.0472811355068921,0.0477010035497636,0.993087418924468
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#2.Sports and social activities attended virtually at least once a week_Pub or social club,34283,-0.00280825588754622,0.0350281068213253,-0.0714633452573438,0.0658468334822514,0.936104008813988
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#3.Sports and social activities attended virtually at least once a week_Religious group,34283,-0.0227479246658582,0.0280949483198539,-0.0778140233727719,0.0323181740410554,0.418161830375923
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#4.Sports and social activities attended virtually at least once a week_Adult education class,34283,0.0402540435487857,0.0468022713345238,-0.051478408266881,0.131986495364452,0.389781385682819
CASQ2,Calsequestrin-2,Lifestyle factors,X29168#5.Sports and social activities attended virtually at least once a week_Other group activity,34283,0.00228798389282237,0.0211774925870342,-0.0392199015777646,0.0437958693634093,0.913969435448162
CASQ2,Calsequestrin-2,Mental health,X29171.Frequency of feeling 'in tune' with people,34201,0.0341569377137947,0.068650080789659,-0.100397220633937,0.168711096061526,0.618822181818854
CASQ2,Calsequestrin-2,Mental health,X29172.Freuency of feeling that lacks companionship,34268,-0.133483674416977,0.0650608539808598,-0.261002948219462,-0.00596440061449177,0.0402525654756869
CASQ2,Calsequestrin-2,Mental health,X29173.Frequency of feeling left out,34235,0.0042200006295571,0.0645112493417881,-0.122222048080348,0.130662049339462,0.947846209703098
CASQ2,Calsequestrin-2,Mental health,X29174.Frequency of feeling isolated from others,34262,-0.130230490633705,0.0720946621005007,-0.271536028350686,0.0110750470832767,0.0709180188080321
CASQ2,Calsequestrin-2,Mental health,X29175.Tendency to bounce back quickly after hard times,34297,0.0685788142219452,0.0542343780597469,-0.0377205667751587,0.174878195219049,0.206112085709599
CASQ2,Calsequestrin-2,Mental health,X29176.Ability to make it through stressful events,34297,-0.0891078077364099,0.0517072709177103,-0.190454058735122,0.0122384432623023,0.0848925653997922
CASQ2,Calsequestrin-2,Mental health,X29177.Quick recovery from stressful events,34297,0.0740845155923577,0.0536437899481458,-0.0310573127060081,0.179226343890723,0.16732547546145
CASQ2,Calsequestrin-2,Mental health,X29178.Hard to snap back when something bad happens,34297,-0.0790235509808722,0.0517200468090185,-0.180394842726549,0.0223477407648041,0.126597022891159
CASQ2,Calsequestrin-2,Mental health,X29179.Comes through difficult times with little trouble,34297,0.0672718201921223,0.052961974756906,-0.0365336503314134,0.171077290715658,0.20407457138618
CASQ2,Calsequestrin-2,Mental health,X29180.Tendency to take a long time to get over setbacks,34297,-0.119892409770459,0.0520919372374708,-0.221992606755902,-0.0177922127850159,0.0214004510890583
CASQ2,Calsequestrin-2,Mental health,X29181.General happiness,34272,-0.0458864591522916,0.0541375771545754,-0.151996110375259,0.0602231920706762,0.396706425091821
CASQ2,Calsequestrin-2,Mental health,X29182.Belief that own life is meaningful,34188,0.0718787441788162,0.0549363119131738,-0.0357964271710043,0.179553915528637,0.190797466940879
CASQ2,Calsequestrin-2,Lifestyle factors,X2926.Number of unsuccessful stop-smoking attempts,34585,-0.0352521807072701,0.0533481737827108,-0.139814601321383,0.0693102399068431,0.50877233534539
CASQ2,Calsequestrin-2,Health and medical history,X2946.Father's age,30014,-0.0240286566452277,0.0305354211011708,-0.0838780820035225,0.0358207687130671,0.431561374525218
CASQ2,Calsequestrin-2,Health and medical history,X2966.Age high blood pressure diagnosed,35516,0.00308726009651807,0.00686015431675152,-0.0103586423643149,0.016533162557351,0.652705831714952
CASQ2,Calsequestrin-2,Blood and urine assays,X30000.White blood cell (leukocyte) count,48023,-0.00678192897058613,0.0038909833679077,-0.0144082563716852,0.000844398430512968,0.0813524094874376
CASQ2,Calsequestrin-2,Blood and urine assays,X30010.Red blood cell (erythrocyte) count,48024,-0.00258995444857656,0.00415469605781449,-0.010733158721893,0.00555324982473984,0.533042384891913
CASQ2,Calsequestrin-2,Blood and urine assays,X30020.Haemoglobin concentration,48024,0.00133534319522279,0.00449181480731921,-0.00746861382712286,0.0101393002175684,0.766253226447913
CASQ2,Calsequestrin-2,Blood and urine assays,X30030.Haematocrit percentage,48024,6.46470492678277e-05,0.00436597093257198,-0.00849265597857325,0.0086219500771089,0.988186290371032
CASQ2,Calsequestrin-2,Blood and urine assays,X30040.Mean corpuscular volume,48024,0.00493712237443938,0.00376634919384668,-0.00244492204550012,0.0123191667943789,0.189924115446226
CASQ2,Calsequestrin-2,Blood and urine assays,X30050.Mean corpuscular haemoglobin,48024,0.00568454348893418,0.00377586899148431,-0.00171615973437506,0.0130852467122434,0.132214206213908
CASQ2,Calsequestrin-2,Blood and urine assays,X30060.Mean corpuscular haemoglobin concentration,48024,0.00241992899525027,0.00368829049337055,-0.004809120371756,0.00964897836225655,0.511760544340002
CASQ2,Calsequestrin-2,Blood and urine assays,X30070.Red blood cell (erythrocyte) distribution width,48024,-0.00324620309127127,0.00380889786164262,-0.0107116429000908,0.00421923671754825,0.394076008377205
CASQ2,Calsequestrin-2,Blood and urine assays,X30080.Platelet count,48024,-0.0035601399273712,0.00373699612636402,-0.0108846523350447,0.00376437248030229,0.340767379888413
CASQ2,Calsequestrin-2,Blood and urine assays,X30090.Platelet crit,48024,-0.00246680181264687,0.00381332356052699,-0.00994091599127977,0.00500731236598602,0.517710864756247
CASQ2,Calsequestrin-2,Blood and urine assays,X30100.Mean platelet (thrombocyte) volume,48024,0.00209390885112476,0.00356088198034912,-0.00488541983035951,0.00907323753260902,0.556518563856456
CASQ2,Calsequestrin-2,Blood and urine assays,X30110.Platelet distribution width,48024,0.00430388387194414,0.00370791170851935,-0.00296362307675378,0.0115713908206421,0.245766485996558
CASQ2,Calsequestrin-2,Blood and urine assays,X30120.Lymphocyte count,47991,0.000816488959836145,0.0036582943213271,-0.00635376790996496,0.00798674582963725,0.823391282935026
CASQ2,Calsequestrin-2,Blood and urine assays,X30130.Monocyte count,47991,0.00540367000008544,0.00375555223165142,-0.00195721237395134,0.0127645523741222,0.150210154345956
CASQ2,Calsequestrin-2,Blood and urine assays,X30140.Neutrophill count,47991,-0.00942524221565516,0.00386098438401391,-0.0169927716083224,-0.00185771282298789,0.0146497318150677
CASQ2,Calsequestrin-2,Blood and urine assays,X30150.Eosinophill count,47991,0.00063224925704915,0.00368231780665391,-0.00658509364399251,0.00784959215809081,0.863676239817591
CASQ2,Calsequestrin-2,Blood and urine assays,X30160.Basophill count,47991,0.0318515412444882,0.0302710325996183,-0.0274796826507636,0.0911827651397401,0.292715859866713
CASQ2,Calsequestrin-2,Blood and urine assays,X30170.Nucleated red blood cell count,47991,0.0550401216325349,0.145758280765541,-0.230646108667926,0.340726351932996,0.705722879569501
CASQ2,Calsequestrin-2,Blood and urine assays,X30180.Lymphocyte percentage,47992,0.00579041201264365,0.0036469037860177,-0.00135751940795106,0.0129383434332383,0.112357186597023
CASQ2,Calsequestrin-2,Blood and urine assays,X30190.Monocyte percentage,47992,0.0118830675498921,0.00371360789962216,0.00460439606663271,0.0191617390331516,0.00137717201965545
CASQ2,Calsequestrin-2,Blood and urine assays,X30200.Neutrophill percentage,47992,-0.00851516604581551,0.00362588262831563,-0.0156218959973141,-0.00140843609431686,0.0188625624525489
CASQ2,Calsequestrin-2,Blood and urine assays,X30210.Eosinophill percentage,47992,0.00365223542969542,0.00366262142250962,-0.00352650255842345,0.0108309734178143,0.318697588175143
CASQ2,Calsequestrin-2,Blood and urine assays,X30220.Basophill percentage,47992,0.00919293251892749,0.00365172302263751,0.00203555539455798,0.016350309643297,0.0118299161739227
CASQ2,Calsequestrin-2,Blood and urine assays,X30230.Nucleated red blood cell percentage,47991,0.0551036355770622,0.145742453562948,-0.230551573406317,0.340758844560441,0.705368662333253
CASQ2,Calsequestrin-2,Blood and urine assays,X30240.Reticulocyte percentage,47678,-0.00817498449811167,0.00395332471264183,-0.0159235009348897,-0.000426468061333677,0.038665583764805
CASQ2,Calsequestrin-2,Blood and urine assays,X30250.Reticulocyte count,47678,-0.00891549162159089,0.00402561410762481,-0.0168056952725355,-0.00102528797064626,0.0267934255722053
CASQ2,Calsequestrin-2,Blood and urine assays,X30260.Mean reticulocyte volume,47678,0.00352426487724623,0.00370284869906624,-0.00373331857292361,0.0107818483274161,0.341225458624981
CASQ2,Calsequestrin-2,Blood and urine assays,X30270.Mean sphered cell volume,47678,0.00808682804574617,0.00375088757246971,0.000735088403705542,0.0154385676877868,0.0310983084373685
CASQ2,Calsequestrin-2,Blood and urine assays,X30280.Immature reticulocyte fraction,47678,-5.02130354619036e-05,0.00391156881094905,-0.00771688790492205,0.00761646183399824,0.989757929509113
CASQ2,Calsequestrin-2,Blood and urine assays,X30290.High light scatter reticulocyte percentage,47678,-0.00622584951817692,0.00403092165672587,-0.0141264559653596,0.0016747569290058,0.122478904738798
CASQ2,Calsequestrin-2,Blood and urine assays,X30300.High light scatter reticulocyte count,47678,-0.00701097625848816,0.00408145052636846,-0.0150106192901703,0.000988666773194011,0.085856084919929
CASQ2,Calsequestrin-2,Blood and urine assays,X30500.Microalbumin in urine,35820,0.00204617501475553,0.00611957778971995,-0.00994819745309558,0.0140405474826066,0.738114435224255
CASQ2,Calsequestrin-2,Blood and urine assays,X30510.Creatinine (enzymatic) in urine,48012,-0.000413594112237687,0.00407571261139,-0.00840199083056209,0.00757480260608672,0.919172306921871
CASQ2,Calsequestrin-2,Blood and urine assays,X30520.Potassium in urine,47980,-0.000545366277914944,0.00380915368391407,-0.00801130749838652,0.00692057494255663,0.886155437367921
CASQ2,Calsequestrin-2,Blood and urine assays,X30530.Sodium in urine,47964,0.00025240801531646,0.00401300496634152,-0.00761308171871292,0.00811789774934584,0.94984878831563
CASQ2,Calsequestrin-2,Blood and urine assays,X30600.Albumin,46140,-0.00447886391893718,0.00395471942830788,-0.0122301139984206,0.00327238616054625,0.257424991418307
CASQ2,Calsequestrin-2,Blood and urine assays,X30610.Alkaline phosphatase,47659,0.00880358096396379,0.00390740706178243,0.00114506312287024,0.0164620988050573,0.0242677234159116
CASQ2,Calsequestrin-2,Blood and urine assays,X30620.Alanine aminotransferase,47662,-0.00233997876624948,0.00414658183133164,-0.0104672791556595,0.00578732162316053,0.572546555749018
CASQ2,Calsequestrin-2,Blood and urine assays,X30630.Apolipoprotein A,46015,-0.00779332843534309,0.00436075765765389,-0.0163404134443447,0.000753756573658532,0.0739312332646531
CASQ2,Calsequestrin-2,Blood and urine assays,X30640.Apolipoprotein B,47577,0.00121213969959374,0.00362003840098048,-0.005883135566328,0.00830741496551548,0.737748346230043
CASQ2,Calsequestrin-2,Blood and urine assays,X30650.Aspartate aminotransferase,47605,0.00372497706865438,0.00396880885767438,-0.0040538882923874,0.0115038424296962,0.347967479587177
CASQ2,Calsequestrin-2,Blood and urine assays,X30660.Direct bilirubin,44946,-0.00550761759612732,0.00416689509225035,-0.013674731976938,0.00265949678468337,0.186268688786174
CASQ2,Calsequestrin-2,Blood and urine assays,X30670.Urea,47651,-0.00189797869030111,0.00389919161859447,-0.00954039426274628,0.00574443688214406,0.626432713416023
CASQ2,Calsequestrin-2,Blood and urine assays,X30680.Calcium,46138,-0.00214715459628953,0.0038491085206674,-0.00969140729679764,0.00539709810421858,0.576966710943274
CASQ2,Calsequestrin-2,Blood and urine assays,X30690.Cholesterol,47665,-0.000723994207290118,0.00365830063117908,-0.00789426344440112,0.00644627502982088,0.843121950446822
CASQ2,Calsequestrin-2,Blood and urine assays,X30700.Creatinine,47659,5.51699012223513e-05,0.00439707112787712,-0.0085630895094168,0.00867342931186151,0.989989367884929
CASQ2,Calsequestrin-2,Blood and urine assays,X30710.C-reactive protein,47610,-0.0017436177916198,0.00412411972931506,-0.00982689246107731,0.00633965687783772,0.672456744922233
CASQ2,Calsequestrin-2,Blood and urine assays,X30720.Cystatin C,47674,0.00242513961622044,0.0043024108040078,-0.00600758555963484,0.0108578647920757,0.572985621988503
CASQ2,Calsequestrin-2,Blood and urine assays,X30730.Gamma glutamyltransferase,47659,-0.00334153276381711,0.0041771031926843,-0.0115286550214783,0.00484558949384412,0.423741865194523
CASQ2,Calsequestrin-2,Blood and urine assays,X30740.Glucose,46126,-0.0046868983838042,0.00395553718792519,-0.0124397512721376,0.00306595450452918,0.236075380384381
CASQ2,Calsequestrin-2,Blood and urine assays,X30750.Glycated haemoglobin (HbA1c),47670,-0.00481465885722213,0.00404923508167222,-0.0127511596172997,0.00312184190285542,0.234443447421967
CASQ2,Calsequestrin-2,Blood and urine assays,X30760.HDL cholesterol,46131,-0.00470878235607586,0.00446484612196034,-0.0134598807551181,0.00404231604296641,0.291607398956875
CASQ2,Calsequestrin-2,Blood and urine assays,X30770.IGF-1,47560,-0.00289734941410785,0.00383015779437837,-0.0104044586910895,0.00460975986287376,0.44938498785322
CASQ2,Calsequestrin-2,Blood and urine assays,X30780.LDL direct,47620,0.000795905627048065,0.00358556136982914,-0.00623179465781704,0.00782360591191317,0.824335665611999
CASQ2,Calsequestrin-2,Blood and urine assays,X30790.Lipoprotein A,43905,0.000190949072691666,0.0040558620936828,-0.00775854063092661,0.00814043877630995,0.96245028615772
CASQ2,Calsequestrin-2,Blood and urine assays,X30810.Phosphate,46110,-0.00272361254798995,0.00411641305237643,-0.0107917821306477,0.00534455703466784,0.508206459628428
CASQ2,Calsequestrin-2,Blood and urine assays,X30830.SHBG,45991,0.00336816897921067,0.00476444070633719,-0.00597013480521022,0.0127064727636316,0.479614189206264
CASQ2,Calsequestrin-2,Blood and urine assays,X30840.Total bilirubin,47590,-0.00398515541911596,0.00402717021361789,-0.011878409037807,0.0039080981995751,0.322398740123849
CASQ2,Calsequestrin-2,Blood and urine assays,X30850.Testosterone,45474,0.00841259231903652,0.0062652272418735,-0.00386725307503554,0.0206924377131086,0.179373807839148
CASQ2,Calsequestrin-2,Blood and urine assays,X30860.Total protein,46126,0.00162936409811686,0.00385753106812362,-0.00593139679540544,0.00919012499163916,0.672749229516507
CASQ2,Calsequestrin-2,Blood and urine assays,X30870.Triglycerides,47656,-0.00444571634215955,0.00417374833946685,-0.0126262630875146,0.00373483040319547,0.286816750125741
CASQ2,Calsequestrin-2,Blood and urine assays,X30880.Urate,47637,0.000611536433138897,0.00454134359874728,-0.00828949702040576,0.00951256988668356,0.892882325842686
CASQ2,Calsequestrin-2,Blood and urine assays,X30890.Vitamin D,46734,-0.00334562647789871,0.00421478059432469,-0.0116065964427751,0.0049153434869777,0.427331778101801
CASQ2,Calsequestrin-2,Physical measures,X3137.Number of measurements made,46476,0.0346621104349113,0.0358247794143239,-0.0355544572171636,0.104878678086986,0.333284859293162
CASQ2,Calsequestrin-2,Physical measures,X3143.Ankle spacing width,40109,0.0014959399701055,0.00655354344802152,-0.0113490051880167,0.0143408851282277,0.819445056838858
CASQ2,Calsequestrin-2,Physical measures,"X3144.Heel Broadband ultrasound attenuation, direct entry",40109,0.0110529015161167,0.00509702124127768,0.00106273988321244,0.0210430631490209,0.0301420290178696
CASQ2,Calsequestrin-2,Physical measures,X3146.Speed of sound through heel,40109,0.00768819987480831,0.00489761107508814,-0.00191111783236444,0.0172875175819811,0.116493959927328
CASQ2,Calsequestrin-2,Physical measures,"X3147.Heel quantitative ultrasound index (QUI), direct entry",40109,0.00906049735455267,0.00495595562710736,-0.000653175674577752,0.0187741703836831,0.067546236671156
CASQ2,Calsequestrin-2,Physical measures,X3148.Heel bone mineral density (BMD),40098,0.00832329630489174,0.00496843173607469,-0.00141482989781466,0.0180614225075981,0.0939165866131153
CASQ2,Calsequestrin-2,Health and medical history,X3526.Mother's age at death,45282,0.000271935701767863,0.00382805067693299,-0.00723104362502079,0.00777491502855651,0.943368678442834
CASQ2,Calsequestrin-2,Health and medical history,X3581.Age at menopause (last menstrual period),37067,0.00517729845172235,0.00539509586415673,-0.00539708944202484,0.0157516863454695,0.337270686656414
CASQ2,Calsequestrin-2,Health and medical history,"X3761.Age hay fever, rhinitis or eczema diagnosed",32215,-0.00221331113408342,0.00862272015597681,-0.019113842639798,0.0146872203716311,0.797440486306776
CASQ2,Calsequestrin-2,Physical measures,X4100.Ankle spacing width (left),35625,-0.00298387029002961,0.00845455804457469,-0.019554804057396,0.0135870634773368,0.724152209729673
CASQ2,Calsequestrin-2,Physical measures,X4101.Heel broadband ultrasound attenuation (left),35623,0.002478677511879,0.00660316525085316,-0.0104635263797932,0.0154208814035512,0.707392361916284
CASQ2,Calsequestrin-2,Physical measures,X4103.Speed of sound through heel (left),35625,0.000218430976936281,0.0063155765675876,-0.0121600990955354,0.012596961049408,0.972410882300944
CASQ2,Calsequestrin-2,Physical measures,"X4104.Heel quantitative ultrasound index (QUI), direct entry (left)",35625,0.000991927109559907,0.00640132215091569,-0.0115546643062348,0.0135385185253547,0.876860395805754
CASQ2,Calsequestrin-2,Physical measures,X4105.Heel bone mineral density (BMD) (left),35622,0.000867173574335246,0.00639472037732439,-0.0116664783652206,0.0134008255138911,0.89213563304012
CASQ2,Calsequestrin-2,Physical measures,"X4106.Heel bone mineral density (BMD) T-score, automated (left)",35625,0.00099394824595732,0.0064013306548989,-0.0115526598376445,0.0135405563295592,0.876611659129199
CASQ2,Calsequestrin-2,Physical measures,X4119.Ankle spacing width (right),35626,-0.00863154773479446,0.0083699663126327,-0.0250366817075546,0.00777358623796564,0.302461254921522
CASQ2,Calsequestrin-2,Physical measures,X4120.Heel broadband ultrasound attenuation (right),35626,0.00236887210837604,0.00656277500256968,-0.0104941668966605,0.0152319111134126,0.718144297056936
CASQ2,Calsequestrin-2,Physical measures,X4122.Speed of sound through heel (right),35626,0.0032083255722323,0.00627007358328194,-0.0090810186510003,0.0154976697954649,0.608886487423476
CASQ2,Calsequestrin-2,Physical measures,"X4123.Heel quantitative ultrasound index (QUI), direct entry (right)",35626,0.00315441460121574,0.00636229484555768,-0.00931568329607731,0.0156245124985088,0.62005370478648
CASQ2,Calsequestrin-2,Physical measures,X4124.Heel bone mineral density (BMD) (right),35622,0.0027327687683302,0.00635639257725199,-0.00972576068308371,0.0151912982197441,0.667264989431745
CASQ2,Calsequestrin-2,Physical measures,"X4125.Heel bone mineral density (BMD) T-score, automated (right)",35626,0.00314751800944963,0.00636227149143467,-0.00932253411376232,0.0156175701326616,0.620817446755274
CASQ2,Calsequestrin-2,Physical measures,X4194.Pulse rate,35926,0.00166910230000801,0.00603989626742036,-0.0101690943841359,0.0135072989841519,0.782290668010884
CASQ2,Calsequestrin-2,Physical measures,X4195.Pulse wave reflection index,35926,-0.00350228392549681,0.00650031471605902,-0.0162429007689725,0.00923833291797888,0.5900517710438
CASQ2,Calsequestrin-2,Physical measures,X4196.Pulse wave peak to peak time,35921,-0.0039237900857299,0.0059766493423949,-0.0156380227968239,0.00779044262536411,0.511512032253097
CASQ2,Calsequestrin-2,Physical measures,X4198.Position of the pulse wave peak,35926,-0.000937922229535865,0.0063141501218923,-0.0133136564684448,0.0114378120093731,0.881918773780798
CASQ2,Calsequestrin-2,Physical measures,X4199.Position of pulse wave notch,35926,-0.00327257142058701,0.00605775243139077,-0.0151457661861129,0.0086006233449389,0.589057227262701
CASQ2,Calsequestrin-2,Physical measures,X4200.Position of the shoulder on the pulse waveform,35926,0.000564646048603203,0.00623849093043922,-0.0116627961750577,0.0127920882722641,0.927884610558401
CASQ2,Calsequestrin-2,Physical measures,X4269.Number of triplets attempted (left),35778,0.115628274913433,0.154978722787243,-0.188130021749563,0.419386571576429,0.455638965387094
CASQ2,Calsequestrin-2,Physical measures,X4270.Volume level set by participant (left),35706,0.0831533266291924,0.045538909336594,-0.00610293567053193,0.172409588928917,0.0678984389718352
CASQ2,Calsequestrin-2,Physical measures,X4276.Number of triplets attempted (right),35772,0.0476815286879741,0.143570025994148,-0.233715722260555,0.329078779636503,0.739814238829143
CASQ2,Calsequestrin-2,Physical measures,X4277.Volume level set by participant (right),35695,-0.0101524590387416,0.0472870585565137,-0.102835093809509,0.0825301757320253,0.830009154162558
CASQ2,Calsequestrin-2,Cognitive function,X4288.Time to answer,35932,-0.004983758187797,0.00719784640936709,-0.0190915371501565,0.00912402077456249,0.48871270101801
CASQ2,Calsequestrin-2,Cognitive function,X4290.Duration screen displayed,35932,-0.00355482046478869,0.0066991529875014,-0.0166851603202914,0.00957551939071405,0.595687629490137
CASQ2,Calsequestrin-2,Physical measures,X46.Hand grip strength (left),48531,0.000995718305267678,0.00529558686969849,-0.00938363195934137,0.0113750685698767,0.850856719591069
CASQ2,Calsequestrin-2,Physical measures,X47.Hand grip strength (right),48550,-0.00308948196865832,0.00526514592714842,-0.0134091679858692,0.00723020404855258,0.557358359786869
CASQ2,Calsequestrin-2,Physical measures,X48.Waist circumference,48607,0.00118728728402348,0.00798565865244715,-0.0144646036747729,0.0168391782428199,0.881809708020282
CASQ2,Calsequestrin-2,Health and medical history,X4803.Tinnitus,35847,-0.0909016004464242,0.0536910136395318,-0.196135987179906,0.0143327862870581,0.0904926827907623
CASQ2,Calsequestrin-2,Working and living environment,X4825.Noisy workplace,35921,0.0299964843986643,0.0620858715366588,-0.0916918238131869,0.151684792610515,0.629008443943077
CASQ2,Calsequestrin-2,Working and living environment,X4836.Loud music exposure frequency,35880,0.0225226185381755,0.103973844327823,-0.181266116344358,0.22631135342071,0.828512575238619
CASQ2,Calsequestrin-2,Physical measures,X49.Hip circumference,48602,0.00801652492217211,0.00648357940994238,-0.00469129072131496,0.0207243405656592,0.216311851771385
CASQ2,Calsequestrin-2,Physical measures,X50.Standing height,48589,0.00287144386681911,0.00514385739019019,-0.00721051661795367,0.0129534043515919,0.576695327016725
CASQ2,Calsequestrin-2,Health and medical history,X5057.Number of older siblings,34885,-0.0316003137720228,0.0498160326592903,-0.129239737784232,0.0660391102401861,0.525884306713004
CASQ2,Calsequestrin-2,Physical measures,X51.Seated height,48516,-0.00314002256373716,0.00482212608815645,-0.0125913896965238,0.00631134456904949,0.51494466914068
CASQ2,Calsequestrin-2,Eye measures,X5181.Ever had eye surgery,33747,0.0899271337715995,0.0933546396536059,-0.093047959949468,0.272902227492667,0.335455646368369
CASQ2,Calsequestrin-2,Eye measures,X5186.Duration visual-acuity screen displayed (right),33734,0.00410944974602556,0.00750177018000131,-0.010594019806777,0.0188129192988281,0.583857995692294
CASQ2,Calsequestrin-2,Eye measures,X5188.Duration visual-acuity screen displayed (left),33733,-0.00709724580563048,0.00774948844750882,-0.0222862431627478,0.00809175155148681,0.359802565808232
CASQ2,Calsequestrin-2,Eye measures,X5190.Duration at which refractometer first shown (right),33673,-0.00885619507564725,0.00795880116999843,-0.0244554453688442,0.00674305521754968,0.265873422967527
CASQ2,Calsequestrin-2,Eye measures,X5193.Duration at which refractometer first shown (left),33671,-0.0102742978608265,0.00804724804406792,-0.0260469040271996,0.00549830830554665,0.201757885063951
CASQ2,Calsequestrin-2,Eye measures,"X5199.logMAR, initial (right)",33720,-0.0164596981792976,0.0565909933202711,-0.127378045087029,0.0944586487284338,0.771176564695987
CASQ2,Calsequestrin-2,Eye measures,X5200.Final number of letters displayed (right),33720,0.436065822454083,0.456100381335381,-0.457890924963263,1.33002256987143,0.339085816830115
CASQ2,Calsequestrin-2,Eye measures,"X5201.logMAR, final (right)",33668,-0.00206221773084535,0.00834045111134621,-0.0184095019090839,0.0142850664473932,0.804722274870156
CASQ2,Calsequestrin-2,Eye measures,X5202.Number of rounds to result (right),33720,0.0199862136404871,0.0522264720242924,-0.082377671527126,0.1223500988081,0.701972399257304
CASQ2,Calsequestrin-2,Eye measures,"X5206.logMAR, initial (left)",33715,-0.053278557235085,0.0555986008638981,-0.162251814928325,0.0556947004581553,0.33797710042152
CASQ2,Calsequestrin-2,Eye measures,X5207.Final number of letters displayed (left),33715,0.492811168549148,0.420559115934828,-0.331484698683114,1.31710703578141,0.241339141517807
CASQ2,Calsequestrin-2,Eye measures,"X5208.logMAR, final (left)",33664,-0.00254510069244518,0.00823574347508372,-0.0186871579036093,0.0135969565187189,0.757312287964962
CASQ2,Calsequestrin-2,Eye measures,X5209.Number of rounds to result (left),33713,-0.0813129962128003,0.0522791275466568,-0.183780086204248,0.021154093778647,0.119929949104235
CASQ2,Calsequestrin-2,Eye measures,"X5254.Intra-ocular pressure, corneal-compensated (right)",33507,0.00856963968388427,0.00780363653591998,-0.0067254879265189,0.0238647672942874,0.272196031669596
CASQ2,Calsequestrin-2,Eye measures,"X5255.Intra-ocular pressure, Goldmann-correlated (right)",33507,0.0059572158007285,0.00786790170605805,-0.00946387154314527,0.0213783031446023,0.448998771502085
CASQ2,Calsequestrin-2,Eye measures,X5256.Corneal hysteresis (right),33507,-0.00877078302681476,0.00787135093957619,-0.0241986308683841,0.00665706481475457,0.265226942727642
CASQ2,Calsequestrin-2,Eye measures,X5257.Corneal resistance factor (right),33507,-0.00210485147507936,0.00792936942516733,-0.0176464155484073,0.0134367125982486,0.790675474147253
CASQ2,Calsequestrin-2,Eye measures,"X5262.Intra-ocular pressure, corneal-compensated (left)",33498,0.0154267916508247,0.00783001057539925,7.99709230422073e-05,0.0307736123786073,0.0488779270024859
CASQ2,Calsequestrin-2,Eye measures,"X5263.Intra-ocular pressure, Goldmann-correlated (left)",33498,0.00984142763048271,0.00783857895123795,-0.00552218711394368,0.0252050423749091,0.209361218030482
CASQ2,Calsequestrin-2,Eye measures,X5264.Corneal hysteresis (left),33498,-0.0138341822020788,0.00797580489732937,-0.0294667598008444,0.00179839539668678,0.082897696525054
CASQ2,Calsequestrin-2,Eye measures,X5265.Corneal resistance factor (left),33498,-0.00414702611682118,0.0079667244054456,-0.0197618059514945,0.0114677537178522,0.602711635868141
CASQ2,Calsequestrin-2,Lifestyle factors,X5364.Average weekly intake of other alcoholic drinks,33804,-0.0674441138088257,0.340436960976578,-0.734700557322919,0.599812329705268,0.842967399175607
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#1.Never eat eggs, dairy, wheat, sugar_Eggs or foods containing eggs",48560,-0.0246474506420106,0.0195999246439051,-0.0630633029440646,0.0137684016600434,0.208577733204733
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#2.Never eat eggs, dairy, wheat, sugar_Dairy products",48560,0.011862678026241,0.0209539681642406,-0.0292070995756706,0.0529324556281526,0.571311710301338
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#3.Never eat eggs, dairy, wheat, sugar_Wheat products",48560,0.0327401101984583,0.0542395192786429,-0.0735693475876818,0.139049567984598,0.546102750318423
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#4.Never eat eggs, dairy, wheat, sugar_Sugar or foods or drinks containing sugar",48560,-0.017991782550909,0.00840456972707841,-0.0344647392159827,-0.00151882588583535,0.0323095344686918
CASQ2,Calsequestrin-2,Diet and food preferences,"X6144#5.Never eat eggs, dairy, wheat, sugar_I eat all of the above",48560,0.0124755544818849,0.00791463090133502,-0.00303712208473174,0.0279882310485015,0.114981113002586
CASQ2,Calsequestrin-2,Mental health,"X6145#3.Illness, injury, bereavement, stress in last 2 years_Death of a close relative",36792,-0.00136422849707869,0.0111125082539288,-0.0231447446747792,0.0204162876806218,0.902296336155665
CASQ2,Calsequestrin-2,Mental health,"X6145#4.Illness, injury, bereavement, stress in last 2 years_Death of a spouse or partner",36792,-0.00978783077509744,0.0235031424694445,-0.0558539900152086,0.0362783284650137,0.677094157740839
CASQ2,Calsequestrin-2,Mental health,"X6145#5.Illness, injury, bereavement, stress in last 2 years_Marital separation or divorce",36792,-0.0218206373974173,0.0289365165437517,-0.0785362098231706,0.0348949350283359,0.450820632907598
CASQ2,Calsequestrin-2,Mental health,"X6145#6.Illness, injury, bereavement, stress in last 2 years_Financial difficulties",36792,0.0436076004636804,0.0158400416905504,0.0125611187502015,0.0746540821771592,0.00591925374284909
CASQ2,Calsequestrin-2,Eye measures,X6147#1.Reason for glasses or contact lenses_For short-sightedness,48621,-0.00425326714955899,0.0162165125470985,-0.0360376317418721,0.0275310974427541,0.793108349728447
CASQ2,Calsequestrin-2,Eye measures,X6147#2.Reason for glasses or contact lenses_For long-sightedness,48621,-0.00425326714955899,0.0162165125470985,-0.0360376317418721,0.0275310974427541,0.793108349728447
CASQ2,Calsequestrin-2,Eye measures,X6147#3.Reason for glasses or contact lenses_For just reading or near work as you are getting older (called 'presbyopia'),48621,-0.000719522312148582,0.0130706134387554,-0.0263379246521092,0.024898880027812,0.956100107687933
CASQ2,Calsequestrin-2,Eye measures,X6147#4.Reason for glasses or contact lenses_For 'astigmatism',48621,0.0127794488131383,0.0222424005691765,-0.0308156563024477,0.0563745539287243,0.565599969543164
CASQ2,Calsequestrin-2,Eye measures,X6147#5.Reason for glasses or contact lenses_For a 'squint' or 'turn' in an eye since childhood (called 'strabismus'),48621,-0.00983180072108304,0.056015283170396,-0.119621755735059,0.0999581542928931,0.860672911267913
CASQ2,Calsequestrin-2,Eye measures,X6147#6.Reason for glasses or contact lenses_For a 'lazy' eye or an eye with poor vision since childhood (called 'amblyopia'),48621,-0.0667390928557133,0.0367886618801137,-0.138844870140736,0.00536668442930956,0.069674481773898
CASQ2,Calsequestrin-2,Eye measures,X6147#7.Reason for glasses or contact lenses_Other eye condition,48621,-0.042689282482308,0.0582763106355781,-0.156910851328041,0.071532286363425,0.4638525457299
CASQ2,Calsequestrin-2,Health and medical history,X6149#1.Mouth or teeth dental problems_Mouth ulcers,48560,-0.0138277737149497,0.0120855787592108,-0.0375155080830028,0.0098599606531034,0.252573559680224
CASQ2,Calsequestrin-2,Health and medical history,X6149#2.Mouth or teeth dental problems_Painful gums,48560,0.0198607806103647,0.0203187954999218,-0.019964058569482,0.0596856197902114,0.328354393109335
CASQ2,Calsequestrin-2,Health and medical history,X6149#3.Mouth or teeth dental problems_Bleeding gums,48560,0.0039781360765272,0.0120658344687023,-0.0196708994821293,0.0276271716351837,0.741628312448102
CASQ2,Calsequestrin-2,Health and medical history,X6149#4.Mouth or teeth dental problems_Loose teeth,48560,0.00273788097452398,0.0169870405276614,-0.0305567184596924,0.0360324804087404,0.871957496944505
CASQ2,Calsequestrin-2,Health and medical history,X6149#5.Mouth or teeth dental problems_Toothache,48560,-0.000617962173148197,0.0206515234805175,-0.0410949481949625,0.0398590238486661,0.976128514788693
CASQ2,Calsequestrin-2,Health and medical history,X6149#6.Mouth or teeth dental problems_Dentures,48560,-0.00109913187415031,0.00810947156807669,-0.0169936961475806,0.01479543239928,0.892188874477603
CASQ2,Calsequestrin-2,Health and medical history,X6150#1.Vascular or heart problems diagnosed by doctor_Heart attack,37212,0.00520828738714588,0.0186233500686535,-0.031293478747415,0.0417100535217068,0.779742233528271
CASQ2,Calsequestrin-2,Health and medical history,X6150#2.Vascular or heart problems diagnosed by doctor_Angina,37212,0.0203214008274907,0.015981079602494,-0.0110015151933975,0.0516443168483788,0.203555273875385
CASQ2,Calsequestrin-2,Health and medical history,X6150#3.Vascular or heart problems diagnosed by doctor_Stroke,37212,-0.00931333716226381,0.0229093676884105,-0.0542156978315484,0.0355890235070207,0.684364328135952
CASQ2,Calsequestrin-2,Health and medical history,X6150#4.Vascular or heart problems diagnosed by doctor_High blood pressure,37212,0.000200683345892584,0.0179136949609437,-0.034910158777557,0.0353115254693422,0.991061933252561
CASQ2,Calsequestrin-2,Health and medical history,X6151#1.Fractured bone site(s)_Ankle,48550,-0.0250264785654066,0.0273985292206076,-0.0787275958377974,0.0286746387069842,0.361030880473006
CASQ2,Calsequestrin-2,Health and medical history,X6151#2.Fractured bone site(s)_Leg,48550,0.115997781918659,0.0437251685689291,0.0302964515235582,0.20169911231376,0.00798725175278428
CASQ2,Calsequestrin-2,Health and medical history,X6151#3.Fractured bone site(s)_Hip,48550,-0.073033848082826,0.0668867081058624,-0.204131795970316,0.0580640998046643,0.274888995430413
CASQ2,Calsequestrin-2,Health and medical history,X6151#4.Fractured bone site(s)_Spine,48550,0.00238464106267436,0.0701059671248837,-0.135023054502098,0.139792336627446,0.972865692610948
CASQ2,Calsequestrin-2,Health and medical history,X6151#5.Fractured bone site(s)_Wrist,48550,0.0478060952562758,0.0231009285221756,0.00252827535281164,0.09308391515974,0.0385176089587971
CASQ2,Calsequestrin-2,Health and medical history,X6151#6.Fractured bone site(s)_Arm,48550,-0.043124883171781,0.031977583796685,-0.105800947413284,0.0195511810697216,0.177482126776283
CASQ2,Calsequestrin-2,Health and medical history,X6151#7.Fractured bone site(s)_Other bones,48550,-0.0136295006121822,0.016839782542075,-0.0466354743946491,0.0193764731702848,0.418316200848308
CASQ2,Calsequestrin-2,Health and medical history,"X6152#5.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the leg (DVT)",34931,0.00335859328922027,0.0224336249922499,-0.0406113116955896,0.0473284982740301,0.880996736266708
CASQ2,Calsequestrin-2,Health and medical history,"X6152#6.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Emphysema or chronic bronchitis",34931,0.0168198705136587,0.0233033553523511,-0.0288547059769494,0.0624944470042667,0.470459831172692
CASQ2,Calsequestrin-2,Health and medical history,"X6152#7.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Blood clot in the lung",34931,-0.0151641007428689,0.032885249141929,-0.0796191890610496,0.0492909875753119,0.644728801655964
CASQ2,Calsequestrin-2,Health and medical history,"X6152#8.Blood clot, DVT, bronchitis, emphysema, asthma, rhinitis, eczema, allergy diagnosed by doctor_Asthma",34931,-0.00440246058224481,0.0136444754574281,-0.0311456324788038,0.0223407113143142,0.746968162763689
CASQ2,Calsequestrin-2,Health and medical history,"X6154#1.Medication for pain relief, constipation, heartburn_Aspirin",38718,0.0137608160390547,0.0106043000403924,-0.00702361204011451,0.0345452441182239,0.194434324528284
CASQ2,Calsequestrin-2,Health and medical history,"X6154#2.Medication for pain relief, constipation, heartburn_Ibuprofen",38718,-0.0133433072719042,0.0124573030335665,-0.0377596212176945,0.0110730066738862,0.284141144757075
CASQ2,Calsequestrin-2,Health and medical history,"X6154#3.Medication for pain relief, constipation, heartburn_Paracetamol",38718,-0.00422078693207056,0.0103815249227467,-0.0245685757806541,0.016127001916513,0.684335068714653
CASQ2,Calsequestrin-2,Health and medical history,"X6154#4.Medication for pain relief, constipation, heartburn_Ranitidine",38718,0.0164610131924489,0.023954521379635,-0.0304898487116356,0.0634118750965334,0.491987479830769
CASQ2,Calsequestrin-2,Health and medical history,"X6154#5.Medication for pain relief, constipation, heartburn_Omeprazole",38718,0.0104517056077421,0.0133172997591653,-0.0156502019202219,0.0365536131357061,0.432577646161092
CASQ2,Calsequestrin-2,Health and medical history,"X6154#6.Medication for pain relief, constipation, heartburn_Laxatives",38718,0.016908160020318,0.0191646155735366,-0.0206544865038139,0.0544708065444498,0.377658875313452
CASQ2,Calsequestrin-2,Health and medical history,X6155#1.Vitamin and mineral supplements_Vitamin A,48560,-0.0289699643226747,0.0226017341521218,-0.0732693632608334,0.015329434615484,0.199942729833364
CASQ2,Calsequestrin-2,Health and medical history,X6155#2.Vitamin and mineral supplements_Vitamin B,48560,0.00821220859874999,0.0170365430397634,-0.0251794157591863,0.0416038329566863,0.629786590054828
CASQ2,Calsequestrin-2,Health and medical history,X6155#3.Vitamin and mineral supplements_Vitamin C,48560,-0.0567330150379249,0.0462042900856285,-0.147293423605757,0.0338273935299071,0.219509450143751
CASQ2,Calsequestrin-2,Health and medical history,X6155#4.Vitamin and mineral supplements_Vitamin D,48560,0.0119521762550372,0.0159423619811749,-0.0192948532280655,0.04319920573814,0.453437430455237
CASQ2,Calsequestrin-2,Health and medical history,X6155#5.Vitamin and mineral supplements_Vitamin E,48560,0.00190680113632968,0.0184853253865989,-0.0343244366214042,0.0381380388940636,0.917843280688987
CASQ2,Calsequestrin-2,Health and medical history,X6155#6.Vitamin and mineral supplements_Folic acid or Folate (Vit B9),48560,-0.0502877985773797,0.0225779775883234,-0.0945406346504936,-0.00603496250426581,0.0259390654839812
CASQ2,Calsequestrin-2,Health and medical history,X6155#7.Vitamin and mineral supplements_Multivitamins + or - minerals,48560,-0.00731450718255144,0.00758072669994562,-0.0221727315144449,0.00754371714934197,0.334615937166507
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#1.Why stopped smoking_Illness or ill health,33990,-0.023324079737539,0.018811231373113,-0.0601940932288405,0.0135459337537625,0.215072364908245
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#2.Why stopped smoking_Doctor's advice,33990,-0.00330450790179612,0.0232953927632655,-0.0489634777177965,0.0423544619142042,0.887202532222239
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#3.Why stopped smoking_Health precaution,33990,-0.0028013695081987,0.0161544307268456,-0.0344640537328161,0.0288613147164187,0.862335038167993
CASQ2,Calsequestrin-2,Lifestyle factors,X6157#4.Why stopped smoking_Financial reasons,33990,0.0157011554218024,0.0151003566417684,-0.0138955435960638,0.0452978544396685,0.298491246953989
CASQ2,Calsequestrin-2,Health and medical history,X6159#1.Pain type(s) experienced in last month_Headache,48637,0.0101626212003141,0.0100967174973538,-0.00962694509449935,0.0299521874951275,0.314174540650622
CASQ2,Calsequestrin-2,Health and medical history,X6159#2.Pain type(s) experienced in last month_Facial pain,48637,-0.0237199867330125,0.0281087146387078,-0.0788130674248797,0.0313730939588547,0.398754708305623
CASQ2,Calsequestrin-2,Health and medical history,X6159#3.Pain type(s) experienced in last month_Neck or shoulder pain,48637,-0.00274514659526462,0.00843935226948813,-0.0192862770434613,0.0137959838529321,0.744973196323391
CASQ2,Calsequestrin-2,Health and medical history,X6159#4.Pain type(s) experienced in last month_Back pain,48637,0.00170843043920225,0.00811948735214816,-0.0142057647710082,0.0176226256494127,0.833349018166982
CASQ2,Calsequestrin-2,Health and medical history,X6159#5.Pain type(s) experienced in last month_Stomach or abdominal pain,48637,-0.0225331869064885,0.0137842993546742,-0.0495504136416499,0.00448403982867289,0.102128251564854
CASQ2,Calsequestrin-2,Health and medical history,X6159#6.Pain type(s) experienced in last month_Hip pain,48637,-0.0163963206070946,0.0103195128256112,-0.0366225657452925,0.00382992453110331,0.112106962125114
CASQ2,Calsequestrin-2,Health and medical history,X6159#7.Pain type(s) experienced in last month_Knee pain,48637,-0.000423743025054043,0.00845769676397258,-0.0170008286824403,0.0161533426323322,0.960042044439213
CASQ2,Calsequestrin-2,Health and medical history,X6159#8.Pain type(s) experienced in last month_Pain all over the body,48637,0.0448776743436872,0.0261063367323589,-0.00629074565173626,0.0960460943391107,0.0856241410861444
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#1.Leisure or social activities_Sports club or gym,43042,0.0109338771205811,0.00890422255097809,-0.00651839907933601,0.0283861533204981,0.219489263514655
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#2.Leisure or social activities_Pub or social club,43042,-0.00102802827434578,0.00925936400707255,-0.019176381728208,0.0171203251795164,0.911597498657185
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#3.Leisure or social activities_Religious group,43042,0.00342138341975046,0.00980883558485146,-0.0158039343265584,0.0226467011660593,0.72724005379607
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#4.Leisure or social activities_Adult education class,43042,0.00309757086149005,0.013278815973626,-0.0229289084468169,0.029124050169797,0.815553945606127
CASQ2,Calsequestrin-2,Lifestyle factors,X6160#5.Leisure or social activities_Other group activity,43042,-0.00469334390315788,0.00891981308987814,-0.022176177559319,0.0127894897530033,0.598778066739957
CASQ2,Calsequestrin-2,Physical activities,X6162#1.Types of transport used (excluding work)_Car or motor vehicle,48454,-0.00198407197711114,0.00887798977378076,-0.0193849319337214,0.0154167879794991,0.823162667529495
CASQ2,Calsequestrin-2,Physical activities,X6162#2.Types of transport used (excluding work)_Walk,48454,-0.00451044428065793,0.0072247950531704,-0.0186710425848719,0.00965015402355605,0.532437548793389
CASQ2,Calsequestrin-2,Physical activities,X6162#3.Types of transport used (excluding work)_Public transport,48454,0.00580522484170998,0.00747378371272862,-0.00884339123523813,0.0204538409186581,0.437318714700608
CASQ2,Calsequestrin-2,Physical activities,X6162#4.Types of transport used (excluding work)_Cycle,48454,-0.0139861473056397,0.0162468370201112,-0.0458299478650575,0.0178576532537782,0.389329424207132
CASQ2,Calsequestrin-2,Physical activities,X6164#1.Types of physical activity in last 4 weeks_Walking for pleasure (not as a means of transport),48468,0.00159981214308665,0.00804228029596171,-0.0141630572369983,0.0173626815231716,0.842323362058516
CASQ2,Calsequestrin-2,Physical activities,X6164#3.Types of physical activity in last 4 weeks_Strenuous sports,48468,0.0257606132365877,0.0158279740718329,-0.00526221594420479,0.0567834424173801,0.103639445236856
CASQ2,Calsequestrin-2,Health and medical history,X6179#1.Mineral and other dietary supplements_Fish oil (including cod liver oil),48560,-0.00179931774527044,0.00731750808991751,-0.0161416336015088,0.0125429981109679,0.805768332000417
CASQ2,Calsequestrin-2,Health and medical history,X6179#2.Mineral and other dietary supplements_Glucosamine,48560,0.00722787239367733,0.00834825326517362,-0.00913470400606296,0.0235904487934176,0.386613549785409
CASQ2,Calsequestrin-2,Health and medical history,X6179#3.Mineral and other dietary supplements_Calcium,48560,0.0063254875076522,0.0126727590943024,-0.0185131203171805,0.0311640953324849,0.617686066626707
CASQ2,Calsequestrin-2,Health and medical history,X6179#4.Mineral and other dietary supplements_Zinc,48560,-0.00596844846601064,0.0175827450914548,-0.040430628845262,0.0284937319132407,0.734275053367569
CASQ2,Calsequestrin-2,Health and medical history,X6179#5.Mineral and other dietary supplements_Iron,48560,-0.00350821600393855,0.0223823603175913,-0.0473776422264175,0.0403612102185404,0.875451224430671
CASQ2,Calsequestrin-2,Health and medical history,X6179#6.Mineral and other dietary supplements_Selenium,48560,-0.0226091608947589,0.0207140928398151,-0.0632087828607965,0.0179904610712786,0.275072273823343
CASQ2,Calsequestrin-2,Physical measures,"X78.Heel bone mineral density (BMD) T-score, automated",40109,0.00906043060804766,0.00495592991594008,-0.000653192027194893,0.0187740532432902,0.0675468343228566
CASQ2,Calsequestrin-2,Physical activities,X864.Number of days or week walked 10+ minutes,48162,-0.00445026595854466,0.0269082625439198,-0.0571904605446274,0.0482899286275381,0.868641465967689
CASQ2,Calsequestrin-2,Physical activities,X874.Duration of walks,45568,-0.00518354290244465,0.00402431573268538,-0.013071201738508,0.00270411593361868,0.19774476937694
CASQ2,Calsequestrin-2,Physical activities,X884.Number of days or week of moderate physical activity 10+ minutes,47357,-0.019133161500099,0.0264054265109599,-0.0708877974615803,0.0326214744613823,0.468711688830028
CASQ2,Calsequestrin-2,Physical activities,X894.Duration of moderate activity,43289,0.0160790415794887,0.0321521016574216,-0.0469390776690577,0.0790971608280351,0.61701738934029
CASQ2,Calsequestrin-2,Physical activities,X90087.No-wear time bias adjusted average acceleration,32806,-0.00754515126112074,0.00959315920722054,-0.026347743307273,0.0112574407850315,0.431618186083626
CASQ2,Calsequestrin-2,Physical activities,X904.Number of days or week of vigorous physical activity 10+ minutes,47300,0.0244229422933455,0.0274111127173753,-0.0293028386327101,0.0781487232194012,0.372948042405456
CASQ2,Calsequestrin-2,Physical activities,X914.Duration of vigorous activity,38655,0.000197544687024043,0.00492032102314769,-0.00944628451834543,0.00984137389239352,0.967975391745753
